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ABSTRACT 
Iron sulfur (FeS) clusters are ubiquitous metallocofactors required by a large 
number of proteins involved in myriad cellular processes.  Nuclear and cytosolic FeS 
proteins depend on the cytosolic iron sulfur cluster assembly (CIA) pathway for cluster 
acquisition.  The CIA pathway begins with a scaffolding complex, comprising Nbp35 and 
Cfd1 in Saccharomyces cerevisiae.  Nbp35 and Cfd1 each harbor a deviant Walker A 
domain for nucleotide hydrolysis that is essential for their FeS cluster scaffolding activity.  
Since there is little information about the CIA scaffold’s nucleotide hydrolysis activity, it 
has been challenging to discern the role nucleotide is playing in FeS cluster biogenesis.  
This thesis investigates the nucleotide driven steps of FeS cluster assembly and transfer, 
and the individual roles of the scaffold subunits Nbp35 and Cfd1. 
First addressed was answering the question of why two different scaffold subunits 
are needed for CIA function, and identifying the scaffold’s quaternary structure.  Size 
exclusion chromatography revealed that the CIA scaffold exists as homodimers and 
heterodimers.  Only Nbp352 and Nbp35-Cfd1 exhibited detectable ATPase activity.  
Though Cfd12 did not have detectable ATPase activity, it bound nucleotide with an affinity 
 
 ix 
comparable to Nbp352 and Nbp35-Cfd1.  Site directed mutagenesis and nucleotide binding 
studies revealed that the Cfd1 subunit is the high affinity binding site for ATP in Nbp35-
Cfd1, and that the Nbp35 subunit binds nucleotide at saturating concentrations.  Cfd1 
therefore controls nucleotide binding in Nbp35-Cfd1.  Additionally, it was found that the 
Cfd1 subunit is hydrolysis competent when complexed with Nbp35, identifying Nbp35 as 
an activator of Nbp35-Cfd1’s ATPase activity.   
Next, ATP’s role in FeS cluster biogenesis by CIA was identified.  Mutation of the 
ATPase domain of Nbp35 impaired the ability of the scaffold to assemble and transfer FeS 
clusters in vivo.  Four phenotypes were identified by observing how each mutation affected 
the scaffold’s nucleotide binding and hydrolysis.  In vitro experiments established that 
cluster occupancy of the bridging cluster site of Nbp35-Cfd1 decreased the scaffold’s 
affinity for nucleotide.  These results support a model of FeS cluster biogenesis in which 
nucleotide binding and FeS cluster binding regulate one other, with the bridging cluster 
site translating information to the ATPase site and vice versa.  Nucleotide binding is also 
proposed to drive a conformational change that mediates interaction with another CIA 
component, later identified as Dre2.  Dre2 was found to stimulate the rate of ATP 
hydrolysis by Nbp35-Cfd1 in an FeS cluster dependent manner.  It is likely that nucleotide 
hydrolysis is then needed for the scaffold to assemble and/or transfer the FeS cluster.  The 
results of these experiments have allowed us to describe the critical role of nucleotide in 
FeS biogenesis by CIA and explain the requirement for two distinct scaffold subunits.   
Finally, a fluorescent [Fe4S4] cluster sensor based on bacterial FNR (fumarate and 
nitrate reductase transcription factor) was designed, developed, and tested for practicality.  
 
 x 
FNR was fused to a SNAP tag protein which was then covalently labeled with a fluorescent 
molecule.  The loss of cluster by the sensor resulted in an increase in fluorescence intensity, 
due to the cluster’s ability to quench fluorescence.  As such, cluster decay rates could be 
measured as a function of increasing fluorescence intensity.  The rates observed via 
fluorescence followed the same trends as the rates obtained by measuring the decay of 
clusters via absorbance.  Encouragingly, the rates observed for the cluster decay were 
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CHAPTER 1: Introduction to Iron-Sulfur Clusters, the CIA Pathway, and the CIA 
Scaffolding Complex 
1.1 Iron-Sulfur Clusters Overview 
1.1.1 Ancient and Essential Protein Cofactors 
Iron is an essential and incredibly versatile transition metal.  It is a component of 
many critical protein cofactors including heme, diferic centers, and iron-sulfur (FeS) 
clusters.  FeS clusters are one of the most ubiquitous iron cofactors and are an essential 
component of FeS proteins.  FeS proteins are involved in myriad processes, most notably 
those required for redox reactions of the electron transport machineries within the 
mitochondria and chloroplasts, DNA replication and repair in the nucleus, and protein 
biosynthesis within the cytosol.1-3  The most common types of FeS clusters are [Fe2S2], 
[Fe3S4], and [Fe4S4] (Figure 1.1) yet many other forms exist such as the iron-molybdenum 
cofactor of nitrogenase (Fe7MoS9C).
4, 5  Given the wide variety of FeS proteins required 
for biological functions in different cellular compartments, organisms have come to rely 
on many complex systems for the biosynthesis of FeS clusters.  
 
Figure 1.1. Common FeS Cluster Types 
The most common FeS cluster forms are rhombic [Fe2S2] (left), [Fe3S4] (middle), and cubic 
[Fe4S4] (right).  Dotted lines represent point of ligation to proteins.  FeS clusters are 
typically ligated to proteins via cysteine residues. 
 
 
FeS clusters are assembled on specialized proteins and then inserted into FeS 




protein via four cysteine residues (dotted lines in Figure 1.1).  However, FeS cluster 
proteins can employ a variety of other cluster ligands.  These ligands range from the three 
cysteine and one histidine residues of mitoNEET,6, 7 to the histidine ligand of IbaG in the 
IbaG-Grx4 complex,8 to even small molecules like glutathione (GSH).9  In vivo assembly 
of FeS clusters requires a host of cellular components that are necessary for numerous 
tasks.  These tasks include creating sulfide ions, sequestering and supplying iron, protecting 
clusters from oxidation, providing reducing equivalents, and bringing all the FeS cluster 
biogenesis components together.  Given the great importance, relative fragility, and 
scarcity of bioavailable precursors, biosynthetic pathways have evolved to generate, 
protect, and traffic these cofactors to FeS proteins.10-12 
1.2 Iron-Sulfur Cluster Biogenesis  
1.2.1 Cluster Biogenesis Systems and Pathways 
 FeS cluster biogenesis systems include the ISC (iron sulfur cluster), SUF (sulfur 
utilization factor), NIF (nitrogen fixation), and CIA (cytosolic iron-sulfur cluster assembly) 
systems.3, 11-16  Most organisms rely on one or more of these systems for their FeS cluster 
needs.  The ISC and SUF pathways are the major FeS cluster production systems in 
bacteria.11, 12, 15, 17  In eukaryotes, homologs of the bacterial ISC system are found in the 
mitochondria while homologs of the bacterial SUF system are localized to the 
chloroplasts.18-20  NIF is a dedicated pathway for the maturation of the iron and sulfur 
containing metallocofactors of nitrogenase, including FeS clusters.21  The NIF pathway 
was key in the original identification of the ISC pathway, as the two systems are 




extramitochondrial FeS clusters.23, 24  Components of the ISC, SUF, and NIF pathways are 
not universally conserved in archaea.  However, homologs of CIA components are 
conserved in some archaea.20, 25  Therefore, FeS cluster biogenesis is prevalent throughout 
all domains of life.  
 
Figure 1.2. General Schematic for De Novo Assembly of FeS Clusters 
Sulfide is obtained from cysteine via cysteine desulfurase (orange).  An FeS cluster is 
assembled on the scaffold (blue) from this sulfide along with iron and reducing equivalents.  
The scaffold transfers this FeS cluster to an FeS cluster carrier (green).  The carrier protein 
transfers the FeS cluster to an apo-FeS protein (light brown) to form a holo-FeS protein 
(dark brown).  Figure adapted from Ref. 11.  
 
 
The multiple pathways of FeS cluster biogenesis are complex but they are generally 
thought of as occurring in two major steps.  First, an FeS cluster is assembled on a scaffold 
protein.  During de novo assembly, sulfide is provided via a cysteine desulfurase while the 
iron and reductants are supplied by unidentified sources (Figure 1.2).  Once a nascent 
cluster has been assembled, it is transferred from the scaffold to the apo-enzyme active site 
in the second step of FeS biogenesis, called the transfer step.  This second major step 




scaffold to an apo protein target.  This generalized scheme is common to all FeS cluster 
biogenesis pathways and is helpful for simplifying the complex steps that are involved. 
1.2.2 A Scaffold for FeS Cluster Assembly 
 The assembly of the FeS clusters occurs on scaffold proteins and at least three 
different types of scaffolds are known.  The scaffolds of the bacterial and mitochondrial 
ISC pathways are called ‘U-type scaffolds’.  A prototypical U-type scaffold is NifU, the 
scaffold for the NIF pathway.21, 26, 27  NifU contains two FeS cluster binding domains, a C-
terminal domain that can bind a [Fe4S4] cluster and an N-terminal domain that can either 
bind a [Fe2S2] cluster or a [Fe4S4] cluster.
28  IscU is the U-type scaffold for the bacterial 
ISC pathway.12, 29  IscU forms a homodimer that assembles two [Fe2S2] clusters.
12, 30  The 
two [Fe2S2] clusters can be reductively coupled to form a [Fe4S4] cluster at the dimer 
interface.30  However, recent evidence supports that the form of IscU that ligates a single 
[Fe2S2] cluster is the physiologically relevant form.
12  The mitochondrial ISC pathway also 
relies on a U-type scaffold, Isu1.  Isu1 is proposed to build a [Fe2S2] cluster which is 
released to Grx5 via a Jac1/Ssq1 complex for further maturation into a [Fe4S4] cluster on 
the Isa complex.14  Release of the cluster is dependent upon the ATP hydrolysis activity of 
Ssq1.31  Therefore, FeS cluster assembly in the mitochondrial and bacterial ISC systems 
occurs on a U-type scaffold and is concluded upon release of the cluster by the action of 
an ATPase. 
 Like the ISC system, the SUF system utilizes a scaffold for FeS biogenesis.  SufU 
was once proposed to be the scaffold for FeS cluster assembly in the SUF system as it 




However, SufU was recently reported by Dos Santos and coworkers to be a zinc dependent 
sulfurtransferase and not the scaffold for SUF.33  The Dos Santos lab further proposed that 
the protein SufB was a scaffolding component for SUF, after demonstrating that it 
interacted with the desulfurase, SufS.34  SufB is able to assemble and transfer both [Fe2S2] 
and [Fe4S4] clusters.
35, 36  The SUF scaffold is proposed to be a multi-protein complex 
containing SufB along with two additional proteins, SufC and SufD.36  Based on this multi-
protein model, SufB and SufD form a heterodimeric complex that is bound to a head-tail 
dimer of the ATPase, SufC.36  ATP binding to SufC causes a large conformational change 
in SufBD, exposing FeS cluster binding residues.36  Therefore, like ISC, SUF requires ATP 
at a major step to complete FeS biogenesis. 
1.2.3 FeS Cluster Mobilization 
 The insertion of the FeS cluster into a target FeS protein typically involves a carrier 
protein and/or other interacting proteins to facilitate the mobilization of cluster from the 
scaffold.  In the mitochondrial ISC pathway, the [Fe2S2] cluster assembled on the Isu 
scaffold is mobilized with the assistance of two chaperone proteins, Ssq1 and Jac1.14  The 
[Fe2S2] cluster is transferred to a Grx5 homodimer or a Grx5-Bol1 heterodimer for delivery 
to cluster recipients within the mitochondria.14, 37  The identity of the target proteins for the 
Grx52 or Grx5-Bol1 carrier complexes has yet to be established.
14, 37  Assembly of the 
[Fe4S4] cluster takes place on the A-type scaffolds, Isa1 and Isa2.
14, 38  Two [Fe2S2] clusters 
are delivered to the Isa complex by Grx5 and condensed to form a [Fe4S4] cluster with the 




1.2.4 Iron-Sulfur Clusters: Diseases 
 FeS cluster biogenesis is linked to a number of disorders and diseases as FeS 
proteins are essential for many vital processes including the respiratory complex of the 
mitochondria and DNA replication and repair.1, 2, 41-44  FeS cluster biogenesis is also critical 
for the maintenance of genome integrity.45-48  Defects in FeS enzymes or the cluster 
biogenesis pathways that provide the FeS proteins with FeS clusters can lead to a variety 
of disorders or diseases in the cytosol, nucleus, or mitochondrion (Table 1.1).  
Understanding the mechanisms of cluster biogenesis pathways will help to identify how 
defects in these pathways lead to disease.  
Table 1.1. Selection of FeS Enzymes and Related Diseases 
Defect in Cytosolic FeS Biogenesis 
Name Function Disease/Disorder Ref. 
CIAO1/Cia2 CIA Component Genome Instability 2, 49 
CIAPIN1/Dre2 CIA Component Various Cancers 50, 51 
MMS19/Met18 CIA Component Various Cancers 45, 46, 52, 53 
 
Defect in Mitochondrial FeS Biogenesis 
Name Function/Role Disease/Disorder Ref. 
Frataxin ISC Component Friedrich’s Ataxia 54, 55 
IscU ISC Component IscU Myopathy 41, 56 
Nfu & BOLA3 FeS Cluster Carrier MMDS1 & MMDS2* 41, 57, 58 
Iba57  FeS Cluster Assembly 
Factor 
MMDS3 & MMDS4 41, 59 
IscA1/2 FeS Cluster Assembly 
Factor 
MMDS3 & MMDS4 41, 60 






Defect in FeS Cluster Target Protein 
Name Function/Role Disease/Disorder Ref. 
MUTYH Base excision repair Colorectal Cancer 62 
FANCJ Strand break repair Fanconi Anemia 63 
XPD/Rad3 Nucleotide excision repair Xeroderma Pigmentosum 1, 52 
RTEL1 Telomere Maintenance Various Cancers 41, 64 
*MMDS = Multiple mitochondrial dysfunction syndrome 
7 
1.3 Cytosolic Iron-Sulfur Cluster Assembly System 
1.3.1 Overview of CIA 
The cytosolic iron sulfur cluster assembly pathway (CIA) is responsible for the 
assembly and delivery of FeS clusters for a majority of cytosolic and nuclear FeS proteins.2, 
10, 65  CIA is present within the cytosol and nucleus of the eukaryotic cell.10, 65-67  The 
mitochondrial ISC system, in addition to Atm1, are required for CIA to function (Figure 
1.4).65, 68  Cluster assembly by CIA is proposed to begin on a scaffold.2, 23, 69  Once 
assembled, the FeS cluster is transferred to an apo-FeS protein ‘target.’  Cluster transfer 
and target recognition are proposed to be mediated by a multi-protein complex, called the 
CIA Targeting Complex (CTC).70-72  The CTC is responsible for the recognition of apo-
FeS protein targets and for maturation of the FeS protein.45, 46, 70-73 
1.3.2 CIA Scaffold 
Nbp35 and Cfd1 are the proposed scaffolding proteins for the CIA pathway in the 
majority of eukaryotic organisms.23, 66, 69, 74  Nbp35 and Cfd1 have been reported to form 
both homocomplexes and heterocomplexes but it is unknown which of the quaternary 
structure forms are physiologically relevant.23, 75  The quaternary structure of the 
scaffolding complex has been reported as a heterotetramer by the Lill lab.76 
1.3.2.1 Nbp35-Cfd1’s Cluster Binding and ATPase Sites 
Nbp35 and Cfd1 are homologous to one another and share a number of key 
sequence and structural features.23, 66, 69  Both Nbp35 and Cfd1 have a CxxC motif close to 
their C-termini and situated at the interface between Nbp35 and Cfd1 (Figure 1.3).76  




‘bridging’ [Fe4S4] cluster at the dimer interface (Figure 1.3B).
76, 77  In addition to the 
bridging cluster, Nbp35 has an additional [Fe4S4] cluster bound at its N-terminus.
23  The 
N-terminal domain found in Nbp35 is absent in Cfd1 (Figure 1.3A).  Both [Fe4S4] clusters 
are required for CIA function, yet the roles of the N-terminal and bridging clusters are not 
clearly defined.  The current working model is that the N-terminal cluster is stably bound 
and the bridging cluster is destined for downstream recipient proteins.23, 75, 76 
 
Figure 1.3. Domains and Motifs of Nbp35 and Cfd1 
(A) Schematic of Nbp35 and Cfd1’s primary structure with the positions of the FeS cluster 
binding domains and the conserved motifs of the ATPase site.  The lengths of Nb35 and 
Cfd1, and the location of the motifs are drawn to scale.  (B) Crystal structure of 
Chaetomium thermophilum Cfd12 (PDB ID 6G2G) bound to a [Fe4S4] cluster (spheres).
77  
Subunits are depicted in cyan with the ATPase site motifs and bridging cluster binding 
motifs color coded as in (A).  The grey circle denotes where the N-terminal domain of 




The last common feature shared by both Nbp35 and Cfd1 is that they both are 
members of the deviant Walker A family of NTPases.23, 66, 69, 78  This is the most interesting 
and defining feature of the CIA scaffold, as the prototypical U-type scaffolds are not 
ATPases.  Other proteins involved in the NIF and ISC pathways are ATPases, but the NIF 
and ISC scaffolds are not themselves ATPases.11, 29, 79, 80  Although the ATPase domain of 
the CIA scaffold has been demonstrated to be essential for scaffolding function, the role of 
ATP hydrolysis during cluster biogenesis by the CIA scaffold is not understood.23, 66, 69 
1.3.2.2 Nbp35-Cfd1’s FeS Cluster Scaffolding Function 
 
The essential function of the Nbp35-Cfd1 scaffold is to assemble [Fe4S4] clusters 
from basic building blocks.23, 65, 76  As of yet, the identity of the cluster building blocks for 
CIA are not known.  The source of the sulfide moiety is proposed to be a small, sulfur 
containing molecule exported by the mitochondria (Figure 1.4).24, 81-84  The sulfur species 
is hypothesized to be synthesized and exported by the mitochondrial ISC pathway for use 
by CIA, but its identity is not known.81, 82, 84  The involvement of mitochondrial protein 
Atm1 in CIA has been strongly debated by several focal labs.  The Lill lab initially 
proposed that CIA was dependent on Atm1 in order to build FeS clusters.68  However, the 
yeast strain used in these experiments was producing a surplus of Leu1, an FeS protein that 
depends on CIA for its cluster.49, 68  Work by Isaya and coworkers suggested that the high 
activity of Leu1 observed by Lill and coworkers in the Atm1 sufficient cells was a result 
of this upregulation, and misinterpreted to mean that Atm1 exports the FeS cluster needed 
by Leu1.85-87  The same yeast strain was used in experiments undertaken by Lindahl and 




incorporated into mitochondrial FeS proteins.68, 88, 89  As the debate into whether or not 
Atm1 is an essential part of CIA continues, different sulfur species have been proposed to 
be exported by Atm1.  The proposed sulfur species have included glutathione polysulfide,83 
and an unidentified sulfur species ranging in mass from 700 – 1100 Da.82  The sulfur 
species has also been implicated as an intermediate in heme biosynthesis.90 
A very recent development by the Pain lab regarding the debate over the identity of 
the sulfur species has postulated that there are two distinct sulfur species produced within 
the mitochondria, Sint and (Fe-S)int.
91  While Sint is utilized in tRNA thiolation, (Fe-S)int 
contains both iron and sulfur and is utilized by CIA to assemble FeS clusters.  Interestingly, 
these experiments also demonstrated that CIA was unable to make use of cytosolic iron 
sources, instead incorporating the iron from (Fe-S)int into its FeS clusters.
91  It has been 
recently proposed that the homologous cytosolic proteins Grx3 and Grx4 (Grx3/4) are the 
donors of iron to the CIA scaffold.92-94  This is an interesting proposal, as Grx3/4 is 
purportedly not reliant upon CIA for its [Fe2S2] cluster.
92  However, the findings of Pain 
and coworkers refutes the claims of Grx3/4 as the iron donor, suggesting that the CIA 
system is dependent solely upon the mitochondria for its FeS cluster building blocks.  The 
scaffold utilizes the exported (Fe-S)int along with reducing equivalents supplied by the 
Dre2-Tah18 complex to build a [Fe4S4] cluster (Figure 1.4).
23, 91, 95, 96  The mechanism by 





Figure 1.4. Overview of the CIA Pathway 
Nbp35-Cfd1 is the proposed scaffold for FeS cluster assembly.  The proposed iron and 
sulfide source is the (Fe-S)int moiety exported from the mitochondrial ISC pathway.  The 
Tah18-Dre2 complex is proposed to deliver reducing equivalents to the scaffold for the 
assembly of Nbp35’s N-terminal FeS cluster.95  The role of ATP binding and hydrolysis in 
cluster assembly/transfer is unknown.  After assembly, the cluster is proposed to be 
transferred from the scaffold to a downstream recipient.  The CIA Targeting Complex 
(CTC - comprised of Cia1, Cia2, and Met18) is proposed to recognize the apo-FeS protein 




1.3.3 Other CIA Factors Involved in FeS Cluster Biogenesis 
1.3.3.1 Dre2-Tah18 Complex 
 
 Dre2 was identified in a genetic screen as being an essential component of CIA.97  
Dre2 is proposed to bind one [Fe4S4] and one [Fe2S2] cluster at its C-terminus, though the 
exact stoichiometry has been debated.96-99  Intriguingly, the FeS clusters of Dre2 have been 




Additionally, it has been demonstrated that Dre2 is involved in the maturation of the 
diferric-tyrosyl radical cofactor (FeIII2-Y
●) of ribonucleotide reductase (RNR), 
independently of CIA.93, 100 
Dre2 forms a complex with the diflavin reductase Tah18 and this interaction is 
required for CIA function.95, 96, 99  Tah18 interacts with Dre2 in vivo and transfers electrons 
to the [Fe2S2] cluster of Dre2.
95, 101  Dre2 and Tah18 are thought to be involved upstream 
of the Nbp35-Cfd1 scaffold, as depletion of Dre2 and Tah18 decreases FeS cluster 
incorporation into Nbp35 and Nar1.95  In one study, the depletion of FeS cluster 
incorporation into TAP-tagged Nbp35 upon depletion of Dre2 lead to the hypothesis that 
Tah18-Dre2 was required for the assembly of Nbp35’s N-terminal cluster (Figure 1.4).95  
In support of this hypothesis, an interaction between Dre2 and Nbp35 homologs in 
Arabidopsis thaliana has been reported.102  However, this report also made the unexpected 
proposition that the N-terminal domain of Nbp35 is not the major determinant of this 
interaction.102  Although some evidence supports Dre2 interacting with Nbp35, the 
significance of this interaction in FeS biogenesis is unknown.  The recipient of Dre2’s 
reducing equivalents is also unknown, but it is possible that Dre2 is delivering the reducing 
equivalents to the scaffold to build the FeS cluster.76, 95  
1.3.3.2 Grx3/Grx4 
 
Recently, the monothiol glutaredoxins Grx3 and Grx4 have been proposed to be the 
source of the iron for CIA FeS cluster biogenesis.92-94  Because Grx3 and Grx4 are 
homologous proteins with overlapping functions, they will be referred together as Grx3/4.  




molecules acting as cluster ligands in addition to two cysteine residues, one from each 
protomer.9, 92, 94  In humans, the Grx3/4 homolog, Grxl3, forms a complex with BolA2 to 
bind a [Fe2S2] cluster.
37  The Grxl3-BolA2 complex is able to transfer its [Fe2S2] cluster to 
Ciapin1, the human homolog of Dre2.37, 103  The transfer of cluster from Grxl3-BolA2 to 
Ciapin1 is especially interesting as the yeast homologs (Dre2 and Grx3/4) obtain their 
clusters independently of the CIA scaffold.92, 95  The scaffold independent acquisition of 
cluster suggests that Grx3/4 are upstream of the scaffold.  It remains to be seen if Grx3/4 
is indeed the source of FeS cluster building blocks or if Grx3/4 is working in some other 
capacity such as acting as a source of labile [Fe2S2] clusters. 
1.3.3.3 Nar1 
 
 Nar1 is another component of the CIA pathway.  Nar1 purportedly contains two 
[Fe4S4] clusters and is a homologue of FeFe hydrogenase.
104, 105  Nar1 is dependent on the 
early acting CIA proteins Dre2 and Tah18 in order to obtain its FeS clusters.95  Depletion 
of Nar1 does not affect CIA scaffold expression or its cluster acquisition, implying that 
Nar1 is downstream of the scaffold.23, 104  Based on the observation that depletion of the 
CTC components did not affect Nar1’s ability to obtain FeS clusters, it has been proposed 
that Nar1 is acting upstream of the CTC.23, 95, 104  In fact, mutation of Nar1’s FeS cluster 
binding cysteine residues decreased the FeS dependent activity of Leu1, indicative of 
decreased flux through CIA.104, 105  Protein-protein interaction studies further support that 
Nar1 acts at an intermediate step between the scaffold and the CTC.  Although A. thaliana 
(At) Nar1 has not been shown to interact with AtNbp35,102 Nar1 has been demonstrated to 




demonstrated to interact with human Cfd1 and is dependent on hCfd1 for maturation.77  It 
is possible that Nar1 could be acting at an intermediate step in CIA between the Nbp35-
Cfd1 scaffold and the CTC (Figure 1.4). 
1.4 Role of Nucleotide in CIA Scaffolding Function 
The ATPase domains of Nbp35 and Cfd1 are each essential for cluster biogenesis 
in vivo.76, 109  In order to determine the essential role(s) of the ATPase domains, the 
nucleotide binding affinity and hydrolysis activity of Nbp35 and Cfd1 was investigated.110  
Nbp35 was found to bind one fluorescent nucleotide analogue (mantATP) per ATPase site 
with a KD of 16 ± 1.9 μM.
110  Most intriguingly, it was found that the ATPase activity of 
the three different quaternary forms of the scaffold (Nbp352, Cfd12, and Nbp35-Cfd1) 
exhibited differing steady state kinetic profiles (Table 1.2).110  The ATPase activity of 
Cfd12 was not detectable, even though it contains all of the same ATPase site motifs as 
Nbp35 (Figure 1.3).  It was also shown that mutation of Nbp35’s ATPase site resulted in 
changes to both its nucleotide affinity and hydrolysis activity.110  It is therefore clear that 
the ATPase sites of Nbp35-Cfd1 are nonequivalent and likely have distinct roles in FeS 
cluster biogenesis. 
Table 1.2. Steady State Kinetic Constants of CIA Scaffold Quaternary Forms 
Protein kcat (min-1) Km (mM) kcat/Km (M-1s-1) 
Nbp352 4.6 ± 0.1 0.4 ± 0.1 192 
Cfd12 <0.7 ND* ND 
Nbp35-Cfd1 3.9 ± 0.2 5.0 ± 0.6 13 
*ND = not determined.  All kinetic assays were previously reported in Ref. 110.  
 
 
Recently, the Dobbek lab reported the crystal structure of a fungal (Chaetomium 
thermophilum) Cfd1 homolog bound to its [Fe4S4] bridging cluster.




article, nucleotide binding to both C. thermophilum (ct) and human Nbp35 and Cfd1 was 
demonstrated via micro-scale thermophoresis (MST).77  Surprisingly, while ctCfd1 bound 
ATP 10-fold tighter than GTP, the exact opposite was observed in ctNbp35 which preferred 
GTP.77  In the same report, collaborators in the Lill lab described that human Nbp35 and 
Cfd1 displayed no preference for either ATP or GTP, with KD values of ~5 μM as 
determined by MST.77  This was an unexpected finding as ApbC, a bacterial homolog of 
Nbp35 and Cfd1, has been demonstrated to bind and hydrolyze ATP.111, 112  Moreover, it 
was previously determined that the scaffold proteins in yeast do not possess GTPase 
activity.110  However, Lill did not report any hydrolysis activity of either ATP or GTP by 
the human or fungal scaffolding proteins.  Altogether, the data from our lab and the Lill 
lab leaves some unanswered questions.  It must be determined which of the purine 
nucleotides is the substrate for the CIA scaffold. 
1.4.1 The Deviant Walker A Family 
Nbp35 and Cfd1 are members of the deviant Walker A branch of SIMIBI (signal 
recognition particle, MinD, BioD) NTPases.78, 113, 114  The functions of deviant Walker A 
family members range from metal cofactor maturation and trafficking, heavy metal 
resistance, membrane protein insertion, and regulation of proteins involved in bacterial cell 
division.78, 113-118  While the functions of deviant Walker A proteins are diverse, the family 
members share a common mechanism of coupling conformational or oligomerization 
changes with nucleotide binding and hydrolysis.78, 113, 114, 117  The ‘deviant’ in the family 
name comes from the inclusion of an additional, or signature, lysine residue within the 




along with the conserved Switch I and Switch II motifs, appear to be the conductors of the 
conformational changes within deviant Walker A proteins.  These conformational changes 
control dynamic interactions with other protein-protein interaction partners (Table 1.3).78, 
113, 114, 117, 121  It is not known whether Nbp35 and Cfd1 undergo a nucleotide mediated 
conformational change as do the other deviant Walker A proteins.  If Nbp35 and Cfd1 are 
experiencing a change in conformation, it remains to be seen how this is coupled with FeS 
cluster assembly and transfer. 
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Figure 1.5. Deviant Walker A Motif of Yeast Cfd1 and Nbp35 
The sequence of the deviant Walker A motif containing the signature, deviant lysine 
residue (bold and underlined) in relation to the canonical, Walker lysine (bold).78, 120  The 
deviant Walker A motif of Cfd1 and Nbp35 is shown in a similar fashion.  The term ‘h’ is 
a hydrophobic residue. 
 
 
1.4.2 Deviant Walker A Proteins Offer Insight into Nbp35-Cfd1 
 The relationship between ATP hydrolysis and FeS cluster biogenesis by the CIA 
scaffold Nbp35-Cfd1 has not yet been elucidated.  However, much work has focused on 
investigating other deviant Walker A ATPases over the past two decades and these studies 
were influential in helping to develop our understanding on the role of nucleotide 
hydrolysis in Nbp35-Cfd1.  What follows are summaries of four deviant Walker A 
proteins: ApbC, MinD, Get3, and ArsA.  Information learned from these examples will 
guide predictions and expectations of the CIA scaffold’s function in both FeS cluster 
biogenesis and ATPase activity.  
1.4.2.1 ApbC 
 
 ApbC is a bacterial homolog of Nbp35 and Cfd1.  Salmonella enterica ApbC is 
able to bind and transfer [Fe4S4] clusters and exhibits ATPase activity in vitro.
25, 111, 112  The 
two functions of ApbC, FeS cluster transfer and ATP hydrolysis, were investigated by 
Boyd, et al.111, 112  The addition of ATP to in vitro FeS cluster transfer reactions neither 




[Fe4S4] cluster did not affect the ATP hydrolysis rate of ApbC.
111  However, mutations to 
two residues of ApbC’s deviant Walker A site (K116A, and K121A) halved the rate of in 
vitro cluster transfer to Leu1 as compared to WT ApbC.111  This result indicates that there 
is a connection between the ATPase site and cluster binding site of ApbC, but the details 
of how the sites are connected have not yet been elucidated. 
1.4.2.2 MinD 
 
 MinD is involved in regulating bacterial cell division.117, 132-134  Unlike Nbp35-
Cfd1, the dimerization of MinD is synergistic with ATP binding.76, 118, 132  MinD exhibits 
slow ATPase activity, on the order of 0.9 nmol Pi released min-1 mg-1.135  However, in the 
presence of one of its partner proteins, MinE, the ATPase activity increases by almost 20-
fold.135  The MinE mediated ATPase stimulation of MinD is asymmetric, and could be 
important for MinD’s interactions with both of its partner proteins: MinE and MinC.136  
The regulation of MinD interactions with MinE and MinC modulate MinD binding to the 
bacterial cell membrane.137, 138  Identifying the partner protein(s) of deviant Walker A 
proteins is crucial for further investigating the ATPase characteristics of this family of 
proteins.  Most importantly, it would allow for assessing the activation of ATPase activity 




 Get3 is a homodimer responsible for the insertion of tail-anchored (TA) membrane 
proteins.130, 131, 139-142  Get3’s interaction with nucleotide, partner proteins, and the TA cargo 




Get3, is regulated by specific partner protein interactions with Get3.130, 131, 139, 141  For 
example, Get3 only interacts with the partner protein complex Get4-5 when Get3 binds 
ATP.141  This spatiotemporal regulation of the ATPase cycle in the GET system ensures 
precise targeting and insertion of the TA substrate.  Furthermore, the binding of ATP in 
Get3 is cooperative, and the second ATP molecule binds with an order of magnitude higher 
affinity than the first ATP molecule.130  All of this regulatory processing ensures that the 
correct conformation is achieved.  It will be interesting to see if the conformations of all 
deviant Walker A proteins are regulated in such a way, and whether or not cooperativity in 
nucleotide binding exists between the subunits. 
1.4.2.4 ArsA 
 
 ArsA is involved in heavy metal efflux in bacteria.143-148  ArsA is a pseudodimer 
containing two deviant Walker A nucleotide binding domains (NBDs) fused onto a single 
polypepetide.115, 146  To our knowledge, ArsA and the CIA scaffold are the only members 
of the deviant Walker A family that are not homodimeric.  Site directed mutagenesis 
experiments of ArsA revealed two NBDs that differ in their nucleotide affinities.  One 
NBD possesses a high affinity nucleotide binding site, and the other NBD is a low affinity 
nucleotide binding site.149-152  As a function of its heavy metal efflux, ArsA binds arsenite 
as a ‘cargo’, a small molecule that is ‘carried’ by deviant Walker A proteins.  Binding of 
the arsenite cargo to the ArsA protein triggers ATP binding at the low affinity NBD and 
stimulates the rate of ATP hydrolysis by ArsA.153, 154  Coupling of cargo binding/release to 




1.4.3 Predictions for the CIA Scaffolding Mechanism 
 Nucleotide binding and hydrolysis plays a crucial role in FeS cluster assembly and 
transfer by the CIA scaffold.66, 76  However, the mechanism by which the scaffold couples 
nucleotide binding and hydrolysis to cluster acquisition and transfer is unknown (Figure 
1.4).  The heterodimeric nature of the Nbp35-Cfd1 scaffold and the fact that Nbp35 and 
Cfd1 are essential suggests that the subunits are undertaking specific roles in nucleotide 
mediated FeS cluster biogenesis.  Preliminary evidence for different roles of the subunits 
is observed in the differences in ATPase activity between the three different scaffolding 
constructs (Nbp352, Cfd12, and Nbp35-Cfd1).
110  As members of the deviant Walker A 
family of ATPases, the scaffold is proposed to integrate nucleotide binding and hydrolysis 
into the mechanism of cluster assembly and transfer.  Given the low ATPase activity of the 
scaffold,110 it is also expected that there might be a partner protein that stimulates the ATP 
hydrolysis rate of the scaffold, as is seen with other deviant Walker A proteins.  It’s 
expected that this partner protein, or proteins, is one of the other CIA factors (Figure 1.4).  
The identification of such a partner(s) would be a massive revelation towards 
understanding further mechanistic details of the pathway. 
1.5 Summary 
This thesis describes my work on the CIA scaffold, Nbp35-Cfd1, and the role of 
nucleotide during FeS cluster biogenesis.  The Nbp35-Cfd1 complex assembles a [Fe4S4] 
cluster and transfers it to downstream FeS cluster recipients, though the identity of the 




each subunit’s ATP binding and hydrolysis activity is connected to cluster acquisition and 
transfer has not been investigated.   
Chapter 2 identifies each of the CIA scaffold subunits’ unique interactions with 
ATP.  The Cfd1 subunit is able to bind nucleotide and regulates nucleotide binding to both 
ATPase sites of the Nbp35-Cfd1 complex.  Nbp35 activates hydrolysis activity at both 
ATPase sites of the Nbp35-Cfd1 complex.   
Chapter 3 establishes that the ATPase site and the bridging cluster binding site are 
in allosteric communication with each other.  The presence of the bridging cluster 
decreases the affinity for nucleotide.  By using a combination of in vivo and in vitro analysis 
of Nbp35 site-directed mutants, a working model of the scaffold’s FeS cluster biogenesis 
cycle is proposed.   
Chapter 4 reports the identification and characterization of Dre2 as a partner protein 
of Nbp35-Cfd1 during the FeS cluster biogenesis cycle.  Further work on this lead by 
Christa Molé and Laney Browder revealed the identity of two partner proteins for Nbp35-
Cfd1, the CIA factors Dre2 and Nar1.  It was also discovered the N-terminal domain of 
Nbp35 was dispensable for the ATPase activation of Nbp35-Cfd1 by Dre2.  Preliminary 
work elucidating the mechanism by which Dre2 stimulates Nbp35-Cfd1’s ATPase activity, 
such as the effect of the FeS clusters, has been done. 
Finally, Chapter 5 details a side project whose goal was the creation of a fluorescent 
sensor for the detection of [Fe4S4] clusters.  A fluorescent [Fe4S4] cluster sensor was created 
from and FNR and SNAP-tag fusion protein.  The sensor was able to indicate that the FeS 




of cluster decay post oxygen exposure were then determined by following the rate of 
fluorescence increase and the decrease in the A410 of the cluster.  The cluster could 





CHAPTER 2: Identifying the Roles of Nbp35 and Cfd1 in FeS Cluster Biogenesis 
(Adapted from Grossman, et al., (2019), Biochemistry 58, 1587-1595.) 
 
2.1 Introduction 
The CIA scaffold is the proposed site of FeS cluster assembly for cytosolic and 
nuclear FeS proteins.  In yeast, the scaffold comprises two homologous proteins, called 
Nbp35 and Cfd1.10, 23, 66, 69  Both Nbp35 and Cfd1 are conserved in eukaryotic organisms 
with the notable exception of the green lineage and the SAR supergroup, which only 
encode Nbp35 orthologs.10, 74  Although both proteins are required for CIA function in 
most eukaryotes, the role of each subunit is poorly understood.  Interestingly, Nbp35 and 
Cfd1 have been reported to form both homocomplexes and heterocomplexes when 
overexpressed in yeast and when heterologously expressed in E. coli.23, 75, 76  It is unclear 
which of these differing quaternary structure forms are physiologically relevant.   
Nbp35 and Cfd1 contain a number of shared sequence and structural motifs.78  Both 
Nbp35 and Cfd1 contain a CxxC motif near their C-termini that binds a [Fe4S4] cluster that 
bridges the dimer interface (Figure 2.1A, D).76, 77  Nbp35 has a unique N-terminal motif 
not found in Cfd1 that contains conserved cysteine residues for binding an additional 
[Fe4S4] cluster.  While both of these FeS clusters are required for an operational CIA 
system, not much is known about their functions.75, 76  It has been proposed that the N-
terminal cluster remains stably bound throughout the reaction cycle, while a more labile 
cluster is assembled at, and transferred from, the bridging cluster site.23, 75, 76  Lastly, both 
Nbp35 and Cfd1 contain four conserved motifs of an ATPase site (Figure 2.1A, B, C) that 




MinD and BioD) family of NTPases.78  Nucleotide binding and hydrolysis is essential for 
CIA function.23, 66, 69  However, the role of nucleotide binding and hydrolysis in the 
mechanism of cluster biosynthesis and transfer is unknown. 
 
Figure 2.1. Domains and Motifs of Nbp35 and Cfd1 
(A) Schematic of Nbp35 and Cfd1’s primary structure depicting the positions of the FeS 
cluster binding and ATPase sites.  The motifs of Nbp35, Cfd1, and the archaeal homologue 
3KB1 are shown in the boxes.  The residues targeted for mutagenesis are shown in red.  
(B) The structure of 3KB1’s ATPase site occupied by ADP (green).  Conserved motifs are 
shown as ribbons and are color coded as in panel (A).  Residues targeted for mutagenesis 
are shown as sticks.  (C) The conserved ATPase site motifs and residues of 6G2G, a Cfd1 
homolog.  The structure is depicted and color coded as in panel (B).77  (D) Structure of C. 
thermophilum Cfd12 (PDB Accession 6G2G) bound to a [Fe4S4] (spheres).
77  Subunits are 
depicted in cyan with the ATPase site motifs color coded as in (A).  (E) Table of residues 




Nbp35 and Cfd1 exhibit differences in their ability to hydrolyze ATP.  It has been 
demonstrated that only Nbp35 and Nbp35-Cfd1 are able to hydrolyze ATP.110  Cfd1 had 
no detectable ATPase activity, even though it contains all of the conserved ATPase site 
motifs as Nbp35.  It was unknown at this point if Cfd1 was capable of binding nucleotide.  
Therefore, the lack of detectable ATP hydrolysis observed for Cfd1 could be the result of 
either a nucleotide binding defect or a hydrolysis defect.   
The observed differences in the ATPase activity between Nbp35, Cfd1, and Nbp35-
Cfd1, coupled with the fact that both Nbp35 and Cfd1 are essential, led to the hypothesis 
that Nbp35 and Cfd1 have differing roles in the Nbp35-Cfd1 heterocomplex.  The 
nucleotide binding affinities of the individual subunits of the Nbp35-Cfd1 complex were 
unknown.  Therefore, the nucleotide binding affinities of Nbp35, Cfd1, and Nbp35-Cfd1 
were assessed using the previously developed mantATP binding assays.110, 155  Moreover, 
the stoichiometry of the scaffolding proteins’ quaternary structure was determined to be 
dimeric via SEC.  Ultimately, the work covered within this chapter revealed distinct roles 
for each subunit of the heterodimer, answering the question as to why both Nbp35 and 
Cfd1 are essential components of the CIA scaffold.  Cfd1 controls nucleotide binding and 
Nbp35 is needed to activate both ATPase sites for hydrolysis.156 
2.2 Materials and Methods 
2.2.1 Size Exclusion Chromatography 
 Size exclusion chromatography experiments were carried out at 4 °C with a 
Superdex 200 5/150 GL column (GE Healthcare) equilibrated with 50 mM Tris (pH 8.0), 




injected onto the size exclusion column at a flow rate of 0.5 mL/min and were eluted from 
the column in the same buffer.  The molecular weight was determined by comparison to a 
standard curve generated with: ferritin, 440 kDa; catalase, 222 kDa; ovalbumin, 45 kDa; 
and myoglobin, 17 kDa.  Standard curves were created by plotting Kav (Eq. 2.1) against 
the log of the molecular weight.  Exclusion volume was determined from the elution 





Eq. 2.1. Kav Calculation for Size Exclusion 
 
Where 𝑣𝑒 is the protein peak’s elution volume, 𝑣0 is the void volume (elution of the first 
peak), and CV is the volume of the SEC column. 
2.2.2 Protein Expression and Purification 
Nbp35, Cfd1, and Nbp35-Cfd1 were expressed in E. coli and purified as described 
previously (Appendix I).110, 155  The Cfd1 (S32A and N195A) and Nbp35 (S87A) 
mutations were generated via Q5-mutagenesis (New England Biolabs) according to the 
manufacturer’s instructions.  S32A was created with primers JDG23 and EC64.  N195A 
was created with primers JDG35 and JDG36.  S87A was created with primers JDG29 and 
JDG30 (Table AII.7).  All other mutations (D53A, D109N, K26A, and K31A) were 
created by Eric Camire and/or Grace Thole as previously described.110, 157  All constructs 
were verified by DNA sequencing (Genewiz). 
2.2.3 Fluorescence Anisotropy Equilibrium Binding Assays 
Equilibrium binding assays using 2’/3’-O-(N-methylanthraniloyl) ATP and ADP 




polypeptide) was incubated for 1 h at 25 °C with mant-labeled ATP or ADP (0.5 μM) in 
TBS-Anisotropy buffer (50 mM Tris (pH 8), 100 mM NaCl, 10% glycerol, and 5 mM 
DTT) in an opaque 96-well round-bottom plate.  Plates were read on a SpectraMax5 plate 
reader at 25 °C.  The excitation wavelength was set at 355nm and emission was recorded 
at 448nm with a 435nm cutoff filter.  Each well was read in triplicate and the average 
anisotropy values ± the standard deviation were plotted against the protein concentration.  
For mantATP, the data was fit to a hyperbolic binding equation in GraphPad Prism 7 (Eq. 
2.2). 
𝑟 = (𝑟𝑚𝑎𝑥 − 𝑟𝑚𝑖𝑛) × (
[𝑃𝑟𝑜𝑡]
[𝑃𝑟𝑜𝑡]+𝐾𝐷
) + 𝑟𝑚𝑖𝑛  
Eq. 2.2. Fluorescence Anisotropy Hyperbolic Binding Equation 
 
Where rmax is the maximum anisotropy, rmin is the minimum anisotropy, [Prot] is the 
protein concentration (monomer), and KD is the dissociation constant.   
For mutants with weakened nucleotide affinity (greater than 5-fold weaker than 
wild type affinity), the contribution of nonspecific binding was subtracted as described.158  
The anisotropy of wells containing the protein (0 – 200 μM monomer) with and without 
0.5 μM 2’/3’-O-(N-methylanthraniloyl) ATP (mantATP) was determined to obtain 
measured and background anisotropy values, respectively. An additional set of wells 
containing the CIA scaffold (0 – 200 μM monomer), 0.5 μM mantATP, and 21 mM ATP 
reported on any anisotropy changes resulting from nonspecific binding between mantATP 
and the protein.  The background and nonspecific anisotropy signals were subtracted from 
the value of the measured anisotropy signal, giving the anisotropy signal that was a result 




protein concentration and fit to Eq. 2.2. For all mutants, rmax value was constrained to the 
value observed with wild type protein. 
 The affinity of the mantADP-Nbp352 interaction was determined as described 
above for mantATP.  For mantADP binding to Cfd12 and Nbp35-Cfd1, the data (anisotropy 
vs. [protein]), was fit to a quadratic binding equation (Eq. 2.3). 
𝑟 = (𝑟𝑚𝑎𝑥 − 𝑟𝑚𝑖𝑛) ∗  
(𝑅𝑇+𝐿𝑇+𝐾𝐷)−√(𝑅𝑇+𝐿𝑇+𝐾𝐷)2−4(𝑅𝑇∗𝐿𝑇)
(2𝑅𝑇)
+ 𝑟𝑚𝑖𝑛  
Eq. 2.3. Fluorescence Anisotropy Quadratic Binding Equation 
 
Where rmax is the maximum anisotropy, rmin is the minimum anisotropy, LT is the 
concentration of protein (monomer), RT is the concentration of the mantADP, and KD is the 
dissociation constant. 
2.2.4 Fluorescence Anisotropy: Stoichiometry of MantADP Binding 
The stoichiometry of mantADP binding was determined using a variation of the 
fluorescence anisotropy binding assays (described above) in which the concentration of 
mantADP was held constant at 25 μM.  The average anisotropy ± the standard deviation 
was plotted against the concentration of protein (dimer).  The stoichiometry of mantADP 
binding was estimated by fitting the data, both at saturation and at low concentrations of 
protein, to a linear equation.  The intersection point of these two lines is the concentration 
of protein (dimer) required to bind all of the mantADP in the assay and corresponds to the 
number of mantADP molecules bound (i.e., an intersection at 25μM indicates one 




2.2.5 Displacement of MantATP with Unlabeled ATP, ADP, and GTP 
Displacement assays were performed to obtain the affinity of the scaffold for 
unlabeled nucleotide.  Protein (12.5 μM Nbp352, Cfd12, or Nbp35-Cfd1) was incubated for 
1 h at 25 °C in the presence of 0.5 μM mantATP.  Unlabeled nucleotides, ATP, ADP, or 
GTP (0 – 50 mM) were titrated into the wells and incubated for an additional hour at 25 
°C.  The anisotropy of the wells were read in triplicate and the average anisotropy values 
± the standard deviation were plotted against the concentration of nucleotide (ATP, ADP, 
or GTP).  Data was fit to a competitive inhibitor model (Eq. 2.4) in GraphPad Prism 7 to 
determine the IC50. 




Eq. 2.4. Competitive Inhibitor Binding (IC50) 
 
Where, rmax is the maximum anisotropy, rmin is the minimum anisotropy, [Nuc] is the 
concentration of competitor nucleotide, and IC50 is the concentration of nucleotide that 
results in 50% displacement of mantATP.  The Cheng-Prusoff equation (Eq. 2.5) was used 
to determine the dissociation constant for the unlabeled nucleotide. 
𝐾𝐷 = 𝐼𝐶50 (1 +
[𝐿∗]
𝐾𝐷
∗ )⁄   
Eq. 2.5. Cheng-Prusoff Equation 
 
Where [L*] is the concentration of mantATP (0.5 μM), and KD
* is the dissociation constant 
for mantATP. 
2.2.6 HPLC Analysis of ATP Hydrolysis 
Assay mixtures (200 µL) contained 12.5 μM Nbp352 in 50 mM Tris (pH 8.0), 100 




carried out at 25 °C. At 0 - 60 min following addition of the enzyme, a 10 μL aliquot of the 
reaction was removed.  The reaction was quenched by addition of ice-cold 1 M HCl (50 
µL).  After incubation on ice for 5 min, 1 M Tris (pH 12, 60 µL) was added and precipitated 
protein was removed by centrifugation (16.1 kG, 45 min).  The supernatant was applied to 
a Phenomenex Luna C18 (2) reverse phase column and separation of ATP and ADP was 
achieved with a mobile phase consisting of 50 mM ammonium acetate (pH 6.5) with 5% 
HPLC grade acetonitrile at a flow rate of 0.5 mL/min.  ATP eluted at 3.1 min and ADP 
eluted at 3.2 min as evidenced by absorbance peaks at 260 nm. 
2.3 Results 
2.3.1 Quaternary Structure of the CIA Scaffold  
 Size exclusion chromatography (SEC) was used to determine the quaternary 
structure of the Nbp35 and Cfd1 homocomplexes and heterocomplexes.  Previously, 
Nbp35 and Cfd1 in complex had been reported to form a heterotetramer, yet the quaternary 
structure of the homocomplexes was not studied.23  The CIA scaffold constructs (Nbp35, 
Cfd1, or Nbp35-Cfd1) eluted near a tetrameric molecular weight or as a mixture of dimers 
and tetramers (Figure 2.2A, C).  As there seemed to be broadening of the absorbance signal 
of the elution peaks of these samples, freshly purified proteins were used in the next 
experiments.  Additionally, the NaCl concentration of the buffer was increased to 300 mM 
(TBS-HS buffer) to match the buffer used for protein purification.110  Nbp35 and Nbp35-
Cfd1 samples eluted predominantly at a volume consistent with the molecular weight of a 
dimer (Figure 2.2B, D).  Though primarily eluting as a dimer, the Cfd1 sample was not 






Figure 2.2. SEC of CIA Scaffold Constructs 
(A,C) Protein samples (10 μL of 2 mg/mL) were loaded onto an SEC column and eluted 
with TBS-LS or (B,D) eluted with TBS-HS with freshly purified proteins.  C and D depict 
a zoomed in look at the peaks displayed in A and B respectively.  Expected elution volumes 
of a monomer, heterodimer, and heterotetramer are indicated (C and D) as vertical dotted 
lines.  (E) Elution profile of standard proteins (1-ferritin, 2-catalase, 3-ovalbumin, and 4-




Therefore, utilizing freshly purified proteins in a buffer containing high salt concentration 
(300 μM NaCl), the CIA scaffold largely exists as a dimer when comprised of Nbp35 or 
Nbp35-Cfd1. 
2.3.2 Cfd1 Specifically and Stoichiometrically Binds Nucleotide 
Since Cfd12 does not have any detectable ATPase activity, mantATP and mantADP 
binding experiments were carried out to determine whether Cfd12 is competent to bind 
nucleotide.  MantATP was titrated with Cfd12, and the resulting protein dependent change 
in anisotropy was fit to a hyperbolic binding equation yielding a KD of 9.7 ± 0.5 μM (Figure 
2.3, Table 2.1).  The binding of mantATP was competitive with ATP and ADP binding 
(see Section 2.3.4).  Additionally, mutation of N195 in the A-loop decreased the affinity 
for mantATP (Figure 2.3).  The observed binding of mantATP was dependent on 
magnesium.  All of these results demonstrated that mantATP was specifically binding to 
Cfd1. 
 
Figure 2.3. Cfd1 Binds MantATP and MantADP. 
Cfd12 (0 – 150 μM dimer) was incubated with 0.5 μM mantATP (▲) or mantADP (Δ). 
The anisotropy (average ± the standard deviation of three replicates) was plotted against 
the concentration of Cfd12 and fit to Eq. 2.2 or Eq. 2.3 for mantATP or mantADP binding, 
respectively. Two controls demonstrated that mantATP binds specifically to Cfd12.  The 
first control was mantATP titrated with Cfd12 in buffer containing 25mM EDTA and no 





MantADP was also titrated with Cfd12 and the affinity was calculated from a 
quadratic binding equation (Eq. 2.3) yielding a KD of 0.9 ± 0.1 μM.  Therefore, Cfd12 is 
able to bind mantATP and mantADP with affinities similar to those observed for Nbp352
 
(Table 2.1).110 
A recent report from the Lill lab has suggested that Nbp35 orthologs preferentially 
bound GTP over binding ATP with affinities in the low-μM range.77  Therefore, the binding 
affinity of mantGTP to Nbp352 and Cfd12 was determined to further investigate nucleotide 
specificity.  MantGTP binding to either Nbp352 of Cfd12 was indistinguishable from 
background anisotropy levels (Figure 2.4).  Therefore, GTP binds much more weakly than 
the adenine nucleotides. 
 
Figure 2.4. MantGTP Does Not Bind to Cfd12 or Nbp352. 
Titrations of 0.5 μM mantGTP or mantATP with 0 – 125 μM Nbp352 (squares) or Cfd12 
(triangles) completed as described for Figure 2.3.  MantGTP is not binding to either 
Nbp352 or Cfd12 as evidenced by comparison to the control anisotropy values of mantATP 
binding to N247ANbp352. 
 
After the observation that mantADP bound Cfd12 10-fold tighter than mantATP, 




nucleotide binding to Cfd12 is specific, it is expected that one nucleotide will bind per 
ATPase site.  In order to determine the stoichiometry, 25μM mantADP (in excess of the 
measured KD) was titrated with Cfd12 to give quadratic binding conditions.  The data points 
at high and low concentrations of Cfd12 were each fit to linear regression (Figure 2.5).  
The intersection point of these two lines was used to calculate the number mantADP 
molecules bound per Cfd12.  The calculated intersection point occurred at 14 μM Cfd12, 
which equates to 1.8 ± 0.03 mantADP molecules per Cfd12 dimer.  This data supports that 
Cfd1 specifically and stoichiometrically binds nucleotide. 
 
Figure 2.5. Cfd1 Stoichiometrically Binds MantADP. 
MantADP binding was carried out as described in Figure 2.3 except the mantADP 
concentration was 25 µM. The linear portions of the titration curve were fit to lines which 
intersect at 14 µM Cfd12, corresponding to 1.8 mantADP per Cfd12. 
 
 
Table 2.1. Nucleotide Dissociation Constants 
 
 
Construct mantATP (μM) mantADP (μM) ATP (μM) ADP (μM) 
Cfd12 9.7 ± 0.5 0.9 ± 0.1 540 ± 160 82 ± 13 
Nbp352 21 ± 6
 7.9 ± 0.4 140 ± 32 300 ± 56 




2.3.3 Cfd1 is Hydrolysis Competent in the Nbp35-Cfd1 Complex 
Although Cfd12 binds nucleotide, it does not exhibit detectable ATPase activity.
110  
Despite the lack of ATPase activity observed with Cfd12, mutations to the Cfd1 subunit’s 
Walker A lysine residues, K26 and K31 (Figure 2.1A), in the Nbp35-Cfd1 complex 
decreased ATPase activity to background level.110  To determine if the lack of hydrolysis 
activity was due to a defect in nucleotide binding, the mantATP affinity of the lysine 
mutants (K26A and K31A) in Cfd12 and Nbp35-Cfd1 were assessed.  The KD values for 
K26ACfd12 and 
K31ACfd12 were found to be 10 ± 0.7 μM and 28 ± 2.7 μM, respectively.  
These values are similar to the affinities measured for WTCfd12 (Figure 2.3, Figure 2.6A).  
Similarly, alanine substitutions of K26 or K31 in the Cfd1 subunit of Nbp35-Cfd1 did not 
alter its mantATP affinity (Figure 2.6B, Table 2.2).110  The data indicates that Cfd1 is 
competent to hydrolyze ATP in the context of Nbp35-Cfd1.   
 
Figure 2.6. Walker A Lysine Mutants Do Not Affect MantATP Affinity 
MantATP binding was performed as described in Figure 2.3 for (A) Cfd12, 
K26ACfd12, and 
K31ACfd12 (0 – 150 μM dimer), or (B) Nbp35-Cfd1, Nbp35-
K26ACfd1, and Nbp35-K31ACfd1 
(0 – 150 μM dimer).  The KD values were calculated from Eq. 2.2.  The K26 and K31 







Table 2.2. Walker A Lysine Mutant MantATP Binding Affinities 
CIA Scaffold 
Variant 
Dissociation Constant (μM) 
Homodimer Heterodimer 
WTCfd12 9.7 ± 0.5 14 ± 1 
K26ACfd12 10 ± 0.7 19 ± 3 
K31ACfd12 28 ± 2.7 33 ± 6 
 
2.3.4 The Scaffold Quaternary Structure Determines Affinity for ATP and ADP 
Next, the mantATP and mantADP affinities were assessed for Nbp352 and Nbp35-
Cfd1.  It had been previously determined via fluorescence anisotropy assays that the 
binding affinity of mantATP for Nbp352 was 21 ± 6 μM.  Here, the binding affinity of 
mantADP to Nbp352 was determined to be 7.9 ± 0.4 μM (Figure 2.7A, Table 2.1).  The 
Nbp35-Cfd1 heterodimer bound mantATP with a binding affinity of 14 ± 1 μM and 
mantADP with an affinity of 0.9 ± 0.1 μM (Figure 2.7B, Table 2.1).   
 
Figure 2.7. Mant-labeled Nucleotide Binding to Nbp352 and Nbp35-Cfd1. 
(A) Equilibrium binding of Nbp352 (0 – 100 μM dimer) to mantATP or mantADP was 
completed as described for Cfd12 in Figure 2.3, except both sets of data were fit to Eq. 
2.2. (B) Equilibrium binding of Nbp35-Cfd1 (0 – 125 μM dimer) to mantATP or mantADP 
was completed as described in Figure 2.3.  MantATP binding was fit to Eq. 2.2 and 
mantADP binding was fit to Eq. 2.3. 
 
 Next, the binding affinities of the unlabeled nucleotides ATP, ADP, and GTP were 




displacing mantATP from Nbp352, Cfd12, or Nbp35-Cfd1.  Unlabeled nucleotide binding 
is competitive with mantATP binding, outcompeting mantATP when introduced into the 
assay at higher concentrations.  As mantATP is displaced from the protein by the unlabeled 
nucleotide, the observed anisotropy value decreases.   
 
Figure 2.8. Displacement of MantATP with ATP, ADP, and GTP. 
The KD values of unlabeled nucleotides ATP (●), ADP (○), or GTP (×) was determined by 
adding increasing amounts of nucleotide into a solution containing 12.5 µM CIA scaffold 
and 0.5 µM mantATP. Panels A, B, and C show the data for Nbp352, Cfd12, and Nbp35-
Cfd1, respectively. The anisotropy of each sample was measured three times and the 
normalized, average anisotropy ± the standard deviation was plotted versus the 
concentration of unlabeled competitor. The resulting data was fit to Eq. 2.4 to determine 





The anisotropy values were plotted against the concentration of unlabeled 
nucleotide (ATP, ADP, or GTP) and the IC50 values calculated with Eq. 2.4.  The KD values 
of the unlabeled nucleotides were determined from IC50 values using Eq. 2.5 (Figure 2.8, 
Table 2.1).  Nbp35 binds ATP and ADP with similar dissociation constants of 140 ± 32 
µM and 300 ± 56 µM, respectively. 
Since Nbp352 is hydrolysis competent, the similarity in ATP and ADP affinity 
could have been from hydrolysis of ATP to ADP under the assay conditions.  HPLC was 
used to assess the extent of ATP hydrolysis by Nbp352 in these assays.  It was demonstrated 
that no ATP was converted to ADP over the course of the displacement assays (Figure 
2.9).  Therefore, ATP and ADP were confirmed to bind Nbp352 with similar affinities, 
much like the affinities observed for mantATP and mantADP binding to Nbp352 (Table 
2.1). 
 
Figure 2.9. Nbp35 Does Not Hydrolyze ATP in the Equilibrium Binding Assays. 
Nbp35’s ability to hydrolyze ATP under the conditions of the displacement assays was 
examined via HPLC analysis.  Nbp352 (12.5 μM) was incubated with ATP (10 mM) for 
the indicated time period and then acid quenched with 1 M HCl.  Chromatograms following 
incubation for 15 min or 60 min at 25˚C were indistinguishable from one another and the 






Displacement of mantATP by GTP was tested to determine the nucleotide 
specificity of the ATPase site and further investigate data outlined in a recent report that 
suggested Nbp35 orthologs bound GTP in the low-μM range.77  GTP was observed to 
displace mantATP from Nbp352, Cfd12 and Nbp35-Cfd1 at concentrations at least an order 
of magnitude greater than ATP or ADP (Figure 2.8, Table 2.1).  The displacement assay 
results corroborated the results observed with the mantGTP binding assays (Figure 2.4).   
2.3.5 Cfd1 Controls Nucleotide Binding in the Heterodimer 
 The nucleotide binding affinities of Cfd12 and Nbp35-Cfd1 were similar to each 
other, but differed from the nucleotide binding exhibited by Nbp352 (Table 2.1).  These 
binding assays were performed under conditions where the protein concentration was in 
excess over the concentration of the mant-labeled nucleotides.  Under these conditions of 
excess protein concentration, only one of the two ATPase sites is likely to be occupied by 
nucleotide.  Therefore, the observed binding affinities are for the highest affinity ATPase 
site of the dimer.  As such, the ATPase site of the Cfd1 subunit of Nbp35-Cfd1 was 
hypothesized to be the high affinity binding site in the heterodimer, given the similarities 
in the nucleotide binding affinities between Cfd12 and Nbp35-Cfd1.  Comparatively, the 
ATPase site of the Nbp35 subunit in Nbp35-Cfd1 would be the low affinity binding site.  
To test this hypothesis, mutations were made to ATPase site residues of Nbp35-
Cfd1 that were important for nucleotide binding.  Three individual Nbp35-Cfd1 constructs 
were made with a mutation to one of the three conserved residues of the ATPase site of 
Nbp35 (Figure 2.1A): S87 in the deviant Walker A motif, D109 in the Switch I motif, and 




fold decrease in mantATP affinity of Nbp352 as assessed by FA assays (Figure 2.10, Table 
2.3).  If Cfd1 is the high affinity subunit in Nbp35-Cfd1, then the mutations at the Nbp35 
subunit should have no effect on the mantATP affinity of Nbp35-Cfd1.  While each 
mutation decreased the mantATP affinity in Nbp352, no change in the affinity was 
observed when the same mutation was introduced into Nbp35-Cfd1 (Figure 2.10, Table 
2.3).  The observation that Nbp35 mutations do not alter the heterodimer’s mantATP 
affinity is consistent with the hypothesis that Cfd1 is the high affinity binding site in 
Nbp35-Cfd1.  
Table 2.3. MantATP Affinity of Site-Directed Mutants 
CIA Scaffold 
Variant 
Dissociation Constant (μM) 
Homodimer Heterodimer 
Nbp35WT 21 ± 6 14 ± 1 
Nbp35S87A 230 ± 46 16 ± 2 
Nbp35D109N  190 ± 28 14 ± 1 
Nbp35N247A 180 ± 47 21 ± 2 
Cfd1WT 9.7 ± 0.5 14±1 
Cfd1S32A 110 ± 10 180 ± 34 
Cfd1D53A 140 ± 20 73 ± 5 
Cfd1N195A 95 ± 15 110 ± 20 
 
To gain information on the nucleotide binding affinity of the Nbp35 subunit in 
Nbp35-Cfd1, nucleotide binding to Nbp35 had to be isolated from binding to Cfd1.  In an 
attempt to monitor nucleotide binding solely at the Nbp35 subunit, mutations were made 
to the Cfd1 subunit that were expected to decrease Cfd1’s nucleotide affinity.  Residues in 
Cfd1 were mutated that were equivalent to the residues mutated above in Nbp35: S32 in 
the deviant Walker A motif, D53 in Switch I, and N195 in the A-loop (Figure 2.1A).  
Alanine substitution at these positions in Cfd12 decreased mantATP affinity by eight to 





Figure 2.10. Equilibrium Binding of mantATP to Homo- and Heterodimer Mutants. 
MantATP (0.5 µM) was titrated with Nbp352, Cfd12, or Nbp35-Cfd1 (0 – 150 μM dimer) 
as indicated in the legend for each plot. Mutations are to the Walker A serine (top), Switch 
I aspartate (middle), or A-loop asparagine (bottom) of Nbp35 (left) or Cfd1 (right). The 
data were analyzed as described in Figure 2.3 except the anisotropy values of the site 
directed mutants was corrected for non-specific binding. The data were fit to Eq. 2.2, 
constraining the maximum anisotropy of the mutants to the value determined for the 
corresponding wild-type construct.  Grey points and dashed lines indicate the heterodimer 
mutants.  Solid black indicates anisotropy values observed for mantATP binding to Nbp35-
Cfd1 or the homodimeric mutants.  The colors of the boxes indicate the ATPase site motif 





Therefore, the same Cfd1 mutations in the heterodimer were expected to bind with 
affinities close to 21 μM, based on the mantATP affinity of Nbp352.  However, the binding 
affinities were 3- to 9-fold weaker than the ~21 μM expected (Figure 2.10, Table 2.3). 
The results unexpectedly demonstrated that the binding affinity of nucleotide to the 
Nbp35 subunit could not be isolated via site-directed mutagenesis.  One of two models 
could explain why the Nbp35 subunit is apparently unable to independently bind nucleotide 
in the heterodimer with an affinity similar to that as the homodimer.  In the first model, the 
Nbp35 and Cfd1 ATPase sites have vastly different nucleotide affinities.  Nbp35 affinity 
could be several orders of magnitude lower than Cfd1’s affinity such that the Cfd1 subunit 
is the high affinity site and therefore the preferred site for nucleotide binding in Nbp35-
Cfd1 (Figure 2.11A).  In this model, the Cfd1 subunit always possesses the high affinity 
nucleotide binding site in the heterodimer, even in variants in which the Cfd1 ATPase site 
is mutated.  The second model is that nucleotide binding to the ATPase sites of the 
heterodimer is cooperative.  In this scenario, nucleotide binds to Cfd1, increasing the 
nucleotide affinity of the Nbp35 subunit (Figure 2.11B). 
To discriminate between these two possibilities, the number of nucleotide 
equivalents binding to the heterodimer was assessed (Figure 2.11).  If Nbp35 contains a 
low affinity binding site (with a higher KD than the Cfd1 site), only one equivalent of 
nucleotide will bind to the heterodimer (at the Cfd1 site).  Yet, if both Nbp35 and Cfd1 
have similar affinities for nucleotide in a cooperative model, it is expected that two 





Figure 2.11. Nucleotide Binding Model to Nbp35-Cfd1 
(A) If Cfd1 subunit binds mantADP with an affinity (𝐾𝐷
𝐶) that is orders of magnitude 
greater than the Nbp35 subunit affinity (𝐾𝑁
𝐶), mantADP is expected to only bind to the 
Cfd1 subunit under the conditions of the assay.  Moreover, mutations to the Nbp35 subunit 
should not change the measured stoichiometry.  (B) If the affinities of the two subunits are 
both in the mid-low micromolar range then two molecules of mantADP should bind to the 
heterodimer. Additionally, mutations to the Nbp35 subunit that diminish nucleotide affinity 




Titrations of mantADP with Nbp35-Cfd1 was carried out to differentiate between 
the two scenarios outlined above.  A solution of 25 μM mantADP, which is 25-fold greater 
than the KD for Cfd12 and 3-fold greater than the KD for Nbp352 binding (Table 2.1), was 
titrated with increasing concentrations of Nbp35-Cfd1.  The anisotropy was plotted against 
the concentration of Nbp35-Cfd1 and the number of mantADP molecules bound per dimer 
was determined from the intersection points of the linear portions of the plotted data.  
Nbp35-Cfd1 was found to bind 1.6 ± 0.1 equivalents of mantADP per dimer (Figure 




of nucleotide are binding per dimer.  However, 1.6 is between 1 and 2, so a method was 
needed to determine if Nbp35-Cfd1 was binding 1 or 2 equivalents of nucleotide. 
Table 2.4. MantADP Stoichiometry and Binding Affinities 




WT 1.6 ± 0.1 7.9 ± 0.4 
G80A 2.0 ± 0.2 9.1 ± 1.6 
D109N 1.2 ± 0.04 110 ± 20 
N247A 1.4 ± 0.1 280 ± 70 




Figure 2.12. MantADP Titration 
MantADP (25 μM) was titrated with the indicated Nbp35-Cfd1 variant. Data was collected 
and analyzed as described in Figure 2.5. Concentration of Nbp35-Cfd1 is plotted as the 






 To differentiate whether Nbp35-Cfd1 was binding 1 or 2 equivalents of mantADP 
per dimer, the stoichiometry values of nucleotide binding to Nbp35 heterodimer mutants 
were assessed.  If Nbp35 binds nucleotide in the heterodimer, then mutants that decrease 
Nbp35’s mantADP affinity should decrease the number of bound mantADP per 
heterodimer.  Two Nbp352 mutants, 
D109NNbp352 and 
N247ANbp352, were determined to 
bind mantADP with affinities that were 13- to 35-fold weaker than that of Nbp352 (Figure 
2.13, Table 2.4). 
 
Figure 2.13. MantADP Binding to Nbp352 Variants 
MantADP (0.5μM) was titrated with the indicated Nbp352 variants (0 – 125 μM) as 
described for Figure 2.3. Data were fit to Eq. 2.2. 
 
Titrations of mantADP with D109NNbp35-Cfd1 or N247ANbp35-Cfd1 were carried 
out and the intersection points were shifted to the right as compared to WTNbp35-Cfd1 
(Figure 2.12C/D).  D109NNbp35-Cfd1 bound 1.2 ± 0.04 mantADP per dimer and 
N247ANbp35-Cfd1 bound 1.4 ± 0.1 mantADP per dimer after three independent 
determinations (Figure 2.12, Table 2.4).  Another Nbp35 homodimer mutant, G80ANbp352, 
binds mantADP with an affinity similar to WTNbp352 (Figure 2.13, Table 2.4) and was 




mantADP bound per dimer (Figures 2.12, 2.13, Table 2.4).  The WT level of mantADP 
stoichiometry observed with G80A is consistent with a model of nucleotide binding in 
which the Nbp35 subunit of Nbp35-Cfd1 is able to bind nucleotide. 
2.4 Discussion 
 Nbp35 and Cfd1 are both required for cytosolic iron sulfur cluster assembly in 
yeast.23, 66, 69  Each subunit must be performing a distinct function, as loss of either Cfd1 or 
Nbp35 is lethal in vivo.23, 75  To determine what the functions are for each subunit, this 
chapter has explored the nucleotide binding affinity of Nbp352, Cfd12, and Nbp35-Cfd1.  
Mutagenesis of the ATPase site in conjunction with FA based binding affinity assays has 
provided key information for delineating the individual roles of the subunits.  Nbp352, 
Cfd12, and Nbp35-Cfd1 were assessed for their ability to specifically bind nucleotide and 
fluorescent nucleotide analogs.   
Adenine nucleotides are proposed to be the physiologically relevant substrates of 
the CIA scaffold, based on the results above and the previously observed specificity of 
other deviant Walker A proteins containing a conserved A-loop asparagine.  GTP had 
recently been reported to be the preferred nucleotide substrate, preferentially binding to 
two Nbp352 orthologs (human and C. thermophilum) as measured by thermophoresis.
77  
This GTP preference was at odds with both the study published previously in which there 
was no observable GTPase activity110, and with the results of the displacement assays 
described above.  MantGTP binding experiments were carried out to confirm which of the 
two purines was the physiologically relevant substrate.  The results of the FA binding 




resulted in anisotropy values that suggested little to no binding (Figure 2.4).  The results 
of the FA binding experiments corroborate the results observed in the displacement assays 
(Figure 2.8). 
 
Figure 2.14. Structural Plot of ATP bound to ATPase Site. 
(A) ATP or (B) GTP interactions with residues of the ATPase site based on the structure 
of 3KB1.  The asparagine (Asn190) makes two contacts with the adenine base that would 
be missing in an interaction with GTP (red arrow). 
 
The binding specificity of adenine nucleotide is further supported by the presence 
of a conserved asparagine residue in Nbp35 (N247) and Cfd1 (N195) (Figure 2.1).  This 
residue is conserved in other deviant Walker A ATPases including ArsA, NifH, Get3, and 




asparagine makes contacts with the adenine base (Figure 2.14) and mutation of this residue 
to alanine in Nbp35 or Cfd1 decreases mantATP affinity (Table 2.3).  As this asparagine 
residue would potentially make unfavorable contacts to a guanine nucleotide, it was 
thought that mutation of this residue to an alanine might allow for mantGTP to bind, yet 
N247ANbp352 did not bind mantGTP, evidenced by anisotropy values that were not above 
background levels (Figure 2.4).   
 The results within this chapter suggest that Cfd1 is hydrolysis competent when 
complexed with Nbp35 in the context of the Nbp35-Cfd1 heterodimer.  The specific and 
stoichiometric binding of adenine nucleotides to Cfd12 and the conservation of ATPase 
motifs predicts that Cfd12 should be able to hydrolyze ATP.  Previous work in our lab, 
however, has demonstrated that Cfd12 has no detectable ATPase activity, despite the 
prediction that it should be able to hydrolyze ATP.  Both Nbp352 and Nbp35-Cfd1 did have 
detectable ATPase activity.110  Nbp352 hydrolyzed 4.6 ± 0.1 ATP min
-1 with a Km value of 
0.4 ± 0.1 mM.110  On the other hand, the kcat of Nbp35-Cfd1 was similar to that of Nbp352 
at 3.9 ± 0.2 min-1, but the Km increased by an order of magnitude to 5.0 ± 0.6 mM.
110  
Interestingly, mutation of either of the two Walker A lysine residues (K26 or K31) in the 
Cfd1 subunit of Nbp35-Cfd1 reduced ATPase activity to background levels.110  Mutation 
of K26 or K31 did not alter the binding affinity of mantATP (Figure 2.6, Table 2.2) 
meaning that the hydrolysis defect in Nbp35-Cfd1 was not due to an inability of the Cfd1 
mutant to bind nucleotide.  Cfd1’s ATPase activity is dependent on its binding partner, as 




The differences in Cfd1’s partner dependent ATPase activity is likely linked to the 
conformation of Cfd1 when bound to Nbp35 (Nbp35-Cfd1) versus when bound to Cfd1 
(Cfd12).  In other deviant Walker A proteins, the binding of nucleotide is known to cause 
conformational changes which places the signature lysine residue of one Walker A motif 
in the other protomer’s ATPase site.  This conformational change typically initiates 
nucleotide hydrolysis.  Cfd12 is therefore hypothesized to be unable to undergo the 
conformational change, resulting in its undetectable ATPase activity.  However, when 
Cfd1 is complexed with Nbp35, it can undergo these changes and be active for hydrolysis.  
Since nucleotide hydrolysis is proposed to be required for scaffold function, Cfd12 is likely 
not a physiologically relevant form of the scaffold in vivo.76, 111 
While the Nbp35 subunit activates the Cfd1 subunit for hydrolysis in Nbp35-Cfd1, 
Cfd1 was found to be regulating nucleotide binding to both ATPase sites of Nbp35-Cfd1. 
Site directed mutagenesis of the ATPase sites in Nbp35-Cfd1 was used to isolate nucleotide 
binding at either Cfd1 or Nbp35 subunit.  Mutations to the Nbp35 subunit of Nbp35-Cfd1 
did not change the binding affinities of mantATP although they did decrease binding in 
Nbp352 (Figure 2.10, Table 2.3).  The lack of change in nucleotide affinity in Nbp35 
mutants in the heterodimer supported the idea that nucleotide binding to Nbp35-Cfd1 had 
only been reporting on the Cfd1 subunit’s affinity.  Conversely, Cfd1 mutants resulted in 
decreased affinities when introduced in either Nbp35-Cfd1 or Cfd12 (Figure 2.10, Table 
2.3).  One possibility was that Nbp35 could not bind nucleotide in Nbp35-Cfd1.  However, 
mantADP assays indicated that both ATPase sites of Nbp35-Cfd1 were occupied in the 




Nbp35-Cfd1 are occupied under physiological concentrations of ATP, the binding of which 
is regulated by the Cfd1 subunit.   
2.5. Conclusions 
The heterodimeric quaternary structure of the Nbp35-Cfd1 scaffold is atypical of 
the deviant Walker A family.  Almost all of the other family members form obligate 
homodimers as the minimal functional unit.  To our knowledge, ArsA is the only other 
member that does not form a homodimer.115, 146  ArsA is involved in heavy metal efflux 
and forms a pseudodimer, with two deviant Walker A domains fused together in a single 
peptide.  The two ATPase sites of ArsA were differentiated in a mutagenesis approach that 
was similar to the one used in this chapter.  These experiments revealed that the two 
ATPase sites in ArsA are made up of one high affinity binding site and one low affinity 
binding site.149-152  Additionally, the binding of heavy metal (arsenite or antimonite) to 
ArsA elicits both an increase in nucleotide binding affinity and hydrolysis rates.153, 154  The 
changes in nucleotide binding and hydrolysis induced by ‘cargo’ acquisition by a protein 
was also observed for Nbp35-Cfd1 and will be covered in detail in Chapter 3.157 
Even though the other deviant Walker A family members form homodimers, there 
is growing evidence for some amount of asymmetry in their ATPase activities.  MinD for 
example has been proposed to link asymmetric ATP binding and hydrolysis to the 
regulation of MinD’s dynamic interactions with the partner proteins MinC and MinE.114, 
135, 136, 138, 160  Asymmetric ATPase activity has also been observed in the nitrogenase iron 
protein NifH, another member of the deviant Walker A family.161, 162  These asymmetric 




complex.  One regulatory function of the asymmetry of NifH ATPase activity could be to 
control electron transfer into the catalytic MoFe subunit.161, 162  In Nbp35-Cfd1, it will be 
interesting to elucidate how the asymmetry of the two subunits’ ATPase activity and 





CHAPTER 3: Linking Nucleotide Binding and Hydrolysis to the FeS Cluster 
Acquisition and Transfer Steps of FeS Cluster Biogenesis 
(Adapted from Grossman et al., (2019), Biochemistry 58, 2017-2027.) 
 
3.1 Introduction 
The Nbp35-Cfd1 complex is proposed to be the scaffold for FeS cluster biogenesis 
in the CIA pathway.23, 66, 69  An interesting feature of Nbp35 and Cfd1 is that they each 
possess an ATPase site.66, 76, 110  It has recently come to light that this ATPase site is 
required for FeS cluster assembly, as evidenced by genetic studies with Nbp35.66, 76  Other 
information has been obtained from the bacterial Nbp35/Cfd1 homolog ApbC.  The 
ATPase site of ApbC was demonstrated to be involved in the steps of FeS biogenesis via 
in vitro experiments.111, 112  Yet there is a lack of information on how the ATPase and 
scaffolding activities synergize with one another.25, 76, 111   
Nbp35 and Cfd1 share a number of key features that are integral in their ATPase 
and cluster scaffolding activities.  In the three quaternary structures of the CIA scaffolding 
complex (Nbp352, Cfd12, and Nbp35-Cfd1) two pairs of cysteine residues come together 
at the dimer interface and ligate a [Fe4S4] cluster called the bridging cluster (Figure 3.1A, 
D).76, 77  Additionally, both of the ATPase sites of Nbp35 and Cfd1 contain four conserved 
motifs: deviant Walker A, Switch I, Switch II, and A-loop (Figure 3.1).  All four of these 
motifs have a specific or proposed role in ATP hydrolysis by Nbp35-Cfd1.  The deviant 
Walker A motif, with the sequence GKGGhGK[T/S], contains a signature lysine residue 
(underlined) that differentiates it from the canonical Walker A motif, which lacks this extra 




for Nbp35-Cfd1 undergoing a nucleotide dependent conformational change, as the 
signature lysine reaches across the dimer interface to make contacts with the ATP bound 
at the other subunit.78, 110, 114, 121  Similarly, the residues of Switch I and II are proposed to 
be responsible for nucleotide dependent conformational changes in Nbp35-Cfd1 and has 
been demonstrated with other deviant Walker A proteins.136, 142, 144, 145, 163   
 
Figure 3.1. Domains and Motifs of Nbp35 
(A) Schematic of Nbp35’s primary structure depicting the positions of the FeS cluster 
binding and ATPase site.  The sequences of Nbp35’s ATPase site motifs are shown in the 
boxes.  The residues targeted for mutagenesis are shown in red.  (B) The structure of 
3KB1’s ATPase site bound with ADP (green).  3KB1 is an archaeal homolog of Nbp35.164  
Conserved motifs are shown as ribbons and are color coded as in panel (A).  Sticks 
represent the residues that are homologous to those targeted for mutation in Nbp35.  (C) 
The conserved ATPase site motifs of C. thermophilum Cfd1 (PDB Accession 6G2G).  
Sticks represent the homologous residues that were targeted for mutation in Nbp35 and are 
color coded as in panel (B).77  (D) Structure of C. thermophilum Cfd12 bound to a [Fe4S4] 
(spheres).77  Subunits are depicted in cyan with the ATPase site motifs color coded as in 




These conformational changes are thought to be key in allowing for nucleotide binding via 
structural rearrangement to direct interactions between individual subunits and protein-
protein interactions.  Finally, the A-loop includes a conserved asparagine residue (N247) 
which has been shown to make contacts with the adenine base of ATP or ADP in the 
archaeal ortholog 3KB1 and in the bacterial deviant Walker A protein MinD (Figure 
3.1B).133, 142, 159   
Studies with the yeast proteins, Nbp35-Cfd1, and their bacterial homolog, ApbC, 
have provided preliminary evidence that cluster biogenesis and ATP hydrolysis are 
linked,111, 112 but identifying the biochemical basis for how and why the two activities are 
linked has been challenging.  Nbp35 and Cfd1 are essential proteins, making mutagenesis 
and genetics based studies difficult, as mutations to Nbp35 and Cfd1 are generally lethal, 
limiting the information that can be gained from these studies.  The ATPase and cluster 
biogenesis activities are also uncoupled in vitro.76, 110, 111  For example, the rate of FeS 
cluster transfer from bacterial ApbC to the FeS protein target Leu1 did not change in the 
presence of ATP.112  Another example is that the presence of either ATP or GTP did not 
change the EPR spectra of the bridging [Fe4S4] cluster.
76  The rate of ATP hydrolysis by 
Nbp35-Cfd1 and the bacterial homolog ApbC was unaffected by the presence of the [Fe4S4] 
cluster(s).110, 111  The only in vitro evidence for the coupling of these two activities is found 
in ApbC, as mutation of the conserved lysine residues in the ATPase site halved the rate of 
cluster transfer to Leu1.111, 112  Altogether, the molecular basis of the role of ATP hydrolysis 






Figure 3.2. Proposed Cluster Scaffolding Cycle. 
Clockwise, from top left.  Nbp35-Cfd1 binds ATP which is proposed to induce a 
conformational change.  A [Fe4S4] cluster is then assembled at the dimer interface from 
iron, sulfide, and reducing equivalents.  The bridging cluster is then transferred a recipient 
protein.  The involvement of ATP binding, hydrolysis, and release of ADP and Pi within 
this cycle has not yet been defined, but proposed steps of where these events occur are 
depicted.  ‘AXP’ denotes either ATP or ADP. 
 
 
The hypothesis investigated within this chapter is that Nbp35-Cfd1 is coupling ATP 
binding and hydrolysis to regulation and coordination of FeS cluster biogenesis.  This 
chapter demonstrates that nucleotide binding and hydrolysis are necessary for both the 
cluster assembly and cluster transfer steps in the cluster biogenesis cycle (Figure 3.2).  
These findings corroborate the earlier reports of the ATPase site being required for cluster 
acquisition, and further expands upon our understanding of the cluster biogenesis 
reaction.66, 76  Although Cfd12 has no detectable ATPase activity, it binds ATP and ADP 
with affinities that are comparable to those of the hydrolysis capable Nbp352 and Nbp35-




and the ATPase site was established. The presence of the [Fe4S4] bridging cluster 
diminished affinity for two fluorescent nucleotide analogues when compared to apo-
Nbp35-Cfd1.  The data presented herein was used to generate a model for the FeS cluster 
scaffolding cycle.  First, ATP binds to the scaffold to initiate cluster assembly.  A 
conformational change is proposed to follow, which prepares the scaffold for the 
subsequent assembly of the bridging cluster.  The cluster is then transferred to a target 
protein and Nbp35-Cfd1 resets to begin the cycle again. 
3.2 Materials and Methods 
3.2.1 Leu1 and ADH Activity Assays.   
Isopropylmalate isomerase (Leu1) and alcohol dehydrogenase (ADH) activity 
assays were carried out as previously described.165  Briefly, plasmids harboring each 
Nbp35 variant were constructed with the Nbp35 allele under control of a methionine 
repressible promoter in the pRS314 vector (pRS314-MET3.1-MutNbp35).  These constructs 
were transformed into the Nbp35-tsm (translation start codon mutation) yeast strain 
(courtesy of Dr. William Walden) which decreases Nbp35 expression to ~10% that of wild-
type (Figure 3.3C).69, 75  Overnight cultures (50 mL in SD-His-Trp media) were grown for 
20 h at 30°C in the presence of 2.5 mM methionine.  Cells were collected via centrifugation, 
washed three times with sterile water, and then resuspended in 50 mL SD-His-Trp-Met-
Leu at a starting OD600 of 0.02.  The cells were grown overnight (20 h at 30 °C) to an OD600 
of 3.0.  The cells were collected via centrifugation and the cell pellet frozen at -80 °C.   
The frozen cell pellet was brought into the Coy chamber and resuspended in 250 




Triton X-100) in a 2 mL tube containing 250 μL glass beads (sterilized, ~1 mm diameter).  
Cells were mechanically lysed by vortexing for 1 min, then incubating on ice for 2 min, for 
a total of six repeats.  Protein concentration of the cell lysate was assessed by Bradford 
assay. 
Leu1 activity assays (500 μL) contained 40-300 μg protein extract in 100 mM Tris-
HCl (pH 7.5), 250 mM NaCl, and 400 μM beta-isopropylmalate (β-IPM) in a 2 mm cuvette.  
Immediately before the assay, an aliquot of the lysate (5-20 μL) was removed from the Coy 
box and directly added to the cuvette, initiating the reaction.  The assay mixture was 
incubated at 25°C and Leu1 activity was determined from the slope of the absorbance 
increase at 235 nm from 0 – 10 minutes.  The 235 nm wavelength detects the double bond 
formed during the isomerization of β-IPM to dimethylcitraconate.166  The change in 
absorbance value was converted to the change in concentration of the conjugated double 
bonded intermediate of the reaction by dividing the slope of the absorbance by the 
extinction coefficient 4.35 mM-1 cm-1.165, 166  Specific activity was determined by 
calculating μmoles of β-IPM intermediate formed per minute per mg of protein in the assay. 
ADH activity assays (500 μL) contained 4-8 μg protein extract in 50 mM Tris-HCl 
(pH 8.8), 250 mM NaCl, 3.8% (v/v) ethanol, and 20 mM NAD+.  The assay mixture 
excluding extract was preincubated at 25°C for 5 min before the reaction was initiated by 
the addition of extract.  The activity of ADH was determined from the slope of the 
absorbance increase at 340 nm over 5-10 min at 25 °C.  The 340 nm wavelength reports 
on NAD+ reduction to NADH from the dehydrogenase reaction.  Absorbance values were 




extinction coefficient 6.22 mM-1 cm-1.165  Specific activity was determined by calculating 
μmoles of NADH formed per minute per mg of protein in the assay. 
3.2.2 Cloning of SSTNbp35-HisCfd1.   
A Twin-Strep tag167 was added to the N-terminus of Nbp35 by inserting a sequence 
encoding for a flexible linker, a second Strep tag, and a TEV protease site between Nbp35 
and the existing Strep sequence.  The resulting construct incorporates a Strep-Linker-Strep-
TEV sequence (WSHPQFEKGGGSGGGSGGSAWSHPQFEKENLYFQGH) at the N-
terminus of Nbp35.  This was accomplished via a two-step assembly reaction using primers 
JDG16 and JDG17 to amplify the Nbp35-Cfd1 vector and create the ends of the SST 
sequence, followed by a Gibson assembly reaction (New England Biolabs) using primers 
JDG18 and JDG19 to complete the SST sequence and create pJDG14 (SSTNbp35-HisCfd1 
in pRSFDuet).  Primer sequences are listed in Table 3.1 and Table AII.7. 
3.2.3 Site-Directed Mutagenesis, Protein Expression and Purification.   
The N247A, D111A, D111N, K81R, and G80A mutations in Nbp35 or Nbp35-
Cfd1 were generated via Q5-mutagenesis (New England Biolabs) (Table 3.1).  A deletion 
mutant with the 53 N-terminal residues of Nbp35 deleted, termed Δ53Nbp35-Cfd1, was 
generated via Gibson Assembly Cloning (New England Biolabs) using primers JDG08, 
JDG09, and JDG10 (Table 3.1). All constructs were confirmed by DNA sequencing.  Other 
mutants included in this chapter (K86A, D109A, D109N) were created by Eric Camire and 
Grace Thole as previously reported.110  Nbp35 and Nbp35-Cfd1 were overexpressed in E. 





Table 3.1. Primers used for generation of StrepStrepTEV Nbp35-Cfd1 constructs 















































































3.2.4 Reconstitution of FeS Clusters.   
Aerobically purified Nbp35-Cfd1 (typically 1-2 mL of 3–5 mg/mL) was brought 
into the Coy chamber, pre-reduced with dithiothreitol (DTT, 5 mM), and degassed for 2 h 
with gentle stirring.  The protein was diluted to 1.0-1.5 mg/mL with Tris-buffered saline 
(TBS-Box; 50 mM Tris•HCl (pH 8), 100 mM NaCl, 4% glycerol) supplemented with 5 
mM DTT.  Ferrous ammonium sulfate (10 mM) was added dropwise to a final 
concentration that was 12-fold molar excess of the dimer concentration.  The reaction was 
stirred for 10 min at room temperature.  Sodium sulfide (10 mM) was then added dropwise 
to a final concentration that was 12-fold molar excess to the dimer concentration.  The 
reactions were incubated for 2 h at 4 ˚C with gentle stirring.  Excess iron and sulfide was 
removed by passage through a 20 mL G25 column and eluted with anaerobic TBS-Box 
buffer.  Protein was concentrated via an Amicon centrifugal filter unit (10k MWCO) to 7-
10 mg/mL.  Protein concentration was determined by Bradford assay using BSA as a 
standard.  Iron and acid labile sulfur were quantified as described in Appendix I.155, 168, 169 
3.2.5 Fluorescence Anisotropy Binding Assays.   
Equilibrium binding experiments utilizing 2’/3’-O-(N-methylanthraniloyl)-ATP 
(mantATP) were carried out as described in Chapter 2 Section 2.2.3).110 For experiments 
with BODIPY-FL 2’-/3’-O-(N-(2-aminoethyl)urethane ATP (BoATP), the fluorescent 
ATP analogue (0.5 µM) was incubated with scaffold variants (0-300 µM monomer) at 25 
˚C for 1 h in TBS Anisotropy Buffer (TBS-AB; 50 mM Tris-HCl (pH 8), 100 mM NaCl, 
10 mM MgCl2, 0.1 mg/mL BSA, 10% glycerol, and 5 mM DTT) in an opaque, 96-well 




nm and measuring fluorescence polarization at 512 nm using a 495 nm cutoff filter.  The 
resulting anisotropy values were plotted versus the concentration of protein polypeptide 
and fit to a hyperbolic binding equation in GraphPad Prism 7 (Eq. 3.1). 
𝑟 = (𝑟𝑚𝑎𝑥 − 𝑟𝑚𝑖𝑛) × (
[𝑃𝑟𝑜𝑡]
[𝑃𝑟𝑜𝑡]+𝐾𝐷
) + 𝑟𝑚𝑖𝑛  
Eq. 3.1. Fluorescence Anisotropy Hyperbolic Binding Equation 
 
Where rmax is the maximum anisotropy, rmin is the minimum anisotropy, [Prot] is the 
monomeric protein concentration and KD is the dissociation constant.  For experiments 
with holo-Nbp35-Cfd1, the samples were prepared in the anaerobic chamber and removed 
from the box immediately before reading the anisotropy. 
3.2.6 Trinitrophenyl-ATP Binding Assays.   
Binding experiments with trinitrophenyl-ATP (TNP-ATP) were carried out at 25°C 
on a Horiba Jobin Yvon FluoroMax3 fluorimeter with a 1 cm path length cuvette outfitted 
with a screw cap and septum to maintain anaerobic conditions.  Samples (1.5 mL) 
contained 0.5 μM Nbp35-Cfd1 in TBS-TNP (50 mM Tris-HCl (pH 8), 100 mM NaCl, 1 
mM MgCl2, and 10% glycerol).  TNP-ATP was added incrementally through the septum 
via Hamilton syringe up to a final concentration of 10 μM.  After each TNP-ATP addition, 
the cuvette was mixed by inversion.  Fluorescence was recorded in triplicate by excitation 
at 469 nm and monitoring the fluorescence emission at 555 nm.  The total fluorescence 
data were averaged and corrected for the inner filter effect (Eq. 3.2). 
𝐹𝑐𝑜𝑟𝑟 = 𝐹𝑜𝑏𝑠* 10
(𝑂𝐷𝑒𝑥 + 𝑂𝐷𝑒𝑚)/2 
Eq. 3.2. Inner Filter Effect Correction 
 
In Eq. 3.2, Fcorr is the fluorescence corrected for the inner filter effect, Fobs is the observed 




absorbance at the emission wavelength.  After correction, the fluorescence of the samples 
in the presence and in the absence of protein were subtracted to obtain the change in 
fluorescence values (ΔF).  ΔF was plotted versus the concentration of TNP-ATP and fit to 
a quadratic model (Eq. 3.3) in GraphPad Prism 7. 




+ 𝛥𝐹𝑚𝑖𝑛  
Eq. 3.3. Total Fluorescence Quadratic Binding Equation 
 
In Eq. 3.3, F is the change is fluorescence, Fmax and Fmin are the maximal and minimal 
change in fluorescence, respectively, LT is the concentration of TNP-ATP, RT is the 
concentration of the polypeptide, and KD is the dissociation constant.  For experiments with 
holo-Nbp35-Cfd1, the samples were prepared in the anaerobic chamber then removed from 
the box in a stoppered cuvette.  TNP-ATP was added by Hamilton syringe through the 
septum of the stoppered cuvette. 
3.3 Results 
3.3.1 Nbp35’s ATPase Domain is Required for its Essential Function. 
3.3.1.1 Summary of Dr. Kelly Gay’s In Vivo Genetic Screens with Nbp35 
 
Dr. Kelly Gay, during her time as a graduate student in William Walden's lab 
(University of Illinois at Chicago), performed the in vivo assays and genetic screens 
described in this section.170  This work included an investigation into how mutation of 
Nbp35's ATPase site (Figure 3.1A) affected its ability to complement deletion of the wild-
type allele, which is essential.  At least one residue within each of the four ATPase motifs 
of Nbp35 (Figure 3.1) was mutated and evaluated via a plasmid shuffle assay (Figure 




WTNBP35 on a URA3 marked plasmid and a mutant nbp35 allele on a second plasmid 
marked with TRP1 (Figure 3.3A).75  Only transformants carrying a functional nbp35 allele 
will grow on media supplemented with 5-fluoroorotic acid (5-FOA) (Figure 3.3A).  Dr. 
Gay found that of the seven positions that were altered, only alterations to G80 were 
tolerated in the plasmid shuffle assay.  All other mutations to the motifs of the ATPase site 
(at residues K81, K86, D109, D111, D189, and N247), including conservative substitutions 
such as Asp  Glu/Asn, were not tolerated.  Therefore, the ATPase site of Nbp35 is 
exceedingly sensitive to mutation and is critical for Nbp35’s essential function.  
To demonstrate that the ATPase site mutations were affecting CIA function, Dr. 
Gay utilized an IRP1 reporter assay.75  Briefly, if CIA is functional, then IRP1 is converted 
to cytosolic aconitase and the IRP1 reporter strain can grow without supplementing 
glutamate to the growth media (Figure 3.3B).  However, if there is a defect in CIA 
function, then the cells will be auxotrophic for glutamate, as IRP1 will not be converted to 
cytosolic aconitase to provide isocitrate for downstream glutamate production.  When 
NBP35 was introduced into the IRP reporter strain, the cells were able to grow on glutamate 
deficient media.  Surprisingly, both G80 mutants displayed a growth defect even though 
they were able to support viability in the npb35 strain.  The activity of aconitase in 
extracts derived from the reporter strain transformed with the G80A or the G80D variants 





Figure 3.3. Yeast Strains and Genetic Screens Overview  
(A) In the plasmid shuffle assay, the Nbp35 deletion strain was transformed with a plasmid-
born NBP35WT. A mutant nbp35 allele, expressed from the ADH promoter, was introduced 
on a second plasmid. 5-FOA selects for loss of the NBP35WT plasmid. Only those yeast 
transformed with a functional nbp35 mutant allele will grow.  (B) The aco1 mutant strain 
is dependent on c-aconitase for glutamate biosynthesis. When CIA is nonfunctional, the 
FeS cluster of IRP1 is not assembled, resulting in glutamate auxotrophy due to a defect in 
c-aconitase activity. When CIA is functional, IRP1 is converted into c-aconitase, restoring 
glutamate biosynthesis. (C) The Nbp35-tsm strain was created by introduction of plasmid 
borne Nbp35TSM into the Nbp35 deletion strain. This translation start codon mutant results 
in a 90% reduction in Nbp35 expression, which is sufficient to maintain viability but 
insufficient to support high flux through the CIA pathway.69, 75 A mutant nbp35 allele, 
under a methionine repressible promoter, is introduced on a second plasmid. In the absence 




















WT + + - 100% + + 
G80A + - ND 75% ND ND 
G80D + x ND 60% ND ND 
K81A - x - 70% - - 
K86A - x + 20% ND ND 
D109A - x - 20% - - 
D111A - x + 20% ND ND 
D189A - ND5 ND ND ND ND 
N247A - ND ND ND ND ND 
1Relative to WT: (-) = Growth Defective, (x) = No Growth (Relative to WTNbp35) 
2(+) = Growth Inhibited, (-) = Not Growth Inhibited 
3Relative to WT: (+) WT Activity, (-) Decreased Activity 




In order to assess the nonviable Walker A and Switch I variants, Dr. Gay 
transformed the IRP1 reporter into the Nbp35 depletion strain, called Nbp35-tsm 
(translation start codon mutation, Figure 3.3C).  The reduced expression of Nbp35 in the 
Nbp35-tsm strain was enough to support viability, yet not sufficient to avoid glutamate 
auxotrophy.  Nbp35 variants were expressed with a methionine repressible promoter.  The 
Nbp35-tsm strain expressing either K81ANbp35, K86ANbp35, D109ANbp35, or D111ANbp35 
were all unable to grow on glutamate deficient media.  Expression of WTNbp35 restored 
glutamate dependent growth of the Nbp35-tsm strain.  These results indicate these variants 
are not able to support viability due to a defect in CIA function.   
Interestingly, the IRP1 reporter assays also revealed that the K86A and the D111A 
variants were growth inhibitory (Table 3.2).  Both of these variants displayed a growth 




should have been enough WTNbp35 present in the Nbp35-tsm strain to support viability.  
Thus the nonviable alleles form two phenotypic classes.  The K81A and D109A variants 
are recessive negative and the K86A and D111A mutants are dominant negative. 
Finally, Dr. Gay assessed iron acquisition by Nbp35 via metabolic labeling with 
radioactive 55Fe, immunoprecipitation of Nbp35, and quantification of incorporated 55Fe 
by liquid scintillation counting.  G80DNbp35 and G80ANbp35 was immunoprecipitated with 
~60% and ~75% of the iron, respectively, when compared to WTNbp35.  K86ANbp35, 
D109ANbp35, and D111ANbp35 only immunoprecipitated with ~20% of iron as compared to 
WTNbp35.  Interestingly, K81ANbp35 acquired ~70% of iron compared to WTNbp35, even 
though this mutant could not support viability and was defective for trafficking cluster to 
FeS protein targets (Table 3.2). 
3.3.1.2 Recessive Negative Phenotypes Result From Defective CIA 
 
 The Walker A and Switch I mutants were investigated to determine how they 
affected FeS cluster incorporation into the endogenous CIA substrates Leu1 and sulfite 
reductase.  Yeast cells expressing WTNbp35 in the Nbp35-tsm strain had two-fold higher 
Leu1 activity compared to the empty vector control (Figure 3.4A).  Yeast cells expressing 
K81ANbp35 and D109ANbp35 in the Nbp35-tsm strain did not increase Leu1 activity above 
that of the empty vector (Figure 3.4A, Table 3.2).  The activity of alcohol dehydrogenase 
(ADH) is independent of CIA function and was assayed as a control for each variant.  ADH 






Figure 3.4. Nbp35 Walker A and Switch I Mutations Affect CIA Function 
(A) Yeast cells (Nbp35-tsm strain) containing the indicated Nbp35 variants (EV; empty 
vector, WT; wild type) were grown to mid-log phase in SD-His-Trp-Met media. Extracts 
were prepared and the activity of Leu1 and alcohol dehydrogenase (ADH) were monitored.  
The activities of Leu1 and ADH are plotted for each Nbp35 variant tested.  Bars represent 
the average activity ± the standard deviation from three independent experiments.  (B) 
Yeast cells (Nbp35-tsm strain) containing the indicated Nbp35 variants were grown to mid-
log phase in SD-His-Trp media.  Cultures were spotted onto plates containing SD-His-Trp 
media in the absence, (-)Met, or presence, (+)Met, of methionine.  Plate media was 
supplemented with bismuth sulfite. The FeS dependent activity of sulfite reductase results 
in formation of a dark brown precipitate. 
 
 
A second assay was used to evaluate the activity of the FeS protein sulfite reductase, 
which is also dependent upon a functional CIA pathway.  To monitor sulfite reductase 
activity, the Nbp35-tsm strain was grown on plates containing bismuth ammonium citrate 
and sodium sulfite.  If sulfite reductase is active, a dark brown bismuth sulfide precipitate 
is formed.  The Nbp35-tsm strain was transformed with WTNbp35, K81ANbp35, D109ANbp35, 
or an empty vector (EV) control.  All transformants displayed a beige to light brown color 
when expression of the transformed Nbp35 variant was repressed with methionine, leaving 
only the expression of endogenous Nbp35 (Figure 3.3C, Figure 3.4B).  As a comparison, 




vector) were grown on a separate set of plates in the absence of methionine to express the 
Nbp35 mutant variant.  Only yeast expressing WTNbp35 turned a darker brown color, 
indicative of an increase in sulfite reductase activity above that observed solely with 
expression of endogenous Nbp35 (Figure 3.4B, Table 3.2).  Conversely, yeast expressing 
K81ANbp35 or D109ANbp35 did not change color.  Therefore, K81ANbp35 or D109ANbp35 do 
not contribute to an increase in sulfite reductase activity due to a compromised CIA system. 
3.3.2 Impact of ATPase Mutations on ATP Affinity and Hydrolysis Activity.   
Experiments were carried out to determine if the different phenotypes observed for 
Nbp35 mutants could be explained by differences in their ability to bind and hydrolyze 
ATP.  If nucleotide binding or hydrolysis defects are associated with separate steps of the 
scaffolding reaction cycle, it is expected that distinct phenotypes will be observed for 
defects in either nucleotide binding or hydrolysis.  By pairing nucleotide binding and 
hydrolysis data to the observed phenotypes for Nbp35 variants, a working model can be 
created to identify the role of nucleotide in CIA function.   
To determine how Nbp35 variants affect ATPase activity, the binding affinity of 
mantATP for each of the Nbp35 variants was assessed via fluorescence anisotropy 
assays.155  The K81ANbp35, D109ANbp35, and N247ANbp35 variants all bound mantATP with 
affinities that were 8- to 11-fold weaker than WTNbp35 (Figure 3.5A, Table 3.3).  
Therefore, the recessive negative alleles all exhibited diminished mantATP binding.  The 
dominant negative alleles (K86ANbp35 and D111ANbp35) and the partially functionally 
G80ANbp35 all displayed smaller deviations in mantATP affinity compared to the recessive 




functional mutants can bind nucleotide with smaller differences in mantATP affinity 
compared to the recessive negative mutants.  These data outline that a defect in Nbp35 
nucleotide binding results in a recessive negative phenotype. 
 
 
Figure 3.5. Equilibrium Binding of MantATP to Nbp352 Variants 
Variants are grouped by observed phenotype: recessive negative mutants (A), dominant 
negative mutants (B), and partially functional mutant (C).  Nbp35 variants (0-180 µM 
dimer) were added to 0.5 µM mantATP. The anisotropy was measured in triplicate and the 
average ± the standard deviation was plotted against the concentration of Nbp35. The KD 







Table 3.3. MantATP Binding Affinities for Nbp352 Mutants. 
Construct KD (μM)* 
Wild type 21 ± 6.4 
G80A 45 ±7.7 
K81A 160 ± 51 
K81R 24 ± 1.5** 
K86A 54 ± 17 
D109A 230 ± 38 
D111A 120 ± 22 
D111N 15 ± 2.3*** 
N247A 180 ± 47 
*Listed as the average ± standard deviation of three replicate measurements of at least 
three independent preparations. 
**From three replicate measurements of the same sample preparation 
***Obtained from the average ± standard deviation of two independent preparations. 
 
 
The ~6-fold weaker mantATP affinity observed for D111ANbp35 did not seem to fit 
with the other dominant negative and partially functional affinities which only differed by 
~2-fold (Table 3.3).  Dr. Gay had previously observed that substitution with asparagine, 
D111NNbp35, strengthened the dominant negative phenotype (greater degree of growth 
inhibition when compared to D111ANbp35).170  The KD of mantATP binding to 
D111NNbp35 
was determined to be 15 ± 2.3 μM (Figure 3.5B, Table 3.3).  Surprisingly, mantATP 
displacement assays revealed that D111NNbp35 bound ATP and ADP with KD values that 
were ~5-fold and 4-fold lower (respectively) as compared to WTNbp35 (Figure 3.6).  
Therefore, although separate mutations to D111 have been observed to either increase or 
decrease nucleotide affinity, both substitutions resulted in a construct that displayed a 





Figure 3.6. D111NNbp352 Binds ATP and ADP with Higher Affinity than WTNbp352 
Increasing amounts of the unlabeled nucleotide (ATP or ADP) were added into a solution 
containing 12.5 µM D111NNbp352 and 0.5 µM mantATP. The anisotropy was plotted against 
the concentration of nucleotide and the data was fit to Eq. 2.4 to determine the IC50. Eq. 
2.5 was applied to determine the KD values (ATP KD = 25 μM, ADP KD = 76 μM) 
 
 
The mutants were also assessed for nucleotide hydrolysis activity in the Nbp35-
Cfd1 heterodimer to understand if a hydrolysis defect was the cause of one of the observed 
phenotypes.  Nbp35 mutant variants that bound mantATP with an affinity similar to that 
of WTNbp35 were cloned into Nbp35-Cfd1 and their ATPase activity assessed via coupled 
enzyme assay.110, 155  Previously, D109NNbp35-Cfd1 had been determined to have no 
detectable ATPase activity.110  Similarly, N247ANbp35-Cfd1 and K81RNbp35-Cfd1 had no 
detectable ATPase activity (Figure 3.7B).  K81RNbp35 was chosen as an alternative to 
K81ANbp35 in these experiments as K81ANbp35-Cfd1 was unable to be isolated for 
analysis.110  K81RNbp35 bound mantATP with an affinity that was comparable to that of 
WTNbp35 (Figure 3.7A, 3.5A, Table 3.3), and could be produced and purified 
recombinantly.  The lack of detectable ATPase activity in D109NNbp35-Cfd1, N247ANbp35-




affinity (Table 3.3).  If a mutant has perturbed affinity for ATP, then it follows that ATP 
hydrolysis activity will also be compromised. 
 
 
Figure 3.7. Nbp35 Mutant mantATP Affinity and ATPase Activity. 
(A) The indicated Nbp35 variant (0-180 µM dimer) was added to 0.5 µM mantATP. 
Anisotropy data was measured and analyzed as described in Fig. 3.5.  (B) Rate of ATPase 
activity kobs (nmol ATP min
-1 nmol polypeptide-1) versus ATP concentration (mM).  Data 
shown is WTNbp35-Cfd1 (■), G80ANbp35-Cfd1 (○), K81RNbp35-Cfd1 (□), and N247ANbp35-
Cfd1 (Δ).  The shaded area represents the average background rate of ATPase hydrolysis 
in the activity assay.110 
 
 
3.3.3 Nbp35-Cfd1’s Affinity for ATP is Diminished by the Bridging Cluster  
The results presented above indicated that there was likely an allosteric link 
between the ATPase site and the cluster scaffolding site of Nbp35-Cfd1, contradicting 
earlier observations in which the ATPase activity of Nbp35-Cfd1 (and the homolog ApbC) 
was unaffected by the presence of the bridging FeS cluster.76, 110, 111  To resolve this 
apparent discrepancy, the FeS clusters of Nbp35-Cfd1 were investigated to determine if 
the clusters attenuated the nucleotide affinity of Nbp35-Cfd1.  Due to overlap of the FeS 
clusters’ absorbance with that of mantATP’s excitation wavelength, a new nucleotide 




Aminoethyl)Urethane)-ATP (BoATP).  BoATP has an absorbance/excitation maximum 
that is outside that of the FeS cluster envelope (Figure 3.8A, Table 3.4). 
 
 
Figure 3.8. Extinction Coefficients and Structures of Nucleotide Analogs. 
(A) The extinction coefficients (ε, in cm-1M-1) of the fluorescent nucleotides and holo-
Nbp35-Cfd1 are plotted against wavelength.  Spectra were generated by determining the 
concentration of each analog using measured absorbance values and ε values reported in 
the literature, listed in Table 3.4.  The calculated concentration for each analog was applied 
across the entire absorbance spectrum to determine the ε at each wavelength.  For holo-
Nbp35-Cfd1, the ε of a [Fe4S4] cluster at 410 nm was used,
172 assuming a stoichiometry of 
two [Fe4S4] clusters per Nbp35-Cfd1 (ε of Nbp35-Cfd1’s FeS clusters have not been 
determined).  For TNP-ATP, the absorbance and ε at 470nm was used.  Note that the 
absorbance of holo-Nbp35-Cfd1 at 410nm overlaps with the absorbance of TNP-ATP’s 
first peak at 408nm and the absorbance of mantATP at its peak of 355 nm.  The absorbance 
values of TNP-ATP’s second peak and BoATP’s peak (470 and 505nm respectively) are 
outside the influence of the FeS cluster.  The ε used for calculations with BoATP is 
assumed to be the same as the ε for the free BODIPY moiety,173 as an extinction coefficient 
for BODIPY-FL-ATP is not explicitly reported in the literature.  The ε value for free 
BODIPY is in line with other BODIPY functionalized molecules.  The structures of 





Table 3.4. Absorbance Characteristics of [Fe4S4] and Nucleotide Analogs 
Molecule λpeak (nm) ε at λpeak (cm-1M-1) Ref. Notes 
[Fe4S4] 410 16,000 
172 - 
mantATP 355 5,800 174 - 
BoATP 505 80,000 173 ε for BODIPY moiety 
alone 
TNP-ATP 408 & 470 26,400 & 18,500 175 Excitation occurs at 
both wavelengths listed 
 
BoATP was titrated with increasing concentrations of Cfd12, Nbp352, or Nbp35-
Cfd1 and the KD was measured as a function of the increase in fluorescence anisotropy.  
BoATP bound with mid- to low-micromolar affinity to both Cfd12 and Nbp35-Cfd1, as 
evidenced by the hyperbolic increase in fluorescence anisotropy as the concentration of 
protein increased (Figure 3.9A).  However, there was no significant anisotropy change 
with BoATP and Nbp352 (Figure 3.9A).  
 
Figure 3.9. BoATP Binds to Nbp352 but Anisotropy Signal Does Not Increase. 
(A) Equilibrium binding of (0.5 μM) BoATP to (0 – 60 μM) Cfd12 (▲), Nbp352 (■), and 
Nbp35-Cfd1 (●).  BoATP binding to Nbp352 does not result in a significant change in 
anisotropy.  Anisotropy of BoATP binding to Nbp35-Cfd1 in the presence of 25 mM 
EDTA (+) gives background levels of anisotropy.  (B) Displacement of mantATP from 
Nbp352 by BoATP.  The KD (from Eq. 2.4, 2.5) is estimated to be greater than 10
-4 M. 
 
The lack of change in anisotropy for BoATP titrated with Nbp352 could result from 




flexible linker between the nucleotide and the fluorophore (Figure 3.8C) allows for 
significant movement, even when BoATP is bound.  To discriminate between these two 
possibilities, the ability of BoATP to displace mantATP was examined via a competition 
assay.  As increasing amounts of BoATP were added into a solution of Nbp352 and 
mantATP, there was a corresponding drop in the observed anisotropy of mantATP (Figure 
3.9B).  Although mantATP was unable to be completely displaced from Nbp352, the 
estimated KD from Figure 3.9B must be greater than mid- to low-μM.  This is relatively 
close to the KD value of 43.0 ± 8.5 μM determined for BoATP and Nbp35-Cfd1 (see 
below). 
As stated above, BoATP binds to Cfd12 with a KD of 17 ± 3 μM (Figure 3.9A).  
Additionally, BoATP can be competitively displaced from Cfd12 with ATP or ADP 
(Figure 3.10A) which is indicative of specific binding to Cfd12.  Using the same 
fluorescence anisotropy assay described above, BoATP binding to holo-Cfd12 was found 
to be reduced to background levels of binding (Figure 3.10B).  Since BoATP can bind to 
Cfd12 and report on the affinity for holo-Cfd12, BoATP can be used to assay nucleotide 
binding to holo-Nbp35-Cfd1 (by binding at the Cfd1 subunit).   
The binding affinity of BoATP to Nbp35-Cfd1 was determined by titrating a 
constant concentration of BoATP with increasing amounts of Nbp35-Cfd1.  A hyperbolic 
change in the anisotropy was observed (Eq. 3.1) and fit to a KD of 43.0 ± 8.5 μM (Figure 
3.11, Table 3.5).  BoATP binding to Nbp35-Cfd1 was validated by demonstrating that 





Figure 3.10. Displacement of BoATP from Cfd12 and Apo/Holo Cfd12 Affinity 
(A) BoATP bound to Cfd12 was displaced with increasing concentrations of ATP (●) or 
ADP (○).  The trends in displacement seen here are similar to those observed for mantATP 
displacement by ATP and ADP in Figure 2.8 of Chapter 2.  (B) The binding affinity of 
BoATP for holo-Cfd12 is much weaker than its affinity for apo-Cfd12. 
   
To determine the affinity of holo-Nbp35-Cfd1 for BoATP, the FeS clusters of 
Nbp35-Cfd1 were reconstituted.  The resulting holo-Nbp35-Cfd1 contained 11.7 ± 0.2 iron 
and 9.8 ± 0.4 acid labile sulfur per heterodimer.  The amount of isolated iron and sulfide is 
consistent with reconstitution of the two [Fe4S4] clusters of the scaffold.  Although higher 
than the expected 8 Fe and 8 S atoms per heterodimer, the amounts are on par with previous 
studies that suggest some adventitiously bound Fe.23, 76  The BoATP binding assay was set 
up in the anaerobic chamber to prevent oxidative decay of the FeS clusters and the 
anisotropy readings were taken immediately after the sample was removed from the 
chamber.  The affinity of holo-Nbp35-Cfd1 for BoATP was significantly diminished as 
compared to apo-Nbp35-Cfd1, the presence of the FeS clusters increasing the KD by at least 
6-fold to ≥260 μM (Figure 3.11 and Table 3.5).  However, it became necessary to ensure 
that the observed decrease in BoATP affinity of holo-Nbp35-Cfd1 was not a fluorophore 





Figure 3.11. Nbp35-Cfd1’s Bridging [Fe4S4] Cluster Decreases BoATP Affinity. 
Nbp35-Cfd1 (solid black lines) or Δ53Nbp35-Cfd1 (gray dashed lines) was titrated against 
BoATP (0.5 μM). For both constructs, the affinity of apo-scaffold (○ or ○) and holo- 
scaffold, (● or ●) for BoATP was examined. The affinity for BoATP assessed by titration 
with the apo- scaffold in the presence of 25 mM EDTA (+) or 20 mM ADP (×) were used 
as controls. 
 
Table 3.5. BoATP and TNP-ATP KD Values for Apo- or Holo-Nbp35-Cfd1 
Sample ATP Analog Apo KD Holo KD 
Nbp35-Cfd1 BoATP 54 ± 0.7 μM >260 μM 
 TNP-ATP 190 ± 16 nM >10 μM 
Δ53Nbp35-Cfd1 BoATP 46 ± 1.7 μM >240 μM 
 
A second binding assay was developed utilizing another fluorescent ATP analogue, 
TNP-ATP, in order to confirm that the observed nucleotide affinity difference between 
apo- and holo-Nbp35-Cfd1 was independent of the fluorescent nucleotide analog being 
used.  The fluorescence of TNP-ATP is sensitive to its environment and increases upon 
binding to the more hydrophobic environment of the ATPase site (Figure 3.12A).  The 
increase in fluorescence intensity was used to monitor binding of TNP-ATP to Nbp352, 
Cfd12, and Nbp35-Cfd1.  TNP-ATP was titrated into solutions in both the absence and 
presence of a constant amount of Nbp352 or Cfd12 (Figure 3.12C-D).  Cfd12 produced a 
concentration dependent increase in TNP-ATP fluorescence whereas Nbp352 did not 
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(Figure 3.12C-D).  Displacement assays in which mantATP was displaced from Cfd12 and 
Nbp352 with TNP-ATP confirmed that TNP-ATP does not bind to the ATPase site of 
Nbp35 but does bind to the ATPase site of Cfd1 (Figure 3.12B-D). 
Figure 3.12. TNP-ATP Binding Assay Development. 
(A) The fluorescence spectra of 5 μM TNP-ATP in the presence (solid line) and absence
(dashed line) of the Nbp35-Cfd1 heterodimer (0.5 μM).  The fluorescence is plotted as the
fluorescence in counts per second (cps/105) versus wavelength.  (B) A solution of Cfd12 or
Nbp352 incubated with mantATP was titrated with increasing concentrations of TNP-ATP.
TNP-ATP is unable to displace bound mantATP from Nbp352 but can displace Cfd12, with
an IC50 value of approximately 4 μM (from Eq. 2.4).  (C-D) The fluorescence of increasing
concentrations of TNP-ATP were recorded in the presence of absence of the indicated
protein (0.5 μM dimer) TNP-ATP binds to Cfd12, resulting in an increase in TNP-ATP
fluorescence.  TNP-ATP in the presence of Nbp352 does not increase TNP-ATP
fluorescence, indicative of not TNP-ATP binding to Nbp352.
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The binding affinity of apo- and holo-Nbp35-Cfd1 for TNP-ATP was assessed by 
titrating the protein with increasing concentrations of TNP-ATP.  Plotting the change in 
TNP-ATP fluorescence (the difference between the fluorescence of TNP-ATP in the 
presence and absence of Nbp35-Cfd1) against the concentration of TNP-ATP and fitting 
the data to a quadratic binding equation resulted in a KD of 190 ± 16 nM for TNP-ATP 
(Figure 3.13, Table 3.5).   
Figure 3.13. TNP-ATP Binding to Apo- or Holo-Nbp35-Cfd1. 
Apo-Nbp35-Cfd1 (○) or holo-Nbp35-Cfd1 (●) (0.5 μM dimer) were titrated with 
increasing concentrations of TNP-ATP (0-10 μM). The change in fluorescence between 
samples of TNP-ATP (+)Nbp35-Cfd1 and TNP-ATP only (F) at 555 nm (in counts per 
second, CPS) was monitored as a function of TNP-ATP concentration and fit to the 
quadratic binding equation (Eq. 3.3). 
Next, holo-Nbp35-Cfd1 (10.2 ± 0.5 iron and 7.9 ± 0.1 sulfide per heterodimer) was titrated 
with increasing concentrations of TNP-ATP under anoxic conditions.  The titration of holo-
Nbp35-Cfd1 produced little change in total fluorescence (Figure 3.13, Table 3.5).  While 
a KD for holo-Nbp35-Cfd1 and TNP-ATP could not be calculated, it is estimated to be at 




estimation was made with the assumption that if holo-Nbp35-Cfd1 with TNP-ATP 
ultimately results in the same ΔF value as apo-Nbp35-Cfd1, it would require TNP-ATP 
concentrations at least 2-ordes of magnitude above the highest experimentally measured 
TNP-ATP.  This data indicates that the binding of TNP-ATP is weakened by the presence 
of Nbp35-Cfd1’s FeS clusters. 
 Since Nbp35-Cfd1 binds two [Fe4S4] clusters, one in Nbp35’s N-terminal domain 
and one bridging the Nbp35-Cfd1 dimer interface, experiments were carried out to identify 
which of the two FeS clusters, or both, were contributing to the perturbed binding for 
BoATP and TNP-ATP.  To answer the question of which FeS cluster binding site 
contributes the most to nucleotide affinity when occupied by cluster, the N-terminal 
domain of Nbp35 was deleted (∆53Nbp35).  This mutant was co-expressed in E. coli along 
with Cfd1 and was isolated via tandem affinity purification to yield the Δ53Nbp35-Cfd1 
heterodimer.  The binding affinity ∆53Nbp35-Cfd1 for BoATP was 46 ± 1.7 μM (Figure 
3.11, Table 3.5) and Δ53Nbp35-Cfd1 hydrolyzed ATP with kinetics similar to that of the 
full length Nbp35-Cfd1 (Figure 3.14).  Therefore, deletion of Nbp35’s N-terminus does 





Figure 3.14. Steady State ATPase activity of Nbp35-Cfd1 and Δ53Nbp35-Cfd1 
Rates of ATPase activity kobs (nmol ATP min
-1 nmol polypeptide-1) versus ATP 
concentration (mM).  Three independent trials of Nbp35-Cfd1 hydrolyzes ATP with an 
average kcat = 4.5 ± 0.7 min
-1 and Δ53Nbp35-Cfd1 hydrolyzes ATP with an average kcat = 
6.0 ± 0.5 min-1.  Plot is representative of three independent determinations.  The kinetic 
traces of Nbp35-Cfd1 and Δ53Nbp35-Cfd1 are superimposable, indicating no difference in 
their kinetic profiles.  
 
 
Next, Δ53Nbp35-Cfd1 was reconstituted to not only ensure that only one FeS cluster 
was bound (at the bridging site), but also to ensure that deletion of the N-terminus did not 
impact the cluster occupancy of the bridging site.  Reconstitution of Δ53Nbp35-Cfd1 
resulted in isolation of protein with 6.8 ± 0.1 Fe and 5.3 ± 0.3 sulfide per ∆53Nbp35-Cfd1 
heterodimer, consistent with the loss of one [Fe4S4]-binding site in Nbp35’s N-terminal 
domain.  In collaboration with Dr. Maria Eirini-Pandelia and her graduate student Chie 
Ueda (Brandeis University), the EPR and Mössbauer spectra of holo-Δ53Nbp35-Cfd1 was 
obtained.  These spectra confirmed that the reconstitution was successful and that the 






Figure 3.15. EPR and Mössbauer Spectra of Δ53Nbp35-Cfd1 
(A) CW EPR spectra of reconstituted Δ53Nbp35-Cfd1 (144 μM dimer) reduced with 4 mM 
sodium dithionite for 2 min in the anaerobic box.  Spectra were recorded at temperatures 
indicated.  EPR gave signals for [Fe4S4]
1+ and a small amount of [Fe3S4]
1+ (asterisk) 
clusters.  (B) Wider field EPR signal.  Signals can conservatively be assigned to higher 
spin, reduced [Fe4S4].  (C) High temperature Mössbauer spectra of 
Δ53Nbp35-Cfd1 (137 
μM dimer). Spectra are best fit to [Fe4S4] clusters. (D)  Low temperature Mössbauer spectra 
of Δ53Nbp35-Cfd1 (137 µM dimer).  Signal is typical of high Fe in [Fe4S4]
2+ cluster.  Over 
90% of the Fe in complexed in [Fe4S4] clusters.  Analysis provided by Dr. Maria Eirini-





The binding affinity of Δ53Nbp35-Cfd1 for BoATP in the presence of the bridging 
cluster was assessed to determine if occupancy of the bridging cluster site was enough to 
perturb nucleotide affinity.  Holo-Δ53Nbp35-Cfd1 bound BoATP with a KD value ≥240 µM 
(Figure 3.11, Table 3.5).  This mirrors the results seen with BoATP binding to apo- and 
holo-Nbp35-Cfd1 (Figure 3.11, Table 3.5).  Therefore, Nbp35-Cfd1’s bridging FeS 
cluster alone is sufficient to weaken nucleotide affinity. 
Table 3.6. Phenotype Determines Step of FeS Cluster Assembly Blocked 
  
1Relative to WT: (-) = Growth Defective, (x) = No Growth (Relative to WTNbp35) 
2Not determined 
3As compared to Nbp35: WT affinity (++), 2-6 fold decrease (+), >6-fold decrease (-) 
4ATPase activity similar to Nbp35-Cfd1 (+) and indistinguishable from background (-) 
5Phenotypes are defined as: F = functional, PF = partially functional, RN = recessive 
negative, DN = dominant negative 
6Step related to Figure 3.16 
3.4 Discussion 
 Previous efforts to elucidate the FeS cluster scaffolding mechanism of Nbp35-Cfd1 
has been stymied by a number of factors, the most egregious of which has been the 
uncoupling of FeS scaffolding and ATPase activity in vitro.  Therefore, it has been 
challenging to demonstrate a linkage between the ATPase and cluster scaffolding activities 
and describe a model of the scaffold reaction cycle.  Within this chapter, nucleotide binding 




establish an allosteric link between the two activities.  Further in vivo experiments allowed 
for the proposal of specific functions of nucleotide in the steps of FeS cluster biogenesis 
by CIA.  The results of this chapter have allowed for the development of a working model 
for the scaffolding reaction in which ATP binding and hydrolysis regulates the cycle of 
FeS cluster assembly and mobilization.  
 A number of predictions were investigated within this chapter.  First, the ATPase 
site will be essential for CIA function.  Second, if ATPase activity is required for both 
cluster assembly and cluster transfer, mutations to the ATPase site will result in one of 
three different phenotypes in vivo.  The class of phenotype observed will depend on 
whether ATPase activity, cluster assembly, or cluster mobilization is affected by the 
mutation.  Third and finally, the FeS cluster binding site will be in allosteric 
communication with the ATPase site and affect ATP binding and/or hydrolysis.  The 
combination of in vivo and in vitro approaches within this chapter allowed for the creation 
of a working model for Nbp35-Cfd1 linking its ATPase and cluster scaffolding activities. 
 Regarding the first prediction, the ATPase site was found to be essential for CIA 
function.  Of the seven residues mutated, substitutions at six positions were unable to 
support yeast viability in Dr. Gay’s 5-FOA assay (Table 3.6).  The only residue that 
tolerated mutation was G80 in the deviant Walker motif (Figure 3.1, Table 3.6).  The 
ability for the G80 mutants to support viability implies a functional CIA system.  
Unexpectedly, nbp35 harboring either a G80A or G80D mutation displayed a diminished 
level of CIA activity in vivo (Figure 3.1, Table 3.6).  The same diminished CIA activity 




clearly demonstrate that the conserved motifs of the ATPase site of Nbp35 is essential for 
CIA function. 
Defects in iron acquisition and cluster transfer were observed in 55Fe labeling 
experiments performed by Dr. Gay.  Of the seven Nbp35 variants investigated, three 
variants were defective in acquiring iron.  K86ANbp35, D109ANbp35, and D111ANbp35 each 
immunoprecipitated < 20% of the iron as compared to WTNbp35 (Table 3.2).  This is a 
significant loss of iron incorporation, as it suggests that more than one of the two [Fe4S4] 
clusters are absent in these mutants.  In a previous pulse chase experiment, Nbp352 could 
be expected to lose 40% of the iron associated with it.75  However, in our experiments, 
there was twice the amount of iron lost with the above Nbp35 mutants.  The low iron 
loading was important as it indicated that the ATPase site is responsible for the biogenesis 
and/or acquisition of both the bridging and the N-terminal [Fe4S4] clusters of Nbp35.  If 
the ATPase site is only required to assemble one of the clusters, it would have been 
expected that ~50% of the iron should be associated with the K86A, D109A, and D111A 
Nbp35 mutants.75  Therefore, the ATPase site is required for the acquisition of iron and the 
assembly of both the bridging and N-terminal FeS clusters.  This is in agreement with 
previous reports investigating the ATPase site of the scaffold.23, 66, 76   
 Although some mutants were able to acquire iron, they prevented the subsequent 
mobilization of the cluster.  The mutants that acquired larger amounts of iron (> 60% that 
of WT) were G80ANbp35 and K81ANbp35.  These data corroborated the observed ability of 
cells expressing G80ANbp35 to remain viability in the 5-FOA assays.  On the contrary, 




to support viability (Table 3.2).157  K81ANbp35 was interpreted to be defective in 
transferring its FeS cluster further downstream in the CIA pathway, resulting in the 
inability of this mutant to support viability.  In the homologue ApbC, mutation of the 
homologous lysine (K116) resulted in ApbC that was still able to hydrolyze ATP, but the 
rate of in vitro cluster transfer to Leu1 was halved.111  These data support the interpretation 
that K81A is likely defective in cluster mobilization. 
In other deviant Walker A proteins, the binding of a substrate/cargo, a small 
molecule effector, or a partner protein affects nucleotide binding affinity, nucleotide 
hydrolysis, or both.  If the ATPase activity of Nbp35-Cfd1 is needed for cluster scaffolding 
activity, a prediction can be made that the two sites involved (the ATPase site and the 
bridging cluster site) will be in allosteric communication with one another.  To gather 
evidence for allosteric communication between the two sites, the nucleotide binding 
affinity of Nbp35-Cfd1 in both the presence and absence of the two [Fe4S4] clusters was 
assessed.  The binding affinity of two fluorescent nucleotide analogs, BoATP or TNP-ATP, 
were measured.  While the TNP-ATP binding affinity was 20-fold tighter than BoATP, 
this was not unexpected as different analogues have been demonstrated to bind other 
NTPases with different affinities.176, 177  The two FeS clusters in holo-Nbp35-Cfd1 
decreased its affinity for BoATP by ~5-fold (Figure 3.11, Table 3.5) while TNP-ATP 
binding to holo-Nbp35-Cfd1 was not observed at the concentrations of TNP-ATP present 
in the assays (Figure 3.13, Table 3.5).  On reason for the large difference between BoATP 
and TNP-ATP could stem from the conformation of Nbp35-Cfd1 when bound to cluster.  




is would be expected that TNP-ATP binding would be more perturbed than BoATP, given 
the large nitrosyl group of TNP-ATP (Figure 3.8C-D).   
Since the bridging cluster site is proposed to be the site of nascent cluster assembly, 
the N-terminal cluster binding site of Nbp35 was deleted to determine if the bridging 
cluster was the source of the change in nucleotide binding affinity.  Holo-Δ53Nbp35-Cfd1 
bound BoATP 5-fold more weakly than apo-Δ53Nbp35-Cfd1, similar to the results of 
BoATP binding to Nbp35-Cfd1.  Most importantly however, is that the BoATP binding 
data for both Nbp35-Cfd1, and Δ53Nbp35-Cfd1 are superimposable, indicating that BoATP 
binding is wholly independent of the N-terminal cluster binding domain of Nbp35. 
Altogether this data identifies that the bridging cluster alone is sufficient to elicit decreased 
nucleotide binding affinity.  This implies that the N-terminal cluster binding site is not 
allosterically communicating with the ATPase site of Nbp35.  Nbp35’s N-terminal domain 
may be playing a different role in the scaffolding reaction cycle, such as interacting with 
the protein complex Tah18-Dre2 to receive reducing equivalents.95-97 
From the data described thus far, a model of assembly can be introduced that 
integrates nucleotide binding and hydrolysis with FeS cluster assembly and transfer 
(Figure 3.16).  In this model, the first step involves ATP binding to Nbp35-Cfd1.  This is 
proposed as the first step based on the nucleotide affinities observed with apo- and holo-
Nbp35-Cfd1 where the presence of the bridging cluster decreased Nbp35-Cfd1’s affinity 
for BoATP and TNP-ATP (Figures 3.11, 3.13).  The first step of nucleotide binding is 
further supported by expression of D109ANbp35, which negatively impacted the CIA system 




to acquire iron at the same levels as WTNbp35.  In vitro assays revealed that D109ANbp35 
binds mantATP 11-fold weaker than WT (Figure 3.5A, Table 3.3).  Based on these data, 
D109ANbp35 fails to acquire iron as a result of defective nucleotide binding.  Not all Switch 
I motifs contain conserved leading aspartate residue in deviant Walker A proteins, but the 
aspartate is conserved in the bacterial homolog MinD.114  Mutation of the residue 
analogous to D109 in MinD reduced MinD’s nucleotide affinity and prevented the ATP-
dependent dimerization of MinD.163  Since the binding of nucleotide is required by MinD 
for dimer formation, D109 in Nbp35 could be important for translating nucleotide binding 
into a conformational change within Nbp35.  Therefore, it is likely that the mutation of 
D109 in Nbp35 is preventing a conformational change that is necessary for cluster 
acquisition. 
After ATP binds to Nbp35-Cfd1, it is proposed that the cluster is then assembled.  
The dominant negative mutants K86A and D111A were only able to acquire ~20% of the 
amount of iron as WT, indicative of a defect in assembling its FeS cluster(s) (Table 3.2).  
Although the K86A and D111A variants could bind nucleotide (Figure 3.5, Table 3.3), 
they were unable to hydrolyze ATP at a detectable rate.110  The working hypothesis is that 
these mutants bind ATP and undergo a conformational change required to interact with 
another CIA component.  However, the mutants become trapped in a nonfunctional 
complex with this other factor due to their inability to hydrolyze ATP.  The mutation is 
likely stabilizing what is supposed to be a transient and dynamic interaction with the as of 




complex diminishes the amount of unknown CIA factor able to interact with the small 
amount of WTNbp35 leading to the growth inhibition and dominant negative phenotype. 
 
Figure 3.16. Working Model of Nbp35-Cfd1’s Reaction Cycle 
Step 1: Binding of ATP induces a conformational change in Nbp35-Cfd1 (Top, Right).  
The D109A and N247A mutants diminish the affinity for nucleotide.  Step 2: Nbp35-Cfd1 
assembles a [Fe4S4] cluster at the dimer interface.  This is potentially mediated by a partner 
protein (purple).  K86A and D111A mutants block the assembly of cluster.  Step 3: The 
assembled cluster is transferred to an FeS cluster acceptor protein (brown).  The K81A 
mutation diminishes cluster transfer.  Step 4: ADP is released and Nbp35-Cfd1 resets.  At 
this time, ATP hydrolysis cannot definitively be placed in the cycle.  It is likely occurring 
at Step 2 or at Step 3.  Since hydrolysis cannot be placed, bound nucleotide is denoted as 
‘AXP’ as it is either ATP or ADP. 
 
The hypothesis outlined above for the dominant negative phenotype was proposed 




either the Switch I aspartate or the Walker A lysine.  Mutations to the aspartate analogous 
to D111 (in the Switch I motif) in other deviant Walker A ATPases diminished ATPase 
activity and trapped the protein in a stable complex with a partner protein.116, 135, 141, 178  An 
additional homologue, Get3, has been demonstrated to bind ATP but not hydrolyze it when 
inclusive of a D57V substitution.  This mutant has been used to stabilize Get3’s interaction 
with its partner protein Get4/5 to obtain a crystal structure.141  The mutation of the Walker 
A lysine (K86) of the homologue ParA results in a slowly dissociating complex formed 
from ParA and its partner protein ParB.125  These examples show precedent for the 
prediction that Nbp35-Cfd1 is interacting with at least one other CIA factor in an ATP 
dependent manner. 
The next step in FeS cluster biogenesis is mobilization of the FeS cluster to a 
downstream recipient protein (Figure 3.16).  As described above, the 160 ± 51 µM KD 
between mantATP and K81ANbp35 predicts that K81ANbp35 would exhibit low iron 
acquisition, like the other recessive negative mutant D109ANbp35.  Surprisingly, K81ANbp35 
was able to acquire ~70% of the iron that WT accumulated (Tables 3.2, 3.6) while 
D109ANbp35 only acquired 20%.  Although the K81ANbp35-Cfd1 mutant could not be 
isolated, kinetic studies of K81ANbp352 revealed that it was able to hydrolyze ATP.
110  
However, the ATPase activity of K81ANbp352 could not be saturated and displayed a 
significantly increased Km.
110  Therefore, the source of the recessive negative phenotype 
displayed by the K81A mutation must the result of a defect in cluster mobilization. 
The proposed defect in cluster mobilization brought on by the K81ANbp35 mutant is 




homologous proteins.  In this chapter, the decrease in in vivo activities of CIA system 
targets Leu1 and sulfite reductase when K81A was expressed in the depletion strain 
(Figure 3.4, Table 3.2) supports the idea of a mobilization defect.  Other work involving 
the bacterial homolog ApbC demonstrated that this position, K116, is critical to cluster 
transfer in vitro, as K116AApbC transferred cluster half as fast as compared to WTApbC.  
Although K116AApbC was able to hydrolyze ATP, it exhibited a growth defect in vivo 
similar to the K81A mutation in Nbp35.111  Moreover, the rate of transfer of FeS cluster 
from K116AApbC to the target Leu1 in vitro was half that of the rate observed with 
WTApbC.111  Therefore, it is hypothesized that the K81A mutation is affecting the reaction 
cycle at the critical step of cluster transfer (Figure 3.16). 
The proposition that mutants that can bind nucleotide, but not hydrolyze, cause a 
dominant negative phenotype predicts that the G80 mutants should inhibit growth.  
However, G80A was able to support viability via the plasmid shuffle assay and support 
CIA functionality in the IRP1 assay, albeit to a lesser extent than that observed with 
WTNbp35 (Table 3.2).  G80ANbp352 was able to bind mantATP with the same affinity as 
WTNbp352 yet 
G80ANbp35-Cfd1 ATPase activity was undetectable (Figure 3.7A, B, Table 
3.3).  These contradictory observations cannot be fully explained yet, but there are 
plausible reasons for the partially functional phenotype of G80A (Table 3.2, 3.6).  Due to 
the heterologous expression of G80A for in vitro assays, it cannot be ruled out that this 
mutant may have perturbed protein folding or some other defect that could give rise to 




conformation that does not allow it to become trapped with a partner protein like the other 
dominant negative mutants (K86A and D111A). 
3.5 Conclusions 
The results of this chapter revealed new information on the link between the CIA 
scaffold’s ATPase and cluster scaffolding activities.  From this data, a model was proposed 
for nucleotide involvement in CIA’s cluster assembly and transfer.  ATP binding initiates 
the cluster biogenesis process, likely eliciting a conformational change in Nbp35-Cfd1.  
This conformational change is mediated by an interaction with a protein partner that is 
involved in the continuation of the cluster assembly.  This partner protein is potentially 
another CIA protein, yet the identity of the partner and the nature of its role in cluster 
assembly is unknown.  Although the function of ATP hydrolysis cannot yet be placed in 
the model, hydrolysis is required for CIA function.  However, a confident conclusion can 
be made that Nbp35-Cfd1 utilizes its ATP binding and hydrolysis to regulate the different 





CHAPTER 4: The CIA Component Dre2 Acts to Stimulate the ATPase Activity of 
the CIA Scaffold  
4.1 Introduction 
At the end of Chapter 3, it was proposed that Nbp35-Cfd1 required interaction with 
a partner protein to complete its cluster scaffolding function.  The observed dominant 
negative phenotype provided evidence for interaction with a partner protein.  The identity 
of this partner protein was unknown, as few protein-protein interaction partners have been 
identified for Nbp35 and Cfd1. 
The CIA scaffolding complex, Nbp35-Cfd1, is an ATPase.23, 66, 76  Chapters 2 and 
3 discussed nucleotide binding affinity and hydrolysis activity of Nbp35-Cfd1 and how 
these are integrated with FeS cluster scaffolding.110, 156, 157  Although the data in Chapters 
2 and 3 revealed more information on the involvement of nucleotide binding and hydrolysis 
in CIA function, data pertaining to a partner protein’s involvement in the reaction cycle is 
lacking.  The CIA scaffold belongs to the deviant Walker A branch of the SIMIBI NTPase 
family.78, 114  A hallmark of proteins in this family is their nucleotide dependent protein-
protein interactions.78, 113, 114, 117  The identity of Nbp35-Cfd1’s partner protein or proteins 
has remained unknown. 
Nbp35-Cfd1 binds two [Fe4S4] clusters, one at the N-terminal domain of Nbp35 
and one bridging the dimer interface.23, 76  Previous studies have proposed that the N-
terminal cluster binds first and is stably associated with the scaffold and that Dre2, another 
CIA factor, is responsible for the assembly of this cluster.23, 75, 76, 95  In the current working 




these to the scaffold via its own two FeS clusters and the N-terminal cluster of the scaffold 
(Figure 4.1).95, 96, 99  The reducing equivalents are then proposed to be used in assembly of 
the scaffold’s bridging cluster.   
Dre2’s interaction with Nbp35’s N-terminal cluster has been challenged recently as 
yeast variants of Dre2 and Nbp35 have not been observed to interact.179  Yet, an interaction 
between Dre2 and Nbp35 homologs in Arabidopsis thaliana has been detected in a separate 
study, along with the surprising proposition that the N-terminal FeS cluster of Nbp35 is not 
a major determinant of this interaction.102 
 
Figure 4.1. Proposed CIA Scaffolding Cycling Involving Dre2-Tah18 
The FeS cluster is assembled at the dimer interface from sources of iron, sulfide, and 
reducing equivalents.  The Dre2-Tah18 reductase complex has been proposed to deliver 
the reducing equivalents necessary for cluster assembly through the N-terminal domain of 






This chapter investigates the interaction of Dre2 with Nbp35-Cfd1 and how this 
stimulates the ATPase activity of Nbp35-Cfd1.  The requirement of the N-terminal domain 
of Nbp35 for interaction with Dre2 was assessed to parse out the conflicting reports 
regarding interactions and the proposed role of Dre2.96, 102  Although the N-terminal 
domain, and thereby the N-terminal [Fe4S4] cluster, was found to be dispensable for the 
Dre2/Nbp35-Cfd1 interaction, the exact site of the interaction remains unknown.  
Experiments within however suggest that the interaction is dependent on the presence of 
both Nbp35 and Cfd1 subunits, implying a potential interaction at the dimer interface of 
Nbp35-Cfd1.  An examination into whether the FeS clusters of Dre2 can be reconstituted 
in vitro and assessment of the FeS cluster stoichiometry of Dre2 was also done.  Finally, 
the presence and absence of the FeS clusters in both Dre2 and Nbp35-Cfd1 was assessed 
for their effects on the Dre2 mediated ATPase stimulation of Nbp35-Cfd1. 
4.2 Materials and Methods 
4.2.1 Protein Constructs Used 
 12xHisTEVDre2 was created by Christa Molé, Laney Browder, and Bryan 
Seguinot.  The plasmid for expression of this construct was created by the addition of six 
histidine residues and a TEV protease site to 6xHisDre2 via Q5 mutagenesis (New England 
Biolabs).  This construct was confirmed via DNA sequencing (Genewiz). All other 
plasmids encoding for the constructs used here (Nbp35, Cfd1, Nbp35-Cfd1, and Δ53Nbp35-
Cfd1) have been described in previous chapters or elsewhere.110 
A TEV site was added to the Cfd1 sequence of pJDG14 (SSTNbp35-HisCfd1, Section 




resulting plasmid, pJDG16 (SSTNbp35-HisTEVCfd1), encodes a TEV site between the 6xHis 
tag and the start of Cfd1 in addition to the StrepStrepTEV tag encoded on the N-terminus 
of Nbp35.  The resulting protein complex can be treated with TEV protease to yield 
untagged-Nbp35-Cfd1.  
4.2.2 Protein Expression and Purification 
 Nbp352, Cfd12, Nbp35-Cfd1, and 
Δ53Nbp35-Cfd1 were overexpressed and purified 
as described previously (Chapters 2 and 3).155  Plasmids containing Dre2 constructs were 
transformed into chemically competent BL21 (DE3) cells and plated onto LB agar plates 
containing 50 μg/mL kanamycin (LB/Kan).  A single colony was used to inoculate 50 mL 
LB/Kan in a 250 mL Erlenmeyer flask.  The culture was incubated overnight at 37 °C with 
180 rpm shaking.  The overnight culture was diluted 1:200 into 2 L LB/Kan in a 4 L baffled 
Erlenmeyer flask.  The cell culture was incubated at 37 °C with 180 rpm shaking until 
reaching an OD600 of 0.5.  Ferric citrate (125 μM) was added and the temperature was 
lowered to 18 °C.  Upon reaching an OD600 of 0.8, protein overexpression was induced by 
the addition of 250 μM Isopropyl 1-thio-β-D-galactopyranoside (IPTG) for 16 h.  Cells 
were harvested by centrifugation and the cell pellet stored at -80 °C prior to purification.   
 For Dre2 purification, cells were resuspended, lysed, and the clarified lysate 
isolated as described for Nbp35-Cfd1 (Chapters 2 and 3).155  The clarified lysate was 
flowed over Ni-NTA resin (0.5 g of resin per 10 mL clarified lysate) equilibrated with 
TBS-HS (50 mM Tris (pH 8), 300 mM sodium chloride, and 10% glycerol) with 5 mM 
imidazole followed by a second wash of 10 CV TBS-HS with 25 mM imidazole.  Protein 




containing protein were pooled and concentrated with an Amicon centrifugal filter unit 
with a 10k MWCO to reduce the volume to ~2 mL (with a typical concentration of 2.0 – 
10.0 mg/mL).  The concentrated protein was buffer exchanged into TBS-LS (50 mM Tris 
(pH 8), 100 mM sodium chloride, and 10% glycerol) over a prepacked, 8.3 mL PD10 
column according to manufacturer’s instructions (GE Life Sciences).  The purified, buffer 
exchanged protein typically eluted at a concentration of 1 – 2 mg/mL.  The protein was 
flash frozen in liquid nitrogen and stored at -80 °C. 
4.2.3 ATPase Activity Assays 
 ATP hydrolysis by Nbp35-Cfd1, Nbp352, or Cfd12 was monitored by a continuous 
spectroscopic assay.110, 155  Potential partner proteins (Dre2, Leu1, Cia1, Cia2, Met18, 
Tah18, or Dre2-Tah18) were added (1 μM) to the reaction mixture containing 50 mM Tris 
(pH 8), 200mM KCl, 10mM MgCl2, 4 mM phosphoenolpyruvate, 0.2 mM NADH, 1 mM 
DTT, 10 mM ATP, and 20 units each of pyruvate kinase and lactate dehydrogenase.  The 
reaction was initiated by the addition of Nbp35-Cfd1 (0.3 μM dimer), Nbp352 (0.3μM 
dimer), or Cfd12 (3 μM dimer).  The final reaction volume was 500 μL.  ATPase activity 
was monitored at 37 °C by the change in absorbance at 340 nm.   
In order to determine the binding affinity of Dre2 for scaffold constructs, Dre2 
(3.5μM) in either the presence of Nbp35-Cfd1 or Δ53Nbp35-Cfd1 (0.05 μM dimer) were 
titrated with ATP. The rate of ATP hydrolysis was plotted as the initial velocity (nmol ATP 
min-1) versus ATP concentration and was fit to a Michaelis-Menten equation using the 





To determine an apparent dissociation constant for the Dre2/Δ53Nbp35-Cfd1 
complex, a sample of ATP (10 mM) and Δ53Nbp35-Cfd1 (0.6 μM dimer) were titrated with 
Dre2 (0 – 15 μM).  The apparent dissociation constant was calculated using Eq. 4.1. 









) + 𝑉𝑚𝑖𝑛  
Eq. 4.1. Apparent Dissociation Constant Equation from ATPase Assays 
 
Where 𝑣0 is the ATPase rate at a specific concentration of Dre2, 𝑉𝑚𝑎𝑥 is the maximum 
velocity, 𝑉𝑚𝑖𝑛  is the ATPase rate in the absence of Dre2, 𝑅𝑇  is the concentration of 
Δ53Nbp35-Cfd1, 𝐿𝑇  is the concentration of Dre2, and 𝐾𝐷
𝐴𝑝𝑝
 is the apparent dissociation 
constant for Dre2/Nbp35-Cfd1 in units of μM. 
4.2.4 Reconstitution of Dre2 and Nar1 
 Dre2 (20 µM in 1 mL) was brought into an anaerobic glove box in a 1.5 mL 
Eppendorf tube.  DTT (5 mM) was added and the solution stirred for 2 h at room 
temperature.  Iron(II) ammonium sulfate hexahydrate (19 μL of a 10 mM stock, 10-fold 
molar excess over [Dre2]) was added in 3 μL aliquots while gently stirring with a micro 
stir bar.  After 10 min, sodium sulfide nonahydrate (19 μL of a 10mM stock, 10-fold molar 
excess over [Dre2]) was added in 3μL aliquots with continuous gentle stirring.  The mixture 
was incubated at 4°C for 2 h with gentle stirring.  The sample was then centrifuged at 13.4 
krpm for 10 min at room temperature.  The supernatant was applied to a 20 mL G-25 
desalting column equilibrated in TBS-Box (50 mM Tris (pH 8.0), 100 mM NaCl, and 4% 
glycerol).  Protein eluted from the G-25 column and concentrated to 10 - 25 μM (500 μL 




and sulfide content quantified by ferrozine and sulfide assays respectively.155, 168, 169  For 
more detailed reconstitution protocols, please refer to Appendix 1.155  
Nar1 was reconstituted in a similar manner as Dre2 except the initial Nar1 
concentration was 35 μM in 1 mL and a 12-fold molar excess of iron and sulfide was used 
for the reconstitution. 
4.2.5 Cluster Transfer Assays 
 12xHisTEVDre2 or SSTNbp35-HisTEVCfd1 were incubated overnight (12 hours) at room 
temperature with TEV protease at a ratio of 1:25 TEV:protein (by mass) to cleave the 
affinity tags.  Typically, 1 mL of 2 mg/mL protein in TBS-LS was incubated with 100 μL 
of 1 mg/mL TEV protease to achieve the 1:25 ratio.  Cleaved Dre2 or Nbp35-Cfd1 was 
recovered by flowing over 500 μL NiNTA resin equilibrated in TBS-LS.  The column was 
washed with an additional 1 mL of TBS-LS usually resulting in 1.5 mL of 1 mg/mL TEV-
cleaved protein.   
FeS cluster transfer assays were carried out in an anaerobic glove box at room 
temperature.  The holo-protein (either Dre2 of Nbp35-Cfd1) was mixed with its 
complementary apo-protein.  For example, holo-Dre2 was incubated with apo-Nbp35-
Cfd1, and holo-Nbp35-Cfd1 was incubated with apo-Dre2.  Protein concentrations and iron 
and sulfide amounts varied for each assay.  Details for each experimental replicate can be 
found in Section 4.3.5 (Table 4.4).  After 1 h incubation, the mixture was passed over a 
200 μL Ni-NTA column equilibrated in TBS-Box Buffer and the flow through saved for 
SDS-PAGE.  The column was washed with 10 CV of TBS-Box Buffer and eluted with 7.5 




concentrated via micro centrifugal concentrator to approximately 500 μL of 10 μM protein 
(as determined by Bradford assay).  Iron and sulfide incorporation was assessed by 
ferrozine and sulfide assay respectively.155 
4.2.6 Circular Dichroism 
Circular dichroism (CD) spectra were obtained on an Applied Photophysics CS/2 
Chirascan CD spectrometer.  Dre2 was buffer exchanged over a PD10 desalting column 
into CD buffer (10 mM potassium phosphate (pH 8.0), 100 mM NaCl, and 1 mM TCEP).  
The CD spectra of apo-Dre2 (4.7 μM) was measured from 195 – 260 nm and holo-Dre2 
(3.2 μM) was measured from 195 - 650 nm in a 0.1 cm path length cuvette at 25 °C.  CD 
spectra were compiled from the average of three scans and were baseline subtracted to 
remove buffer contribution.  Data was converted to molar ellipticity, and smoothed with 
the included software package. 
4.2.7 BMOE Crosslinking 
 Crosslinking experiments were carried out at room temperature.  SSTNbp35-Cfd1 
was buffer exchanged into crosslinking buffer (50 mM Tris pH7, 100 mM NaCl, 10% 
glycerol, and 5 mM TCEP) via a PD10 desalting column.  The buffer exchanged SSTNbp35-
Cfd1 was concentrated to 40 μM dimer (500 μL).  The cross-linker bismaleimidoethane 
(BMOE) was prepared as a 20 mM solution in DMSO.  SSTNbp35-Cfd1 was incubated with 
0x, 4x, 40x, and 200x molar excess of BMOE for 1 h.  The reaction was quenched by the 
addition of DTT (15 mM) and incubated for 15 min.  The samples were analyzed on a 10% 





4.3.1 Identification of a Partner Protein 
To identify a partner protein of the CIA scaffold, Christa Molé and Laney Browder 
assessed the ATPase activity of Nbp35-Cfd1 in the presence of six CIA factors and two 
CIA substrates (target FeS proteins).  Only Dre2 and Nar1 resulted in a greater than 10-
fold increase in the ATPase activity of Nbp35-Cfd1 (Figure 4.2).   
 
Figure 4.2. Scaffold ATPase Activity Stimulated by Dre2 and Nar1. 
Nbp35-Cfd1 (0.3 µM), Nbp352 (0.3 µM) or Cfd12 (3μM) was incubated with ATP (10 
mM) in the presence or absence of the indicated protein (1 µM).  The fold change in 
ATPase activity is plotted as the average (n ≥ 2) ± standard deviation. Data was collected 
and analyzed by Christa Molé and Laney Browder. 
 
 
Interestingly, only the activity of the heterodimeric Nbp35-Cfd1 scaffold was stimulated 
by Dre2 or Nar1.  The activity of the homodimeric forms of the scaffold, Nbp352 or Cfd12, 
were unaffected by Dre2 or Nar1 (Figure 4.2).  Christa Molé has also demonstrated that 




dissociation constant of 1.4 ± 0.4 μM.  Dre2 was therefore further investigated to 
understand its role as a partner protein of Nbp35-Cfd1. 
4.3.2 Dre2 Stimulation of Δ53Nbp35-Cfd1’s ATPase Activity 
 Nbp35’s N-terminal domain was tested to determine its contribution to the 
interaction between Dre2’s and Nbp35-Cfd1.  To test this, ATPase stimulation experiments 
were carried out on the scaffold truncation construct Δ53Nbp35-Cfd1.  The similar binding 
affinities and hydrolysis activities of Δ53Nbp35-Cfd1 and Nbp35-Cfd1 as determined in 
Chapter 3 support the idea that deletion of Nbp35’s N-terminal domain is not affecting 
nucleotide binding or hydrolysis (Figure 3.9, Figure 3.14).  When Δ53Nbp35-Cfd1 was 
mixed with Dre2, the ATPase stimulation of Δ53Nbp35-Cfd1 was comparable to that of the 
full length construct, a 26-fold increase as compared to a 20-fold increase in ATPase 
activity (Figure 4.3A, Table 4.1).  When Dre2 was titrated into a solution of Δ53Nbp35-
Cfd1, the apparent dissociation constant (𝐾𝐷
𝐴𝑝𝑝
 = 0.5 ± 0.3 μM) was similar to that of the 
full-length scaffold (Figure 4.3B, Table 4.1).  Together, these two results demonstrated 
that the N-terminal domain of Nbp35 is dispensable for interaction with Dre2 and 
subsequent ATPase stimulation of Nbp35-Cfd1. 
Table 4.1. Δ53Nbp35-Cfd1 is Stimulated by and Interacts with Dre2 
Scaffold Initial Rate*  
(-)Dre2 








Nbp35-Cfd1** 2.0 ± 0.1 49 ± 5 20 1.4 ± 0.4 
Δ53Nbp35-Cfd1 3.1 ± 0.3 81*** 26 0.5 ± 0.3 
*Initial Rate is in units of nmol ATP/min/nmol active site 
**Nbp35-Cfd1 data was acquired by Christa Molé 
***This was only measured once, all other values are the average ± standard deviation of 






Figure 4.3. Dre2’s ATPase Stimulation and Interaction with Δ53Nbp35-Cfd1 
(A) The initial velocity (nmol ATP min-1) Δ53Nbp35-Cfd1 (0.05 μM dimer) was monitored 
with increasing concentrations of ATP in both the absence (○), and presence (●) of Dre2 
(3.5 μM) at 37 °C.  Initial velocity was plotted against the concentration of ATP and fit to 
the Michaelis-Menten equation. (B) The initial velocity (nmol ATP min-1) of Δ53Nbp35-
Cfd1 (0.6 μM dimer) with increasing concentrations of Dre2.  Assays were carried out in 
the presence of 10 mM ATP at 37 °C.  Data was fit to Eq. 4.1 to calculate 𝐾𝐷
𝐴𝑝𝑝
 for the 




4.3.3 FeS Cluster Reconstitution 
Dre2 and Nar1 are FeS cluster containing proteins and were tested to determine if 
their FeS clusters could be reconstituted to form holo-Dre2 and holo-Nar1.  When purified 
aerobically, Dre2 and Nar1 copurify with sub-stoichiometric amounts of iron and acid-
labile sulfur bound and display low absorbance at the characteristic [Fe4S4] cluster 
absorbance peak of 410 nm (Figure 4.4). 
4.3.3.1 Dre2 Reconstitution 
  
 FeS cluster reconstitution of Dre2 was attempted first.  During aerobic purification, 
Dre2 was isolated with 1.4 ± 0.6 iron and 1.9 ± 1.5 sulfide bound, < 30% of the expected 




failed when using the standard protocols (Table 4.2).155  Therefore, the standard 
reconstitution protocol had to be optimized for Dre2 by adding an increasing molar ratio 
of iron and sulfur sources.  Addition of iron and sulfide at a 12-fold molar excess to Dre2 
gave the best results for reconstitution (Figure 4.4, Table 4.2).  
 
Figure 4.4. UV-Vis Spectra Pre and Post Reconstitution 
Normalized absorbance scans of (A) Dre2 and (B) Nar1, pre and post reconstitution.  A 
[Fe4S4] cluster has a characteristic absorbance band at 410 nm.  This peak is absent in the 




Table 4.2. Dre2 and Nar1 Cluster Reconstitution Summary 






Dre2 8x 35% 7.7 ± 0.1 9.1 ± 0.7 
12xHisDre2 8x 59% 4.6 ± 0.1 4.6 ± 0.2 
 10x 54% 6.4 ± 0.2 6.4 ± 0.5 
 12x 54% 7.9 ± 0.1 7.2 ± 0.2 
Nar1 12x 56% 7.3 ± 0.2 6.1 ± 0.1 
 12x 55% 7.3 ± 0.1 7.3 ± 1.0 
Iron and sulfide quantities are reported as the average ± the standard deviation of three 
measurements.  Recovery is expressed as the percentage of the starting amount of protein 
prior to reconstitution. 
 
 
After having optimized the reconstitution of Dre2, the efficacy of the reconstitution 




publications on Dre2 have reported the presence of both a [Fe2S2] and a [Fe4S4] cluster, yet 
human Dre2, anamorsin, exclusively contains [Fe2S2] clusters.
96, 97, 103, 180  EPR and 
Mössbauer analyses were employed in collaboration with Dr. Maria Eirini-Pandelia and 
her graduate student, Chie Ueda, at Brandeis University.  The sample of holo-Dre2 (Table 
4.3) was reduced with 4 mM sodium dithionite for 2 min, and flash frozen in liquid 
nitrogen.  The [Fe4S4] cluster exhibited an EPR signal with rhombic symmetry and g-values 
of (2.02, 1.95, and 1.80), essentially identical to those previously published (2.01, 1.95, 
1.80).96  At 45 K, the slower relaxing [Fe2S2] cluster was detected with g-values of (2.01, 
1.96, and 1.92), in agreement to those previously reported; (1.996, 1.96, 1.919).96  The 
presence of both [Fe2S2] and [Fe4S4] clusters on reconstituted Dre2 were observed with the 
EPR experiments carried out by Dr. Pandelia (Figure 4.5A). 
The Mössbauer spectrum of holo-Dre2 was therefore also expected to identify both 
[Fe2S2] and [Fe4S4] clusters.  The Mössbauer spectrum was dominated by a quadrupole 
doublet which can be attributed to diamagnetic [Fe4S4]
2+ clusters (Figure 4.5B). There 
were no detectable signals for the presence of [Fe2S2]
2+ clusters. The rest of the Fe in the 
sample is in the form of high-spin Fe2+ (~22 %), which depicts adventitiously bound Fe not 
assembled in [Fe-S] clusters (Figure 4.5B). 
Table 4.3. Reconstituted Dre2 Samples Prepared for EPR and Mössbauer 
Technique Recovery* Fe/Dre2 S/Dre2 [Dre2] (μM) 
EPR 22% 7.2 ± 0.2 5.6 ± 0.1 135 μM 
Mössbauer 31% 6.7 ± 0.1 5.1 ± 0.1 140 μM 






Figure 4.5. EPR and Mössbauer Spectra of holo-Dre2 
(A) CW EPR spectra of reconstituted Dre2 (135 μM) reduced with 4 mM sodium dithionite 
for 2 min in the anaerobic box.  Spectra of Dre2 were recorded at 10 K (red trace), 20 K 
(blue trace), 33 K (black trace) and at 45 K (magenta trace).  EPR gave signals for both 
Fe4S4 and Fe2S2 clusters.  (B) Mössbauer spectra of Dre2 (140 μM). The blue doublet 
depicts the portion of the signal attributed to [Fe4S4]
2+ and the grey doublet depicts the 
portion of the signal attributed to high spin adventitious Fe2+.  The spectra is dominated by 
the Fe4S4 cluster signal with no detectable Fe2S2 signal.  Spectra and analysis provided by 
Dr. Maria Eirini-Pandelia and Chie Ueda at Brandeis University. 
 
 
4.3.3.2 Nar1 Reconstitution 
 
Aerobically purified Nar1 was isolated with 3.0 ± 0.7 iron and 1.9 ± 0.5 sulfide 
bound, which is < 38% of the expected cofactor loading (Amanda Vo).106  Therefore, a 
trial reconstitution of Nar1 was also carried out.  Previous EPR experiments predict that 
Nar1 should include two [Fe4S4] clusters.
104, 181  After two independent trials of the Nar1 




number of iron and sulfide molecules that was consistent with two [Fe4S4] clusters (Figure 
4.4, Table 4.2).   
Unfortunately, the reconstitution of Nar1 was less successful than initially thought 
after EPR and Mossbauer experiments were carried out by Dr. Maria Eirini-Pandelia and 
Chie Ueda at Brandeis.  The signal obtained for the EPR experiment was unable to be 
assigned to a specific cluster type.  Moreover, the Mössbauer signal showed that there was 
a significant amount of unassociated iron with an estimated 0.3 FeS clusters per Nar1.  
These results clearly demonstrate that the reconstitution of Nar1 (Figure 4.4, Table 4.2) 
was unsuccessful.  At this point, stoichiometric reconstitution of Nar1 was deemed 
unsuccessful. 
4.3.4 Dre2’s Stimulation of Nbp35-Cfd1 ATPase Activity is Cluster Dependent  
 To test how the FeS clusters of Dre2 and Nbp35-Cfd1 affect ATPase activity, 
reconstituted Dre2 was mixed with reconstituted Nbp35-Cfd1 and the ATPase activity 
measured.  The ATPase activity of holo-Nbp35-Cfd1 in the presence of holo-Dre2 was 
significantly less than that observed with the as-isolated forms of the two proteins (Figure 
4.6).  Further experiments showed that the ATPase activity stimulation of Nbp35-Cfd1 by 
Dre2 was decreased by the presence of an FeS cluster, no matter which of the two proteins 





Figure 4.6. Cluster Binding Affects the Magnitude of ATPase Stimulation by Dre2 
Holo- and as isolated Dre2 (5 μM) and Nbp35-Cfd1 (1 μM) were assessed for the ability 
of Dre2 to stimulate ATPase activity of Nbp35-Cfd1 at 10 mM ATP.  The y-axis is the 
specific activity (nmol ATP min-1 nmol Nbp35-Cfd1-1) of the reaction mixture.  Bars 
represent the average ± standard deviation of two independent trials. 
 
 
4.3.5 Cluster Transfer Experiments 
 One possible explanation for the differences in ATPase activity stimulation could 
be that FeS cluster(s) are being transferred between the holo- and apo-forms of the proteins 
in the assays.  Therefore, cluster transfer between the holo and apo forms of the proteins 
had to be investigated.  Holo-untagged-Nbp35-Cfd1 was mixed with apo-12xHisDre2 to 
initiate the transfer (Figure 4.7A).  After incubation, 12xHisDre2 was isolated over a nickel 
affinity column.  The extent of FeS cluster transfer from holo-untagged-Nbp35-Cfd1 to 
apo-12xHisDre2 was assessed by ferrozine and sulfide assays.  The complement to this 
experiment was the opposite: holo-untagged-Dre2 was mixed with apo-SSTNbp35-
HisTEVCfd1 (Figure 4.7B).  In the case of cluster transfer from holo-untagged-Nbp35-Cfd1 
to apo-Dre2, the amount of iron and sulfide transferred and isolated on Dre2 should be 
similar to the iron and sulfide amounts from as isolated Dre2.  Cluster transfer from holo-




Nbp35-Cfd1 is typically isolated with less than one iron/sulfide per heterodimer.  Here, 
holo-untagged Dre2 lost ~55% of the FeS associated with it, yet only ~12% of the total 
FeS was taken up by apo-Nbp35-Cfd1 (Table 4.4).  Across all three trials of the transfer 
experiments, it seemed that an equilibrium was being reached in which the recipient 
recovered ~25-35% of the FeS clusters lost by the donor (Table 4.4). 
 
 
Figure 4.7. FeS Cluster Transfer Assay 
(A) From left to right: Holo-Nbp35-Cfd1 (donor) is mixed with apo-12xHisTEVDre2 
(recipient) in the ratio outlined in Table 4.4.  After a 1 h incubation at room temperature, 
the tagged protein, 12xHisTEVDre2, was isolated on a Ni-NTA column and was eluted with 
7.5 CV of TBS-Box (+) 300 mM imidazole (in TBS-Box).  The stoichiometry of iron and 
sulfide loading on the eluted fraction was assessed via ferrozine and sulfide assays.155  (B) 








Table 4.4. Dre2/Cfd1-Nbp35 FeS Cluster Transfer Summary 












8.0 ± 0.1 7.1 ± 0.4 5.5 ± 0.2 
 










Total Fe/S Fe – 64 nmol 
S – 64 nmol 
Fe – 49 nmol 
S – 50 nmol 
Fe – 72 nmol 
S- 72 nmol 
Donor Recovered -- 4.4 nmol 9.0 nmol 
 
Donor Fe – Post -- 6.0 ± 0.7 3.2 ± 0.04 
 
Donor S – Post -- 5.9 ± 0.4 4.0 ± 0.4 
 
Total Donor Fe/S -- Fe – 26 nmol (53%) 
S – 26 nmol (52%) 
Fe – 29 nmol (40%) 
S – 36 nmol (50%) 
Recipient 
Recovered 
9 nmol 5.6 nmol 4.0 nmol 
Recipient Fe - Post 1.5 ± 0.1 2.6 ± 0.0 2.3 ± 0.1 
 




Fe – 14 nmol (22%) 
S – 16 nmol (25%) 
Fe – 15 nmol (31%) 
S – 12 nmol (24%) 
Fe – 9 nmol (13%) 
S – 8 nmol (11%) 











4.3.6 BMOE Crosslinking and ATPase Activity Assays 
 The transfer experiments described above demonstrate that there is some degree of 
cluster transfer between the holo and apo proteins.  In order to determine if there is cluster 
transfer from Dre2 to Nbp35-Cfd1, the cross-linker BMOE was used to covalently modify 




ligation.  Nbp35-Cfd1 cross-linking was successful utilizing 100x molar excess BMOE, as 
evidenced by the appearance of a molecular weight band at ~75kDa (Figure 4.8A).   
 
Figure 4.8. BMOE Crosslinking and ATPase Activity of SSTNbp35-Cfd1 
(A) SDS-PAGE analysis of BMOE cross-linked Nbp35-Cfd1.  Nbp35-Cfd1 (15 μM dimer) 
was incubated with 0x (1), 2x (2), 20x (3), or 100x (4) molar excess of BMOE.  The 
reactions were quenched and prepared for SDS-PAGE analysis.  The molecular weight 
marker lane is denoted with ‘L’ and lane (5) is untreated Nbp35-Cfd1 (no BMOE, no 
DMSO).  (B) Specific ATPase activity of cross-linked samples with 10 mM ATP.  ‘NT’ is 
the untreated Nbp35-Cfd1 control.  The increasing amounts of BMOE (crosslinking) 
decreases the specific activity of Nbp35-Cfd1 that could not be rescued with Dre2.  kobs is 
in units of nmol ATP/min/nmol active site.   
 
 
However, at the highest concentrations of BMOE there was also a significant yield of very 
large molecular weight bands that populate the gel at the top of the resolving layer.  
Unfortunately, it was later discovered that as the concentration of BMOE increases (and 
the extent of crosslinking as a result), the ATPase activity of SSTNbp35-Cfd1 decreases 
dramatically (Figure 4.8B).  This is initially due to the presence of DMSO in the assay as 
evidenced by the change in activity between columns ‘NT’ and ‘0x’.  However the activity 
continues to decrease in a BMOE/crosslinking dependent fashion.  This precluded the 





Within this chapter, it has been demonstrated that the N-terminal domain of Nbp35 
is not needed for Dre2 to interact with, and stimulate the ATPase activity of, Nbp35-Cfd1 
(Figure 4.3, Table 4.1).  This leaves open the question as to how Dre2 is interacting with 
Nbp35-Cfd1.  The ATPase data gathered by Christa Molé (Figure 4.2) resulted in the 
interesting finding that Dre2 does not stimulate the ATPase activity of the homodimers, 
Nbp352 and Cfd12.  The exclusive stimulation of Nbp35-Cfd1 by Dre2, even in the absence 
of the N-terminus of Nbp35, suggests a model in which the dimer interface of Nbp35-Cfd1 
(or some motif other than Nbp35’s N-terminus) is responsible for the interaction with Dre2.  
This observation advances the model by narrowing in on the possible protein-protein 
interaction sites between Dre2 and Nbp35-Cfd1.  The other work within this chapter also 
uncovers some clues on potential mechanisms by which Dre2 stimulates ATPase activity.  
For example, the magnitude of ATPase stimulation by Dre2 is dependent on whether or 
not Dre2 and/or Nbp35-Cfd1 contain their FeS clusters. 
Dre2 and Tah18 have been hypothesized to be required for the assembly of Nbp35’s 
N-terminal [Fe4S4] cluster in Nbp35-Cfd1.
95  It was proposed that Dre2 (as part of the 
Tah18-Dre2 complex) was delivering reducing equivalents to the N-terminal FeS cluster 
of Nbp35.95, 96  If this is true, it would be expected that Dre2 is primarily interacting with 
Nbp35-Cfd1 via the N-terminal domain of Nbp35.  However, it has also recently been 
suggested by Bastow et al., that the interaction of Dre2 and Nbp35 homologs in A. thaliana 
was independent of the N-terminal domain of Nbp35.102  To settle this discrepancy, the 




the N-terminus and/or N-terminal [Fe4S4] cluster of Nbp35 is a major determining factor 
in Dre2’s interaction, then Δ53Nbp35-Cfd1 should not exhibit an increase in ATPase 
activity in the presence of Dre2.  It was found, however, that Δ53Nbp35-Cfd1 exhibited the 
same ATP hydrolysis kinetics as full-length Nbp35-Cfd1 in both the presence and absence 
of Dre2 (Figure 4.3, Table 4.1).  Additionally, Christa Molé discovered that Dre2 only 
stimulated the ATPase activity of Nbp35-Cfd1, not Nbp352 or Cfd12 (Figure 4.2).  Hence, 
Dre2 is not acting through the N-terminal domain/N-terminal FeS cluster of Nbp35.  Taken 
together, this data suggests a new working model in which Dre2 is interacting with Nbp35-
Cfd1 at a position other than the N-terminus of Nbp35, potentially at the dimer interface 
of Nbp35-Cfd1. 
If Dre2 interacts with Nbp35-Cfd1 at the dimer interface, it is plausible that Dre2 
could be delivering electrons to the bridging cluster of Nbp35-Cfd1, as was previously 
proposed for the N-terminal cluster.95, 96  Consequently, it would be expected that holo-
Dre2 would have the greatest ATPase stimulation of apo-Nbp35-Cfd1 because the bridging 
cluster site is bare, allowing for the assembly of the FeS cluster.  Additionally, Dre2 is 
assumed to be holo in the cell as it would require its clusters to transfer electrons to Nbp35-
Cfd1 as has been proposed.95, 96  Therefore, it came as a surprise when holo-Dre2 stimulated 
the ATPase activity of apo-Nbp35-Cfd1 and holo-Nbp35-Cfd1 to a lesser extent than apo-
Dre2 (Figure 4.6).  In fact, when both Dre2 and Nbp35-Cfd1 were holo, the ATPase 
activity of Nbp35-Cfd1 was at its lowest (Figure 4.6).  Arguably, if Dre2 is required to 
facilitate the building of the bridging cluster by contributing electrons, Dre2 would not 




apo, the ATPase activity was at its highest levels (Figure 4.6), countering the idea that 
holo-Dre2 would have the greatest stimulatory effect on Nbp35-Cfd1’s ATPase activity.   
Interestingly, the ATPase activity of mixtures of holo-Nbp35-Cfd1/apo-Dre2 or 
apo-Nbp35-Cfd1/holo-Dre2 were approximately the same (Figure 4.6).  To resolve why 
this was the case, it was reasoned that there might be some FeS cluster transfer between 
Nbp35-Cfd1 and Dre2 that led to the similar ATPase activities of the two samples.  Over 
the course of the assay, the populations of proteins that were apo or holo proteins would 
reach equilibrium and result in the same levels of ATPase activity observed for the two 
samples.  However, FeS cluster transfer experiments yielded results that indicated that 
there was no significant cluster transfer between Dre2 and Nbp35-Cfd1.  Attempts to 
transfer cluster from holo-Nbp35-Cfd1 to apo-Dre2 only resulted in, at most, 35% 
incorporation of FeS clusters into the recipient (Table 4.4).  This was not a significant 
transfer, as Dre2 typically purifies with this amount of iron and sulfur bound.  In addition, 
Dre2 has been reported to acquire its FeS cluster independently of other CIA factors, 
including Nbp35-Cfd1 in vivo,95 so there is no precedent for FeS cluster transfer from 
scaffold to Dre2.  For transfer from holo-Dre2 to apo-Nbp35-Cfd1, it seemed that there 
was some minimal, sub stoichiometric cluster transfer.  Nbp35-Cfd1 typically purifies with 
less than 1 Fe and S per heterodimer.  However, post incubation with holo-Dre2, Nbp35-
Cfd1 was isolated with ~2 Fe and S bound (Table 4.4).  Although this was suggestive of 
Dre2 transferring cluster to Nbp35-Cfd1, there was a significant amount of Fe and S 
(~47%) that was unaccounted for (Table 4.4).  Moreover, adventitious cluster degrading 




accepting FeS cluster from glutaredoxins, there is no evidence for transfer of any FeS 
cluster from Dre2 to Nbp35-Cfd1.37, 39, 103 
 Nbp35-Cfd1 was cross-linked with the cysteine reactive cross linker BMOE in an 
attempt to block any potential cluster transfer from Dre2 to Nbp35-Cfd1.  Although the 
initial crosslinking was successful (Figure 4.8A), the cross-linked product had greatly 
diminished ATPase activity as compared to an untreated Nbp35-Cfd1 control (Figure 
4.8B).  The reason for the decrease in the ATPase activity of cross-linked Nbp35-Cfd1 is 
not known.  However, it is interesting to note the effect of cysteine mutants in the 
homologous protein ApbC.  In work reported by Boyd et al., mutation of the cysteine 
residues in ApbC (homologous to the bridging cysteine residues of Nbp35-Cfd1) to alanine 
decreased the kcat by ~2- 4-fold as compared to WT ApbC.
111  Although the exact cause of 
this is not known, it goes hand in hand with the data shown here and demonstrates that the 
ATPase activity changes when the bridging site cysteine residues are altered.  It also 
corroborates the findings of Chapter 3 that demonstrated the allosteric communication 
between the ATPase sites and bridging cluster site of Nbp35-Cfd1. 
4.5 Conclusions 
This chapter illustrates a preliminary model of Dre2’s interaction with, and 
stimulation of, Nbp35-Cfd1 in which Dre2 stimulates the ATPase activity of the scaffold 
independently of Nbp35’s N-terminal domain.  In expanding this model, it has been 
speculated above that Dre2 could be interacting with Nbp35-Cfd1 at the dimer interface.  
While there is no direct evidence for an interaction at the interface, the exclusive 




of Nbp35’s N-term could mean that Dre2 acts at the dimer interface.  Although additional 
evidence and details of the interaction will need to be parsed out, such as the residues 
participating in the interaction, this discovery helps to narrow down the search. 
This chapter also shows that Dre2 can be successfully reconstituted and contains 
one [Fe2S2] and one [Fe4S4] cluster as determined by EPR spectroscopy and by chemical 
quantification of bound ferrous iron and sulfide (Figure 4.5A, Table 4.3).  The Mössbauer 
spectrum was dominated by signal arising from [Fe4S4] clusters with no detectable [Fe2S2] 
cluster signal observed (Figure 4.5B).  This discrepancy could be due to the fact that a 
large percentage of iron was unincorporated and adventitiously bound, either as Fe2+ or 
oxidized Fe3+ (broad signal ~4mm/s, Figure 4.5B), potentially from oxidized and degraded 
[Fe2S2] clusters.  This is in agreement with the evaluation of the reconstitution, in which 
the Dre2 sample had less iron and sulfide incorporated than expected (Table 4.2, 4.3). 
It was also revealed that Dre2’s stimulatory affect was attenuated by FeS clusters 
in both Dre2 and Nbp35-Cfd1.  While the underlying reason for this is not yet known, it 
brings up interesting possibilities.  Foremost among these is that Dre2 could be able to 
distinguish between apo- and holo-Nbp35-Cfd1 as a type of regulatory mechanism, 
stimulating the ATPase activity of apo-Nbp35-Cfd1 to facilitate cluster assembly/transfer.  
Yet, this explanation does not fully explain the observation that apo-Dre2 stimulates the 
ATPase activity of Nbp35-Cfd1 more than holo-Dre2.  Perhaps the in vitro activity assays 
are missing some other component that is important for the interaction of holo-Dre2 with 
Nbp35-Cfd1 in vivo.  Future work will be necessary to fully understand the intricacies of 




CHAPTER 5: Design and Development of a Dynamic Fluorescent Sensor for [Fe4S4] 
Cluster Detection 
5.1 Introduction 
 Access to effective methods for investigating the biosynthesis of metallocofactors 
is crucial to understanding the dynamics of metallocofactor flux within the cell.  One such 
group of metallocofactors is FeS clusters, ubiquitous metallocofactors required for a wide 
range of essential cellular processes.1, 2, 43, 44  Deficiencies in FeS cluster biosynthesis can 
lead to disease due to disruption of iron homeostasis and inhibition of critical pathways 
dependent on FeS clusters such as DNA synthesis and repair.43, 53, 182  Therefore, an 
understanding of cluster biogenesis is vital in understanding these diseases.  A number of 
methods have been developed to investigate FeS cluster biosynthesis in both in vitro and 
in vivo contexts.  However, none of these developed approaches are suitable for monitoring 
the dynamics of FeS cluster biogenesis in a cellular context, as they all suffer one or more 
limitations that hinder their utility. 
Absorbance spectroscopy (UV-Vis) has been a mainstay method in observing and 
detecting FeS clusters.183, 184  FeS clusters exhibit distinct spectral features that make it 
easy to differentiate between [Fe2S2] and [Fe4S4] via UV-Vis.  However, the limitations of 
this method begin in in vitro applications as it cannot measure the relative concentrations 
of two different FeS cluster binding proteins in a mixture.  This drawback means that it is 
impossible to monitor FeS cluster transfer from one protein to another without first 




protein from a recipient protein in vivo is unmanageable.  UV-Vis cannot therefore be used 
to develop a continuous in vivo kinetic assay for cluster transfer from a donor to a recipient. 
Circular dichroism (CD) is another spectroscopic technique and has had success in 
monitoring FeS cluster transfer reactions.79, 185-187  The primary advantage of CD is that it 
can be employed as a continuous assay.187  However, a major limitation of CD is that there 
can be a low signal to noise ratio when seeking to obtain good quality spectra.  In many 
cases, this low signal to noise necessitates optimization.  This can be problematic for in 
vitro experiments for example as spectra are largely dependent on the buffer system used.  
The issue is compounded in in vivo experiments due to the large amount of extraneous 
compounds in the cellular milieu.  In vivo experiments are additionally hampered by low 
protein concentration levels along with difficulties in monitoring a specific target protein 
of interest and parsing it out from other proteins.  Moreover, CD requires specialized 
equipment (namely a circular dichrometer) which may not be readily available to 
researchers. 
Monitoring flux through a particular FeS biogenesis system in vivo can be achieved 
by assessing the activity of one or more FeS proteins that are the substrates of the pathway 
of interest.  For example, the FeS cluster dependent activity of Leu1 or sulfite reductase 
can be used to monitor flux through the CIA system (as demonstrated in Chapter 3).  
Assessing the activities of specific FeS proteins can provide general information on overall 
FeS cluster biosynthesis and trafficking in vivo.111, 157, 165  For instance, loss of activity of 
a cytosolic FeS protein could be the result of a defective CIA system.  However, care must 




and not secondary, indirect cases such as changes in protein concentration.  A major 
drawback of these assays is that they are complex and need to be developed and optimized 
for each FeS protein.  Moreover, the amount of temporal information that can be gained 
from these assays is limited. 
Another method to monitor FeS biosynthesis via an in vivo approach is deletion 
studies coupled with radioactive 55Fe labeling.75, 157  These experiments are challenging 
however, as FeS biosynthesis is essential, and most perturbations to FeS pathways are 
lethal.  Yet, in cases where genetic manipulation is not lethal, growth media is 
supplemented with radioactive 55Fe, followed by immunoprecipitation or pull down of the 
target FeS protein is the most widely used method for monitoring FeS cluster biogenesis 
in vivo.  Cells supplemented with radioactive 55Fe will incorporate 55Fe into FeS proteins.  
A low amount of 55Fe incorporated into a target FeS protein is indicative of a defective FeS 
cluster biogenesis pathway.155  What limits this approach is that an antibody for the 
immunoprecipitation target must be available or an epitope tag must be fused to the target, 
a potentially lengthy and costly process.  Regrettably, these assays additionally lack the 
ability to probe cluster transfer between two proteins and obtain kinetic data. 
Fluorescence spectroscopy has the potential to overcome the limitations of the 
approaches outlined above.  FeS clusters quench fluorescence when situated < 100 Å from 
a fluorophore.188, 189  This cluster dependent quenching has led to the development of ‘turn-
off’ sensors for FeS clusters.189, 190  These sensors have an FeS cluster binding protein fused 
to a fluorescent moiety (fluorescent protein or small molecule).189, 190  These sensors were 




binding.  However, they were limited in their application, only having been demonstrated 
in in vitro experiments as it is difficult to introduce these sensors into a cell for in vivo 
measurements.   
While turn-off fluorescent sensors have their limitations, it is much easier to track 
an increase in fluorescence from a ‘turn-on’ sensor.  A prototypical example of a turn-on 
sensor was developed from a fusion of human Grx2 and two complimentary halves of the 
Venus fluorescent protein.191  FeS cluster binding causes Grx2 to dimerize, bringing the 
two halves of Venus together.  The Venus fragments then fuse and become fluorescent.  
Although promising, this sensor suffers from a number of limitations.  The dimerization of 
Grx2 is irreversible due to the covalent fusing of the Venus fragments.  Moreover, this 
sensor could only be used to detect [Fe2S2] clusters, limiting its versatility.  A new class of 
sensors is needed to overcome these drawbacks. 
This chapter describes the design and evaluation of a reversible sensor for [Fe4S4] 
clusters.  The sensor design is based on the fumarate and nitrate reductase transcription 
factor FNR.192-194  In bacteria, FNR is part of one of many mechanisms used as an oxygen 
sensor.192-196  When a [Fe4S4] cluster binds to FNR’s N-terminal domain it induces 
dimerization of FNR.184, 197, 198  The FNR dimer is an active transcriptional repressor.184, 199  
Under oxygen replete conditions, the cluster degrades and FNR returns to its monomeric 
form, alleviating transcriptional repression.200  FNR was utilized as a platform to construct 
a new class of FeS cluster sensor.  The fluorescent FNR construct remains able to bind a 
[Fe4S4] cluster and undergo cluster dependent dimerization.  Finally, the utility of the 




is quenched in the presence of the FeS cluster and can be used to report on the rate of 
cluster decay with good accuracy. 
5.2 Materials and Methods 
5.2.1 Primer Design and Site-Directed Mutagenesis 
N-terminally His tagged FNR (His-TEV-FNR) was created by amplifying FNR 
from genomic DNA utilizing primers JDG03 and JDG04 (Table 5.1) and inserting between 
the NdeI and BamHI sites of the p15b vector, a modified pET15 vector that contains a TEV 
protease site. The resulting construct (pJDG04) encoded His-TEV-FNR.   
The SNAP fused construct called FNR-SNAP (pCG05) was created in 
collaboration with Calina Glynn by amplifying His-TEV-FNR using primers JDG16’ and 
JDG17’ and inserting this amplification product into the pSNAP-tag (T7)-2 vector (New 
England Biolabs) between the NdeI and EcoRI sites.  The D154AFNR-SNAP mutant 
(pCG08) was created via Quikchange mutagenesis using primers CG01 and CG02 and the 
L28HFNR-SNAP mutant (pCG07) was created using primers CG03 and CG04.  All cloned 
constructs were verified with DNA sequencing (Genewiz). 
Table 5.1. Primers Used for FNR Fusion and Site-Directed Mutagenesis 















5.2.2 Protein Expression and Purification 
 
The FNR constructs were transformed into chemically competent BL21 (DE3) cells 
(New England Biolabs) for overexpression.  Cells were grown in the presence of the 
appropriate antibiotic at 37 °C to an OD600 of 0.5 - 0.6 and expression was induced by the 
addition of 0.5 mM IPTG.  After 4 h, cells were harvested by centrifugation and the cell 
pellet stored at -80 °C.   
The cell pellet (typically 12 – 16 g) was resuspended in FNR Buffer (50 mM 
potassium phosphate (pH 6.8), 100 mM potassium chloride, and 10% glycerol) 
supplemented with 5 mM β-mercaptoethanol, 1 mM protease inhibitor (PMSF), and DNase 
(60 U/g cell pellet).  Ten mL of FNR Buffer was used per gram of cell paste to resuspend 
the cells.  The sample (split into aliquots of 50 mL in a 250 mL Erlenmeyer flasks) was 
placed in an ice water bath and lysed by sonication for six cycles of 20 s on and 40 s off at 
65% amplitude.  Lysate was centrifuged (48,000 g for 45 min at 4 °C) and the supernatant 
applied to nickel NTA agarose beads (1 mL of resin for every 5 g of cell paste).  The 
column was washed with 20 column volumes (CV) of FNR Buffer supplemented with 5 
mM imidazole, 10 CV of FNR Buffer supplemented with 10 mM imidazole, and 5 CV of 
FNR Buffer supplemented with 20mM imidazole.  Protein was eluted with FNR Buffer 
supplemented with 250mM imidazole.  Eluted protein was typically concentrated to ~15 
mg/mL in a volume of >2 mL and then buffer exchanged via PD10 column (GE Healthcare) 
into FNR Buffer supplemented with 200 mM ammonium sulfate and 5 mM dithiothreitol.  
The final protein concentrations were typically 8 – 10 mg/mL in a volume of 3 – 4 mL.  




5.2.3 Size Exclusion Chromatography 
The samples (100 μL, 1 mg/mL) were injected onto a Superdex 200 Increase 10/300 
GL column (GE Healthcare) via a 100 μL injection loop.  The proteins were eluted in 50 
mM potassium phosphate (pH 6.8), 100 mM potassium chloride, and 5% glycerol at a flow 
rate of 0.5 mL/min.  Protein elution was monitored at A280.  The molecular weight was 
determined by comparison of the elution volume to a standard curve generated from an 
elution profile of standard proteins containing thyroglobulin (670 kDa), γ-globulin (158 
kDa), ovalbumin (44 kDa), myoglobin (17 kDa), and vitamin B12 (1.35 kDa).  Void 
volume was determined by the elution volume of the first standard protein (thyroglobulin).  
Standards were analyzed immediately before experimental samples were run.   
5.2.4 SNAP-Tag Labeling 
Lyophilized SNAP substrates, Cell 430 or Cell Fluorescein (New England Biolabs), 
were dissolved in DMSO at a concentration of 250 μM and stored at -20 °C.  Typical 
labeling reactions (250 μL) contained 5 μM FNR-SNAP, 10 μM SNAP substrate, and 1 
mM DTT in FNR Buffer.  For aerobic labeling, the reaction was incubated at 37 °C for 30 
min in the dark.  Anaerobic labeling was carried out in the anaerobic chamber for 2 h at 
room temperature in the dark.  Unreacted SNAP substrate was removed by passing the 
reaction mixture over a small (50 μL) nickel NTA column.  The column was washed with 
10 CV of FNR Buffer followed by elution with FNR Buffer supplemented with 300 mM 




5.2.5 Fluorescence Measurements 
Samples (1500 μL) contained ~1 μM labeled FNR-SNAP in FNR Buffer.  
Fluorescence experiments were carried out at 25 °C on a Horiba Jobin Yvon FluoroMax3 
fluorimeter with a 1 cm path length cuvette outfitted with a screw cap and septum for 
anaerobic samples.  Samples labeled with Cell 430 were excited at 421 nm and the emission 
was monitored over 425 – 525 nm.  Samples labeled with Cell Fluorescein were excited at 
500 nm and emission monitored over 505- 605nm.  For labeled, holo-FNR-SNAP, the 
samples were prepared in the anaerobic box prior to recording fluorescence.  
5.2.6 FeS Cluster Reconstitution 
Iron sulfur cluster reconstitutions were carried out in a Coy Anaerobic Chamber 
under an atmosphere of 5% hydrogen balanced nitrogen.  Purified protein (typically 500 
μL of 4 – 6 mg/mL protein) was brought into the box, DTT (5 mM final) was added, and 
the solution allowed to degas for 2 h with gentle stirring at room temperature.  After 2 h, 
the protein solution was diluted to 1.0 - 1.5 mg/mL with anaerobic FNR Buffer 
supplemented with 5 mM DTT.  Stock solutions of 10 mM ferrous ammonium sulfate and 
sodium sulfide were made up in anaerobic water and then added drop-wise to the protein 
solution at an 8x molar excess.  The mixture was incubated for 2 h on a cold block 
(CoolBoxXT, Biocision) with gentle stirring.  Samples were centrifuged (13.4 krpm for 10 
min) and the supernatant was applied to a 20 mL G-25 resin desalting column equilibrated 
with anaerobic FNR Buffer.  Protein-containing fractions were pooled and concentrated 
via Amicon spin concentrators to 5 – 10 mg/mL in a volume of 3 – 5 mL.  Protein 




and sulfide quantification.  Quantification of iron and sulfur of the reconstituted proteins 
was carried out as described previously.155, 168, 169 
5.2.7 Cluster Decay Kinetic Measurements 
Absorbance was measured on a Cary 50 UV-Vis.  The temperature was held 
constant at 25 °C for the duration of the assay.  A 1 cm stoppered cuvette contained 500 
μL of Cell 430 labeled holo-FNR-SNAP (~20 μM).  Aerated FNR Buffer (100 μL) was 
added and the UV-Vis spectrum was recorded every 2.5 min for 6.5 h. 
Fluorescence was measured on a Horiba Jobin Yvon FluoroMax3 fluorimeter with 
excitation set to 421 nm, emission to 484 nm, and slit widths of 2 nm.  The temperature 
was held constant at 25 °C via Peltier temperature control system.  A 1 cm stoppered 
cuvette contained Cell 430 labeled holo-FNR-SNAP (~1 μM) in 1500 μL.  Cluster decay 
was initiated by the addition of 300 μL aerated FNR buffer.  The emission intensity was 
read every 2 min for 6.5 hours.   
 For absorbance data, normalization was calculated by setting the absorbance (A410) 
at time zero as 100% of the signal.  Fluorescence data was normalized in a similar manner 
by setting 100% emission signal (Em at 484 nm) at the end time point of the assay.  
Normalized absorbance and fluorescence data was plotted as a function of time.  The data 
was fit to an exponential decay equation (Eq. 5.1) in GraphPad Prism 7: 
𝑦 =  (𝑦0 − 𝑦𝑚) ∗ 𝑒
(−𝑘∗𝑡) + 𝑦𝑚  





where 𝑦 is the percent maximum signal at time point t, 𝑦0 is the percent maximum signal 
when t = 0, 𝑦𝑚 is the 𝑦 value at infinite time, and 𝑘 is the rate constant in units of inverse 
t (min-1-). 
5.3 Results 
5.3.1 Sensor Design 
The goal of this project was to develop a reversible fluorescent sensor for the 
detection of [Fe4S4] clusters.  This design of a [Fe4S4] cluster sensor is based on the 
fumarate and nitrate reductase transcription factor FNR.  FNR was chosen because it binds 
a [Fe4S4] cluster and undergoes a cluster dependent dimerization.
184, 192, 201  It was these 
two characteristics of FNR that made it an ideal candidate for the sensor.  Not only does 
FNR allow for the creation of a fluorescent construct, the ability of it to undergo cluster 
dependent dimerization opens up the development of FRET experiments.  With FNR 
chosen as the platform for the sensor, a SNAP-tag protein could be fused to the C-terminus 
of FNR (Figure 5.1A).  The SNAP-tag protein can then be covalently labeled with a wide 
range of commercially available fluorescent substrates.  The correct pairing of two different 
fluorescent constructs allows for a ‘turn-on’ FRET response between two FNR-SNAP 
fusions.  Cluster binding results in a FRET interaction and an increase in the fluorescence 





Figure 5.1. Design of the FNR-SNAP Fluorescent Sensor.   
(A) FNR (purple) fused to SNAP (orange) is covalently labeled with Cell 430 (FRET 
Donor) or Cell Fluorescein (FRET Acceptor).  Cluster induced dimerization of FNR-SNAP 
results in FRET.  The magnitude of the FRET deteriorates as cluster oxidatively decays.  
(B) FNR-SNAP labeled with Cell 430 is quenched in the presence of the [Fe4S4] cluster.  
Cluster decay upon oxygen exposure alleviates the fluorescence quenching.   
 
This design also allows for a ‘turn-off’ sensor, dependent on the fluorescence emission 
quenching of the bound cluster (Figure 5.1B).  Acquisition of FeS cluster would show a 
decrease in the total fluorescence. 
FNR-SNAP was purified following the general purification procedure outlined by 
Lazazzera et al.184  Typical yields from the purification procedure were in the range of 4.0 
mg/g of cell paste at a purity of approximately 90% (Figure 5.2A).  The FNR-SNAP 
constructs were labeled with SNAP substrates and analyzed via SDS-PAGE (Figure 5.2B).  
Therefore, pure FNR-SNAP was readily obtained and could be successfully labeled with 





Figure 5.2. SDS-PAGE Analysis of FNR-SNAP 
(A) Purification of FNR-SNAP was followed by SDS-PAGE.  Molecular weight ladder 
(lane 1) migrations on the left are in kDa.  Lane 2: whole cell lysate; Lane 3: clarified 
lysate; Lane 4: His column flow through of clarified lysate; Lanes 5-6: 5 mM imidazole 
wash; Lanes 7-8: 10 mM imidazole wash; Lanes 9-10: 20 mM imidazole wash; Lane 11: 
250 mM imidazole elution, of isolated FNR-SNAP.  (B) SDS-PAGE and fluorescent 
imaging of FNR-SNAP labeled with SNAP-Cell substrates.  An Xcita Blue filter set was 
used to image the fluorescence of the gel.  Fluorescent ladder bands (lane 1) are 75 kDa 
and 25 kDa.  Lanes 2-4 contain 2, 4, and 8 μg of Cell 430 labeled FNR-SNAP and Lanes 
5-7 contain 2, 4, and 8 μg of Cell Fluorescein labeled FNR-SNAP. 
 
5.3.2 Size Exclusion Chromatography 
 In order to determine that the FNR-SNAP fusion retained the ability to dimerize, 
the molecular weight of WTFNR-SNAP was determined.  In the absence of the [Fe4S4] 
cluster, FNR-SNAP should elute as a monomer, based on previous SEC experiments with 
apo-FNR.197  An additional FNR-SNAP construct was created in which Asp154 was 
substituted with Ala (D154AFNR-SNAP).  This mutation in FNR has been well characterized 
in the literature and primarily exists as a dimer, even in the absence of the [Fe4S4] cluster.
197, 
198, 200  WTFNR-SNAP eluted predominantly at an elution volume of 14.4 mL, 




at an elution volume of 13.1 mL indicated the presence of some dimeric WTFNR-SNAP 
(Figure 5.3, red line).  D154AFNR-SNAP eluted predominantly at an elution volume of 13.1 
mL, corresponding to the molecular weight of a dimer (Figure 5.3, blue line).  The 
dimerization of D154AFNR-SNAP confirmed that the FNR-SNAP fusion retained the ability 
to form a dimer. 
Table 5.2. Summary of SEC Results 
FNR Construct Elution Vol. (mL) Molecular Weight (kDa) 
  Calculated1 Expected 
WT 13.1 118.9 104.3 
As Isolated -D154A 14.4 58.9 52.2 
As Isolated-L28H 13.1 118.9 104.3 
 14.4 58.9 52.2 
Holo-L28H 12.6 156.7 104.3 
1Calculated from standard curve obtained with Bio-Rad protein standards 
 
 
Figure 5.3. Size Exclusion Chromatography of FNR-SNAP 
(A) Elution profile of FNR-SNAP variants.  WTFNR-SNAP (red) elutes predominantly as 
a monomer while D154AFNR-SNAP (blue) elutes predominantly as a dimer.  Apo-L28HFNR-
SNAP (brown, dotted line) elutes as a mixture of monomers and dimers.  Upon 
reconstitution, the elution volume of holo-L28HFNR-SNAP (brown, solid line) shifts to that 
of a dimer.  Numbers 2 and 3 correspond to the molecular weight standards presented in 
(A).  (B) Depicts a zoomed out version of (A) and the full trace of the molecular weight 
standards.  Numbers from left to right correspond to standards; thyroglobulin (670 kDa), 





Since the FNR-SNAP fusion was able to adopt a dimeric form, as evidenced by the 
D154AFNR-SNAP mutant, this predicts that the SNAP fusion should not prevent a [Fe4S4] 
cluster dependent dimerization.  To test this, it must first be demonstrated that a [Fe4S4] 
cluster be reconstituted on WTFNR-SNAP.  Purified WTFNR-SNAP was reconstituted with 
8x molar excess iron and sulfide.  The UV-Vis spectrum of holo-WTFNR-SNAP showed a 
characteristic [Fe4S4] peak at 410 nm (Figure 5.4A).  Iron and sulfide quantification was 
consistent with the reconstitution of an [Fe4S4] cluster (Table 5.3).  This confirmed that 
the FNR-SNAP fusion could be reconstituted. 
 To test whether the reconstitution of the [Fe4S4] cluster of FNR-SNAP resulted in 
dimerization of the fusion, a mutant FNR-SNAP construct was created in which Leu28 is 
substituted with His (L28HFNR-SNAP).  The L28H substitution is proposed to protect the 
[Fe4S4] from rapid oxidative degradation in an aerobic environment
200, 202 making it ideal 
for testing holo-FNR-SNAP quaternary structure via SEC.  This is important as the SEC 
system used was not contained in an anoxic environment.  Therefore, L28HFNR-SNAP was 
successfully reconstituted with iron and sulfide amounts that indicate the presence of a 
[Fe4S4] cluster (Figure 5.4B, Table 5.3). 
Table 5.3. FNR-SNAP Iron and Sulfide Quantification  
FNR-SNAP Variant Fe/monomer S2-/monomer 
WTFNR-SNAP As Isolated 0.15 ± 0.05 0.07 ± 0.01 
WTFNR-SNAP Reconstituted 7.3 ± 0.1 6.7 ± 0.2 
L28HFNR-SNAP As Isolated 0.74 ± 0.02 0.45 ± 0.02 
L28HFNR-SNAP Reconstituted 6.2 ± 0.1 5.7 ± 0.1 






Figure 5.4. UV/Vis Absorbance Spectra of FNR-SNAP variants. 
The normalized UV-Vis spectra of WTFNR-SNAP (A) and L28HFNR-SNAP (B) of the as 
isolated proteins (dashed lines) and after cluster reconstitution (solid lines). 
 
 
After reconstitution of L28HFNR-SNAP, SEC was used to evaluate the quaternary 
structure of holo-L28HFNR-SNAP.  Two forms of L28HFNR-SNAP were analyzed via SEC, 
the as-purified apo form (Figure 5.4B, Table 5.3) and the reconstituted holo form.  Apo-
L28HFNR-SNAP eluted in two nearly equal peaks.  The larger peak eluted at 58.9 kDa (14.4 
mL), consistent with the molecular weight of the monomer. The second, slightly smaller 
peak eluted at 118.9 kDa (13.1 mL), representing the dimeric form (Figure 5.3, Table 5.2).  
Holo-L28HFNR-SNAP eluted in a volume that was shifted to the left of the monomeric 
elution volume, indicative of a heavier molecular weight.  This showed that the majority 
of holo-L28HFNR-SNAP eluted as a dimer, with only a very small amount eluting as a 
monomer.  The SEC results confirm that FNR-SNAP can dynamically form a dimer and is 
dependent on its FeS cluster in order for this to occur (Figure 5.3, Table 5.2). 
5.3.3 FRET Experiments 
To test the feasibility of utilizing FNR-SNAP in FRET experiments, the 




430 and Cell Fluorescein have not been demonstrated to be a FRET pair, the molecules 
they are derived from (coumarin and fluorescein respectively) have been demonstrated to 
be a FRET pair with a Förster radius of ~50 Å.203, 204  Cell 430 has an excitation maximum 
at 421 nm and an emission maximum at 484 nm.  Cell Fluorescein has an excitation 
maximum at 500 nm and an emission maximum at 532 nm.  The overlap between the 
emission of Cell 430 (FRET donor) and the excitation of Cell Fluorescein (FRET acceptor) 
should allow for FRET to occur. 
 
Figure 5.5. FNR-SNAP FRET Trials Reveal Cell Fluorescein is Excited at 421 nm   
Samples containing 3μM of L28HFNR-SNAP labeled with either SNAP-Cell 430 (blue line) 
or SNAP-Cell Fluorescein (green line) were excited at 421nm and their emission spectra 
recorded.  Cell 430 emits at 484 nm where expected while Cell Fluorescein showed 
substantial fluorescence when excited at 421 nm even though its excitation max is 500nm.  
Equimolar mixtures of labeled L28HFNR-SNAP (1.5μM of each Cell 430 and Cell 




To test whether the FRET acceptor (Cell Fluorescein) is not excited at the same 
wavelength as the FRET donor (Cell 430), apo-L28HFNR-SNAP was labeled with either 
Cell 430 (L28HFNR-SNAP-430) or Cell Fluorescein (L28HFNR-SNAP-Fluor).  When 




(Figure 5.5, Blue) as expected.  A separate cuvette containing only L28HFNR-SNAP-Fluor 
should not fluoresce when excited with 421 nm light (as its excitation maximum is at 500 
nm), yet an emission maximum at 530 nm was observed (Figure 5.5, Green) which was 
not expected. 
To test how much the fluorescence emission of L28HFNR-SNAP-Fluor might impact 
the spectra of L28HFNR-SNAP-430, the two constructs were assayed together.  L28HFNR-
SNAP was labeled with a solution containing an equimolar mixture of Cell 430 and Cell 
Fluorescein.  A cuvette containing the dual labeled L28HFNR-SNAP was excited at 421nm 
and 400 nm.  It was expected that although the 421 nm light might excite Cell Fluorescein, 
the reduction in excitation to a wavelength of 400 nm would excite Cell-430 more than 
Cell Fluorescein.  Excitation at a wavelength of either 421 or 400 nm resulted in the 
observation of two emission peaks, one at 483nm and one at 526nm.  The emission 
wavelengths are attributable to the emission of Cell 430 and Cell Fluorescein respectively 
(Figure 5.5, Red).  Together, this data shows that Cell Fluorescein is excited by 421 nm 
light, precluding the use of this fluorophore as a FRET acceptor, as the only excitation it 
should receive is from the nonradiative energy transfer from excited Cell 430. 
5.3.4 FeS Cluster Dependent Fluorescence Quenching 
To determine if the [Fe4S4] cluster of FNR-SNAP could quench the fluorescence of 
the SNAP-Cell substrates, the fluorescence of the two fluorophores bound to apo-FNR-
SNAP and holo-FNR-SNAP were compared.  Apo-L28HFNR-SNAP-430 was excited at 421 
nm and the spectra recorded from 425-525nm.  The emission peaks at 484 nm are indicative 




to contain approximately one [Fe4S4] per monomer (Table 5.4) and labeled with Cell 430.  
The fluorescence emission of holo-L28HFNR-SNAP-430 samples (Figure 5.6A-B, dashed 
lines) were compared to that of the same concentration of apo-L28HFNR-SNAP-430 
(Figure 5.6A-B, solid lines).  From the change in fluorescence intensity, the fluorescence 
emission of SNAP-Cell 430 was quenched (44 ± 17%) by the [Fe4S4] cluster. 
 
 
Figure 5.6. Fluorescence Quenching is [Fe4S4] Cluster and Substrate Specific 
Fluorescence was normalized to protein concentration and plotted as a function of 
wavelength.  (A-B) L28HFNR-SNAP-430 in either the apo (solid lines) or holo (dashed 
lines) forms were excited at 421 nm.  Cell 430 has an emission maximum at 484nm.  A 
and B depict two separate experiments.  (C-D) Same as (A-B) except that L28HFNR-SNAP 
was labeled with Cell Fluorescein and excitation of the samples was carried out at 500nm.  
Cell Fluorescein has an emission maximum at 532 nm.  C and D depict two separate 






Table 5.4. Fluorescence Change of holo-FNR-SNAP Compared to apo-FNR-SNAP 
 
 
To ensure that the fluorescence quenching of Cell-430 labeled L28HFNR-SNAP was 
specific to Cell-430, it was compared to the fluorescence of apo- and holo- Cell-
Fluorescein labeled L28HFNR-SNAP.  L28HFNR-SNAP-Fluor (Cell-Fluorescein) has an 
absorbance maximum at 500 nm which does not overlap with that of a [Fe4S4].  Therefore, 
the fluorescence of Cell Fluorescein was not expected to be quenched by the presence of 
FNR-SNAP’s FeS cluster.  L28HFNR-SNAP-Fluor was excited at 500 nm and the emission 
spectra recorded from 505-605 nm.  The emission peak at 532 nm is indicative of protein 
bound Cell Fluorescein (Figure 5.6C-D, solid lines).  L28HFNR-SNAP was next 
reconstituted with approximately one [Fe4S4] cluster bound per monomer (Table 5.4) and 
labeled with Cell Fluorescein.  The fluorescence emission of holo-L28HFNR-SNAP-Fluor 
(Figure 5.6C-D, dashed lines) was compared to that of the same concentration of apo-
L28HFNR-SNAP-Fluor (Figure 5.6C-D, solid lines).  Cell Fluorescein only exhibited a 
modest 11 ± 2% change (absolute value) in fluorescence intensity (Figure 5.6C-D, Table 
5.4).  These results were incredibly promising.  Not only was the fluorescence of Cell 430 
quenched by the [Fe4S4] cluster of FNR-SNAP, the quenching was specific to Cell 430, 
and was not observed with Cell Fluorescein.   
SNAP-Cell 
Substrate 
Fe2+/monomer S2-/monomer % Fluorescence 
Change 
Cell 430-1 5.2 ± 0.1 3.3 ± 0.1 -60% 
Cell 430-2 4.1 ± 0.04 3.5 ± 0.1 -27% 
Cell Fluorescein-1 3.9 ± 0.3 3.5 ± 0.1 +9% 




5.3.5 Cluster Decay Kinetics 
 Next, it was determined whether the quenching of the fluorophore by the FeS 
cluster could be used to develop a kinetic assay.  This kinetic assay could be utilized to 
monitor the dynamics of FeS cluster assembly or transfer by following the changes in 
fluorescence intensity.  Therefore, the rates of FeS cluster degradation initiated by oxygen 
exposure was measured by both UV-Vis and fluorescence.  Previously reported 
experiments described cluster decay rates for the L28H variant to be at least an order of 
magnitude slower than that of the WT variant.202  For both L28HFNR-SNAP and WTFNR-
SNAP, the A410 value was expected to decrease while the fluorescence intensity was 
expected to increase, albeit at different rates.  Upon exposure to oxygenated buffer, the 
A410 signal of holo-
WTFNR-SNAP decreased with an average rate constant of (1.4 ± 0.3) x 
10-2 min-1 (Figure 5.7A, Table 5.5).  Holo-WTFNR-SNAP was reconstituted and labeled 
with Cell 430.  After oxygen exposure, the fluorescence emission decreased with an 
average rate constant of (2.9 ± 0.8) x 10-2 min-1 (Figure 5.7B, Table 5.5).  The same cluster 
degradation experiments were repeated for holo-L28HFNR-SNAP.  The A410 signal of holo-
L28HFNR-SNAP decreased with an average rate constant of (2.2 ± 1.1) x 10-3 min-1 (Figure 
5.7A, Table 5.5) while the fluorescence intensity increased with an average rate constant 
of (7.1 ± 0.5) x 10-3 min-1 (Figure 5.7B, Table 5.5).  This is consistent with the magnitude 






Figure 5.7. Cluster Decay Kinetics  
Time course comparing cluster decay rates for holo-WTFNR-SNAP and holo-L28H-FNR-
SNAP.  (A) A representative decay plot for the absorbance decrease of WTFNR-SNAP (n 
= 2) and L28HFNR-SNAP (n = 3).  (B)  A representative plot for the fluorescence increase 
of Cell-430 bound to WTFNR-SNAP (n = 2) and L28HFNR-SNAP (n = 3).  In both plots, the 
data was fit to Eq. 5.1 (dashed lines) to determine the rate constants in Table 5.5. 
 
 
Table 5.5. Rate Constants of Absorbance Decay and Fluorescence Quenching Relief  
FNR-SNAP Variant Rate Constant (min-1) Trials 
 Absorbance Decay Fluorescence Increase  
WTFNR-SNAP (1.4 ± 0.3) x 10-2 (2.9 ± 0.8) x 10-2 2 
L28HFNR-SNAP (2.2 ± 1.1) x 10-3 (7.1 ± 0.5) x 10-3 3 
 
5.4 Discussion 
Assessment of FeS cluster assembly in vivo has long been hampered due to the lack 
of effective tools for making these measurements.  Recently, methods have been developed 
that utilize fluorescence as a signal for FeS cluster detection.189-191, 205  This chapter has 
described the development of a fluorescent, [Fe4S4] cluster sensor that is dynamic and 
reversible. 
The first step in creating this sensor was successfully carried out, with the SNAP 
tag being fused to the C-terminus of FNR.  Importantly, this fusion does not interfere with 




SEC experiments as the apo-WTFNR-SNAP construct existed predominantly as a monomer 
while the mutant D154A formed a dimer (Figure 5.3, Table 5.2).  The presence of dimeric 
WTFNR-SNAP is likely a result of a relatively high concentration of protein being loaded 
onto the column.  The concentration dependent oligomer shift has been observed before in 
other FNR variants.197, 198  Most importantly, L28HFNR-SNAP is a monomer in the absence 
of the FeS clusters, but readily forms a dimer upon binding to FeS clusters.  The FeS cluster 
dependent dimerization of FNR-SNAP demonstrated that the sensor could dynamically 
respond to the presence of [Fe4S4]. 
FNR-SNAP’s cluster dependent dimerization (Figures 5.3, 5.4, Tables 5.2, 5.3) 
opened up an avenue to the development of FRET assays for measuring FeS clusters.  
Initial experiments into optimizing a FRET assay were unsuccessful due to Cell 
Fluorescein’s excitation at the same wavelength as the excitation of Cell 430 (Figure 5.5).  
However, it was still promising that FNR-SNAP could form a dynamic, cluster dependent 
dimer.  The wide range of available SNAP substrates, and the relative ease of synthesizing 
custom SNAP substrates,206 could allow for future optimization and further testing of FNR-
SNAP as the foundation of a FRET sensor.  At the time the experiments in this chapter 
were carried out, the only potential FRET pair that was available was Cell Fluorescein and 
Cell 430. 
The second sensor design, relying on the quenching of the fluorophore by a 
proximal FeS cluster, was more successful (Figure 5.6, Table 5.4).  The magnitude of 
fluorescence quenching for Cell 430 in the presence of the FeS cluster was three- to six-




was essentially not quenched by the FeS cluster).  The greater degree of fluorescence 
quenching with Cell 430 made it a good choice to monitor cluster decay via fluorescence.  
This was because the 30 – 60% decrease in fluorescence intensity between Cell 430 labeled 
apo-FNR-SNAP and Cell 430 labeled holo-FNR-SNAP provided a good difference in 
signal to observe time dependent cluster decay as a function of fluorescence intensity. 
To evaluate whether the changes in fluorescence intensity quantitatively reflects 
the changes in FeS cluster binding, the differences in cluster decay rates were compared 
by monitoring changes in the signals of both UV-Vis and fluorescence intensity.  The decay 
rates were also compared to previously determined FNR cluster decay rates as reported in 
the literature.  In these FNR-SNAP experiments, the [Fe4S4] cluster of the stabilizing 
variant L28HFNR-SNAP decayed approximately an order of magnitude more slowly than 
the cluster of WTFNR-SNAP (Figure 5.7, Table 5.5).  The absorbance measurement of the 
[Fe4S4] cluster of 
L28HFNR-SNAP decreased an average of ~7% after 60 minutes of oxygen 
exposure.  This is in agreement with a previous study of L28HFNR in which 60 minutes of 
oxygen exposure resulted in an ~5% decrease in the absorbance spectra.202  This is in stark 
contrast to the decay rate of WTFNR which exhibited nearly 50% absorbance decrease after 
just 10 minutes of oxygen exposure.207  A more recent study on an S24F variant of FNR 
utilized mass spectrometry to ascertain the identities of the intermediates formed during 
cluster degradation.208   S24F exhibits a slower decay rate than WTFNR and has been 
proposed to stabilize the cluster in a similar manner as the L28H substitution.200, 209  
Therefore, the decay rates determined for L28H we compared with the decay rates for 




Analysis of the rates reported for S24F revealed that the overall decay rate of the [Fe4S4] 
bound dimeric form to the [Fe2S2] bound monomeric form occurs with total rate constants 
on the order of 4.0x10-3 to 9.8x10-5 min-1.  Overall, these decay rates for S24F are similar 
to those observed for the cluster decay and fluorescence quenching relief rates (2.2x10-3 to 
7.1x10-3 min-1, Table 5.5) shown here for L28HFNR-SNAP. 
5.5 Conclusion 
The work described herein demonstrates that the FNR-SNAP construct shows 
promise as a [Fe4S4] cluster sensor.  By exploiting the ability of FeS clusters to quench 
fluorescence over relatively long distances, it was demonstrated that the FNR-SNAP 
construct results in a relief of fluorescence quenching as FeS cluster decays.  The developed 
sensor could accurately report cluster decay rates of two different FNR-SNAP variants.  
The rate of cluster decay as measured by absorbance followed the same trend as the rate of 
decay measured by fluorescence intensity.  The rates fit to both measurements were within 
an order of magnitude and corresponded well to rates of decay previously reported.  
Importantly, this work lays the foundation for developing fluorescence based sensors that 
could be used to monitor cluster assembly on a scaffold and trafficking to downstream 
recipient proteins.  The SNAP protein fusion allows for labeling of SNAP with a variety 
of readily available SNAP substrates and substrates with desired characteristics can be 






Chapter 6: Major Conclusions and Future Directions 
There has long been a deficit in the collective knowledge pertaining to the cluster 
biogenesis cycle of the CIA scaffold.  Although it is clear that the ATPase sites of Nbp35 
and Cfd1 are essential for CIA function, the mechanism underlying why this is had 
remained a relative ‘black box’ of information.23, 66, 76, 157  This is due, in large part, to the 
uncoupling of the ATPase and scaffolding activities of Nbp35-Cfd1 in in vitro experiments.  
To overcome this limitation, a combination of in vitro and in vivo approaches were used to 
gain new information on the link between FeS cluster assembly and transfer, and the 
binding and hydrolysis of ATP. 
The use of in vitro binding assays with fluorescent nucleotide analogs first 
established that, like Nbp352, Cfd12 was able to bind nucleotide, even though it had no 
detectable ATP hydrolysis activity.110  Although Cfd12 lacked ATPase activity, the Cfd1 
subunit in Nbp35-Cfd1 was shown to be capable of hydrolyzing ATP with site-directed 
mutagenesis experiments.  Further studies with Nbp35-Cfd1 mutants revealed that the 
Nbp35 and Cfd1 subunits have similar affinities for nucleotide, although Cfd1 appears to 
be a high affinity binding site relative to Nbp35.  Therefore the subunits of Nbp35-Cfd1 
have distinct roles within the heterodimer: Cfd1 controls nucleotide binding and Nbp35 
activates the complex for hydrolysis.  This, in part, explains the heterodimeric nature of 
the CIA scaffold, and why both proteins are essential.   
It was also discovered in this work that the bridging cluster binding site and the 
ATPase site are in allosteric communication with one another.  Occupancy of the bridging 




and TNP-ATP.  This finding led to the development of a working model for the CIA 
scaffold in which ATP binding to Nbp35-Cfd1 initiates the scaffolding reaction.  The 
binding affinity assays were able to confirm that ATP was the preferred substrate for yeast 
Nbp35-Cfd1, ruling out GTP as a candidate as was suggested in other studies.77   
 The coupling of our in vitro binding and hydrolysis assays with the in vivo analysis 
of Nbp35 mutants conducted by Dr. Kelly Gay allowed for further expansion of the 
working model.  The combination of these in vitro and in vivo techniques afforded a unique 
opportunity to couple ATP binding and hydrolysis defects to specific phenotypes.  The 
most interesting finding in this set of experiments was the observation of a dominant 
negative phenotype in yeast expressing Nbp35 mutants that were able to bind, but not 
hydrolyze ATP.  The observation of this phenotype generated the hypothesis that a partner 
protein was associating with the nucleotide bound form of Nbp35-Cfd1.  This led to the 
discovery of two CIA factors, Dre2 and Nar1, acting as partner proteins that stimulate the 
ATPase activity of Nbp35-Cfd1.  Dre2’s stimulation of the ATPase activity of Nbp35-Cfd1 
was found to be independent of the N-terminal domain of Nbp35 and dependent on the FeS 
cluster occupancy of both Nbp35-Cfd1 and Dre2.  Future work will focus on establishing 
the interaction interface between Nbp35-Cfd1 and Dre2/Nar1 and the mechanism of how 
Dre2 and Nar1 are stimulating the ATPase activity of Nbp35-Cfd1. 
 In chapter 5, the early stages of the development of a fluorescent [Fe4S4] cluster 
sensor based on FNR was discussed.  The initial experiments were promising, as the 
fluorescence of the Cell 430 was quenched in the presence of the FeS cluster.  Moreover, 




intensity.  The rates observed for two FNR-SNAP variants were similar to rates determined 
previously via alternative methods.202, 207, 208  The next steps in the development of this 
sensor is to express the FNR-SNAP sensor in yeast and optimize in vivo fluorescent 
labeling.  Once expression and labeling have been optimized, experiments can be 
developed to monitor FeS cluster flux within the cell. 
 Overall, this thesis has described the development of a working model for FeS 
cluster assembly and transfer by the CIA scaffold.  The development of this model has led 
to increasing our understanding of the long standing question as to what the role ATP plays 





APPENDIX I – Detailed Protocols 
(Adapted from Methods in Enzymology 599, 293-325155) 
 
AI.1 Purification of the CIA Scaffold Constructs 
AI.1.1 Equipment 
- Nickel-NTA agarose resin (GoldBio) or a similar resin from other vendors 
- Streptactin resin (IBA Life Sciences) 
- Amicon Ultra-15 centrifugal concentrator (EMD Millipore) or similar device 
- PD10 desalting column (GE Healthcare) or similar gel filtration columns 
- Standard SDS-PAGE gel equipment 
 
AI.1.2 Buffers and Reagents 
- Lysis Buffer: 50 mM Tris (hydroxymethyl)-aminomethane hydrochloride (Tris–
HCl; pH 8.0), 300 mM sodium chloride (NaCl), 5 mM β-mercaptoethanol (β-
ME), 10 (v/v)% glycerol. The β-ME is added immediately before use. 
- HisWash Buffer: 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 5 mM β-ME, 10 
(v/v)% glycerol 5 mM imidazole 
- HisElution Buffer: 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 5 mM β-ME, 10 
(v/v)% glycerol, 250 mM imidazole 
- StrepWash Buffer: 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 5 mM 1,4-
dithiothreitol (DTT) 10 (v/v)% glycerol. Add DTT immediately before use from a 
1 M stock. 
- StrepElution Buffer: 50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 5 mM DTT, 10 
(v/v)% glycerol, 2.5 mM D-desthiobiotin 
- Storage Buffer: 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 5 mM DTT, 10 (v/v)% 
glycerol 
- PMSF: 100 mM Phenylmethylsulfonyl fluoride (PMSF) in ethanol 
- Pierce universal nuclease, 250U/μL (Thermo-Fisher) 
- Lysozyme from hen egg white (GoldBio)  
 
AI.1.3 Procedure for purification of the Nbp35-Cfd1 complex 
1) Prepare the buffers at room temperature then chill them to 4˚C. Add all reducing 
agents (β -ME or DTT) to buffers immediately before use.  
 
2) Remove frozen cell pellet (Section 2.2) to Erlenmeyer flask and record mass. Add 
10 mL lysis buffer per gram cell pellet. Typically, we purify from ~14-16 g cell 
paste. Stir with spatula and/or stir bar until the mixture is homogeneous and the 





3) Add imidazole (5 mM final concentration), PMSF (1 mM final concentration), 
lysozyme (1 mg/mL final concentration), nuclease (5 U/mL) and stir for 1 h on 
ice. 
 
4) Place sample in an ice water bath inside the sonicator and sonicate for 6 cycles of 
20 sec on and 40 sec off at 65% amplitude. Care should be taken to ensure that 
temperature does not increase and frothing is kept to a minimum. 
 
5) Remove a small sample for SDS-PAGE analysis and centrifuge remaining lysate 
at 48,000 xg for 45 min. While centrifuging, equilibrate Ni-NTA resin with 10 
column volumes (CV) of HisWash Buffer. Typically, we use 2 mL of resin for 
every 10-15 g of wet cell paste. 
 
6) Flow the clarified lysate over the Ni-NTA resin followed by 15 CV of HisWash 
Buffer. Samples of the clarified lysate, flow through, and wash fractions should 
be reserved for SDS-PAGE analysis.  
 
7) Elute protein with 10 CV of HisElution Buffer and pool fractions containing 
protein.  
 
8) Pass pooled His elution over 2mL Streptactin resin pre-equilibrated with 10 CV 
StrepWash Buffer. Wash with 5 CV StrepWash Buffer, followed by elution with 
StrepElution Buffer. Remove small aliquots for SDS-PAGE. Pool fractions 
containing protein. 
 
9) Concentrate pooled Strep elution fractions with an Amicon centrifugal 
concentrator to a final volume of no more than 1.5-2 mL. 
 
10) While protein is concentrating, equilibrate a PD10 desalting column with Storage 
buffer. Once concentrated, buffer exchange the protein over the PD10 and pool 
protein-containing fractions. 
 
11) Determine protein concentration by established methods (i.e., Bradford) then 
aliquot and flash freeze in liquid nitrogen before storing the protein at -80°C.  
 
12) Analyze fractions reserved in steps 5, 6, and 8 via SDS-PAGE. Expected results 






Figure AI.1. SDS-PAGE Analysis of Nbp35-Cfd1 Tandem Affinity Purification. 
Lane 1: Whole cell extract; Lane 2: Clarified lysate; Lane 3: His column flow through; 
Lanes 4-5: His column washes; Lane 6: Pooled His column elution; Lane 7: Streptactin 
column flow through; Lanes 8-9: Streptactin column washes; Lanes 10-13: Streptactin 
column elution fractions. 
 
AI.2 Chemical Reconstitution of FeS Clusters 
AI.2.1 Equipment 
- Anaerobic chamber (COY Lab Products) 
- Coolbox (BioCision) or Lab Armor beads 
- Sephadex G-25 column or equivalent desalting column within the anaerobic 
chamber 
- Microcentrifuge within the anaerobic chamber 
- Anaerobic pipet tips and microcentrifuge tubes 
 
AI.2.2 Buffers and Reagents 
- Iron (II) ammonium sulfate hexahydrate: 100 mM Fe(NH4)4(SO4)2 in anaerobic 
water 
- Sodium sulfide nonahydrate: 100 mM Na2S in anaerobic water 
- Magnesium chloride hexahydrate: 1 M MgCl2 in anaerobic water 
- Dithiothreitol (DTT): 1 M DTT in anaerobic water 






1) Anaerobic water, glycerol, and consumables are prepared at least 72 h before 
beginning the reconstitution as described previously.210  The night before 
reconstitution, bring the following solid reagents into the box: 19 mg 
Fe(NH4)4(SO4)2, 12 mg Na2S•9H2O, 77 mg DTT, and 102 mg MgCl2•6 H2O. The 
following day, add 0.5 mL anaerobic water to make the following solutions: 100 
mM Fe(NH4)4(SO4)2, 100 mM Na2S, 1 M DTT, 1 M MgCl2. 
 
2) To degas and pre-reduce the protein, bring in 1 mL aliquots of 1.0-1.5 mg/mL 
protein in a 1.5 mL tube into the box. Add DTT from the anaerobic stock to a 
final concentration of 5 mM. Slowly stir with a micro stir bar for two hours at 
room temperature with the cap open. For temperature sensitive proteins, 
degassing can be carried out on a cold block or ArmorBeads for 3-4 hours.  
 
3) Make a 1:10 dilution of the 100 mM iron and sulfide stock solutions to make a 10 
mM working stock with anaerobic water. Add in a 12-fold molar excess of iron 
over the dimeric concentration of the Nbp35-Cfd1 complex from the 10 mM 
Fe(NH4)4(SO4)2 solution. Add iron slowly in small aliquots with stirring to limit 
high localized concentrations of the stock. Incubate at room temp for 10 minutes 
with gentle stirring. 
 
4) Add a 12-fold molar excess of sulfide from the 10 mM Na2S solution in the same 
manner as described for the iron in Step 4. Move the tubes to a cold block, cap, 
and incubate with gentle stirring for two hours. During this time, the solution 
should noticeably change color to a yellow-brown to brown color. 
 
5) Centrifuge the sample at maximum speed for 10 minutes to pellet any precipitated 
protein.  
 
6) Apply the supernatant to a 20 mL G-25 desalting column equilibrated with 
anaerobic Storage Buffer without DTT. 
 
7) Collect elution fractions and concentrate protein-containing fractions with an 






Figure AI.2. Absorbance Spectrum of Chemically Reconstituted Nbp35-Cfd1 
UV-Vis spectrum of Nbp35-Cfd1 after reconstitution of its two [Fe4S4] clusters.  The 
characteristic cluster peak is observed at ~410 nm. 
 
AI.3 Quantification of FeS Cluster Insertion 
AI.3.1 Equipment 
- Stoppered quartz cuvette 
- Micro magnetic stir bars 
- UV-Vis spectrophotometer 
- Amicon Ultra-0.5mL centrifugal concentrator (EMD Millipore) or similar 
- Microcentrifuge 
 
AI.3.2 Buffers and Reagents 
- Anaerobic storage buffer 
- Hydrochloric acid: 2 M HCl 
- Ferrozine (3-(2-Pyridyl)-5,6-diphenyl-1,2,4-triazine-4′,4′′-disulfonic acid sodium 
salt): 10 mM in water, make fresh before beginning the assay 
- Sodium ascorbate: 75 mM in water, make fresh before beginning the assay 
- Saturated ammonium acetate (NH4CO2CH3) solution (~19 M) in water 
- Zinc acetate (Zn(OAc)2) dihydrate: 1% solution in water, make fresh before 
beginning assay 
- Sodium hydroxide (NaOH): 12% NaOH 
- Dimethyl-4-phenylenediamine (DMPD): 0.1% DMPD in 5 M HCl 
- Ferric chloride (FeCl3): 23 mM FeCl3 in 1.2 M HCl 
 
AI.3.3 Ferrozine Assay Procedure 
1) Remove three, 30 μL aliquots of the reconstituted protein (Section 2.4.4) from the 
Coy chamber in 1.5 mL Eppendorf tubes. Also remove a 30 μL aliquot of the 





2) Add 70 μL of 2 M HCl and incubate for five minutes on a heat block set to 95°C. 
 
3) After incubation, centrifuge at 16,000 xg for 10-15 minutes to pellet precipitated 
protein. Transfer supernatants to fresh tubes and reserve. 
 
4) Carefully resuspend the pellet in 100 μL of 2 M HCl and incubate at 95°C for 15 
minutes. Centrifuge again as in Step 3. 
 
5) Combine the supernatants from Steps 3 and 4 for a total volume of 200 μL and 
add 360 μL water. 
 
6) Add 40 μL 75 mM sodium ascorbate and 200 μL 10 mM ferrozine to each tube 
and vortex briefly to mix.  
 
7) Add 200 μL of saturated ammonium acetate (~19 M) and vortex to mix. Take care 
when pipetting as the saturated solution is very viscous. The final volume of the 
tubes should be 1 mL and purple in color.  
 
8) Record the UV-Vis spectrum of the samples from 400-700 nm. Samples 
containing iron will display a peak at 562 nm. The absorbance value of this peak, 
minus the absorbance value obtained from the buffer without any protein, can be 
used to calculate the amount of iron associated with the protein using the 
extinction coefficient (27.9 mM-1cm-1). 
 
9) To determine the ratio of iron to protein, determine the protein concentration of 
the reconstituted sample by the method of Bradford using BSA as the standard. 
The concentration of the iron in solution divided by the concentration of the 
dimeric CIA scaffold yields the number of iron atoms bound per dimer.  
 
AI.3.4 Sulfide Assay Procedure 
1) Prepare three, 200 μL aliquots of the protein from the Coy chamber in 1.5 mL 
tubes. These tubes should contain approximately 20 μM of sulfide, calculated 
from the protein concentration and the expected number of sulfur atoms bound. 
Also remove a 200 μL aliquot of the buffer. 
 
2) Add a micro stir bar and stir gently. Load a pipet with 600 μL fresh 1% Zn(OAc)2 
and another pipet with 30 μL 12% NaOH. While stirring gently, add the zinc 
acetate followed immediately by the sodium hydroxide. Cap tubes and stir gently 
at ambient temperature for 45 min. The solution will turn cloudy. 
 
3) After the incubation period, turn off the stir plate and underlay the cloudy solution 




FeCl3 just under the surface of the solution. Cap tubes and resume with stirring 
until homogeneous, more vigorous stirring may be required to fully homogenize 
the solution. Continue stirring for 15 minutes. 
 
4) Remove stir bars and centrifuge the tubes for 20 minutes at room temperature to 
pellet the precipitated protein. Remove the supernatant for analysis. 
 
5) Take a UV-Vis scan of the samples from 550-800 nm. Samples will be blue and 
spectra will display a characteristic spectrum with a valley at 710 nm and two 
peaks at 670 nm and 750 nm. The absorbance value of the sample’s 670 nm peak, 
minus the absorbance value of the buffer only control, can be used to calculate the 
amount of sulfide in the sample using the extinction coefficient (34.5 mM-1cm-1). 
As with the ferrozine assay, the concentration of sulfide divided by the 




Figure AI.3. Ferrozine and Sulfide Assays for Fe2+/S2- Quantification 
(A) Typical ferrozine assay sample trace (solid line) with a peak at A562.  Buffer only 
control is shown as a dotted line.  (B) Typical sulfide assay sample trace (solid line) with 
features at A670, A710, and A750.  Buffer only control is shown as a dotted line. 
 
 
AI.4 Discontinuous Nucleotide Hydrolysis Assay 
AI.4.1 Equipment 
- Spectrophotometer such as CaryBio-100, equipped with a multi-cell changer and 
Peltier temperature control 





AI.4.2 Buffers and Reagents  
- 1 M Tris-HCl, pH 8.0 
- ATP (disodium salt): 150 mM in 1 M Tris-HCl (pH 8.0) 
- 5x ATPase Assay Buffer: 250 mM Tris-HCl (pH 8.0), 1 M KCl, and 50 mM 
MgCl2 
- Phosphoenolpyruvate (PEP) potassium salt: 100 mM in 1x ATPase Assay Buffer 
- NADH, sodium salt: 10 mM in 100 mM Tris-HCl (pH 8.0) 
- Pyruvate kinase/lactate dehydrogenase coupled enzyme mix in 50% glycerol 
(Sigma-Aldrich) 
 
AI.4.3 Coupled Enzyme Assay Procedure 
1) Prepare dilutions of ATP in 1 M Tris-HCl (pH 8.0) varying in concentration from 
0-150 mM to make 10x working stock solutions. 
 
2) Prepare the assay master mix containing PEP, NADH, DTT, and the assay buffer. 
The final volume of each assay is 500 µL, and 380 µL of this master mix is used 
for each assay. Every 380 μL of master mix contains 10 μL 10 mM NADH, 20 μL 
100 mM PEP, 100 μL 5x ATPase buffer, 0.5 μL 1 M DTT, and 249.5 μL water. 
The amount of master mix made depends on the number of assays required. For 
example, if ten assays will be completed, then 3.8 mL of master mix will be 
needed. Generally, it is advantageous to make an excess of master mix in case a 
few points need to be repeated or to account for pipetting error. 
 
3) Set the temperature control on the UV-Vis spectrophotometer to 37°C and blank 
the instrument with 1x assay buffer. 
 
4) Add 380 μL master mix, 20 μL PK/LDH coupling enzyme mix, and 50 μL of the 
ATP solution (concentration varies) to the cuvette. Place cuvette cell holder and 
incubate for five minutes at 37°C. This incubation brings the assay mixture to 
temperature and it serves to convert any contaminating ADP back to ATP. Also 
pre-incubate an aliquot of the CIA scaffold (1 mg/mL) at 37˚C. 
 
5) Initiate reaction by the addition of CIA scaffold (50 µL). Cover cuvette with 
parafilm and carefully mix assay components by inversion. Place cuvette into 
spectrophotometer at 37°C and record the absorbance at 340 nm over time, ≤ 10 
minutes. The absorbance at 340 nm should linearly decrease as NADH is 
consumed. For each concentration of ATP, a separate cuvette should be run 
without the protein to act as a control for background change in A340nm unrelated 
to ATPase activity. 
  
6) Determine the initial rate by determining the slope of the linear portion of the plot 




observed when no CIA scaffold is added to obtain the A340. The initial rate of 







Eq. AI.1. Nucleotide Hydrolysis Initial Rate 
 
Where v0 is in the units of nmol min
-1 mg-1, ΔA340 is the background subtracted 
change in absorbance at 340 nm per minute, volume is the assay volume in mL 
(0.5 mL), l is the pathlength of the cuvette in cm (1 cm), ε is the extinction 
coefficient of NADH (6.22 mM-1cm-1), and mg is the total mass of the protein in 
the cuvette (~ 0.05 mg in a typical assay). 
  
7) Plotting of the initial rate versus ATP concentration (mM) and subsequent fitting 
to the Michaelis-Menten equation (Eq. AI.2) allows for determination of the 






Eq. AI.2. Michaelis-Menten 
 
Where vo is the initial rate (determined for each [ATP] in Step 6), Vmax is the 
maximum rate (nmol min-1 mg-1), KM is the Michaelis constant (units, mM), and 
[ATP] is the mM concentration of ATP. The turnover number, kcat, in units of 
inverse time (min-1) can be obtained from dividing the Vmax by the nmol of 
enzyme in each 0.5 mL assay (~ 1.5 nmol for assays run with ~1 mg/mL CIA 
stock solution). 
 
AI.5 Nucleotide Affinity Measured via Fluorescence Anisotropy 
AI.5.1 Equipment 
- SpectraMax5 plate reader, or equivalent, equipped for fluorescence polarization 
measurements 
- Black, 96-well, round-bottom plate 
 
AI.5.2 Buffers and Reagents 
- 4 mg/mL Bovine Serum Albumin (BSA) in Storage Buffer 
- 200 mM MgCl2 in water 





AI.5.3 Procedure for FA mantATP binding experiment 
1) Prepare 2-fold serial dilutions of the CIA scaffold in the Storage Buffer. Ideally 
the dilutions should cover concentrations ranging from 0.1-10x the expected KD. 
 
2) To each well, add 180 µL of the diluted protein, 10 µL of 200 mM MgCl2, and 5 
µL of 4 mg/mL BSA. Carefully pipet the contents up and down to thoroughly 
mix, paying special attention to avoid formation of bubbles. Any bubbles that do 
form can be removed by popping them with a small pipet tip or small gauge 
needle. 
 
3) Using a plate reader, read the background fluorescence polarization (excitation, 
355 nm; emission 448 nm for mant-labeled nucleotide) of each well to obtain the 
background fluorescence (both parallel and perpendicular modes) in the absence 
of the probe. 
 
4) Add the fluorescent probe to each well. The final concentration of the probe 
should be at least an order of magnitude below the expected KD. For our system, 
we add 5 μL of 20 μM mantATP for a final concentration of 0.5 μM in a 200 μL 
sample. Well contents should be mixed again as described in Step 2. 
  
5) After a one hour incubation at 25˚C to ensure equilibration, the fluorescence 
polarization is read again at the same excitation and emission wavelengths. 
Evaluation of mantATP hydrolysis via the discontinuous assay (Section 3.1) 
revealed no significant hydrolysis to mantADP occurs over the 1 hour incubation. 
After background subtraction, the anisotropy in each well can then be calculated 








Eq. AI.3. Fluorescence Anisotropy Equation 
 
Where r is the anisotropy, Ipara is the intensity of the emitted light in the parallel 
plane, and Iperp is the intensity of the emitted light in the perpendicular plane and r 
is the anisotropy. Background subtraction is achieved by subtracting the average 
𝐼𝑝𝑒𝑟𝑝 and 𝐼𝑝𝑎𝑟𝑎 measurements of the wells without mantATP (Step 3) from the 
measurements following addition of mantATP (Step 4). 
  
6) Plot the anisotropy (calculated via Eq. AI.3) versus the concentration of protein 
and determine the equilibrium dissociation constant, KD, using the hyperbolic 





𝑟 = (𝑟𝑚𝑎𝑥 − 𝑟𝑚𝑖𝑛) (
𝑥
𝑥+𝐾𝐷
) + 𝑟𝑚𝑖𝑛  
Eq. AI.4. Hyperbolic Binding Equation 
 
Where r is the anisotropy, rmax is the maximum anisotropy, rmin is the minimum 
anisotropy, x is the concentration of the protein, and KD is the equilibrium 
dissociation constant. Fitting to a hyperbolic binding curve is appropriate when 
the concentration of mantATP, the fixed component, is an order of magnitude 
below the KD. If instead, the fixed component is on the order of the KD the data 
should be fit with the quadratic binding equation as described for TNP-ATP 
equilibrium binding (Section 4.2.3). Additionally, the variable component (the 
protein) is titrated in over a range of concentrations that span an order of 
magnitude above and below the KD. 
 
AI.6 Equilibrium Binding Assays with TNP-ATP 
AI.6.1 Equipment 
- Horiba Jobin Yvon FluoroMax3 fluorimeter or similar 
- Stoppered fluorescence cuvette fitted with gastight septum cap  
- Gastight Hamilton syringe, capable of small (5 μL) additions 
 
AI.6.2 Buffers and reagents 
- Assay Buffer: 50 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10 mM MgCl2, 10 
(v/v)% glycerol 
- TNP-ATP (ThermoFisher): supplied by vendor as a 5-10 mM solution. 
 
AI.6.3 Procedure for TNP-ATP binding assay 
1) Place the assay solution, either the buffer alone or buffer with the CIA scaffold, 
into the fluorescence cuvette. Our TNP-ATP binding assay is carried out in a 
volume of 1.5 mL. The CIA scaffold is held constant at a concentration of 1μM 
dimer. For the holo-scaffold, the solutions of TNP-ATP and the holo-scaffold 
must be prepared within in the anaerobic chamber using anaerobic solutions as 
described in Section 2.4.3. The titrations are then carried out by injection of the 
nucleotide solution housed within a gas-tight syringe through the cuvette septum. 
 
2) Prepare dilutions of TNP-ATP in Assay Buffer. Dilutions should be designed 
such that the total volume of TNP-ATP added to the assay does not exceed 4% of 
the original assay volume (≤ 60 µL). For example, we make dilutions that range 
from 30 μM to 1600 μM TNP-ATP and add up to twelve 5 μL additions to cover 





3) For fluorimeter setup, the temperature controller should be set to 25 °C, the 
excitation wavelength set to 469 nm, and emission is monitored from 500-600 
nm. 
 
4) Place the cuvette prepared in Step 1 in the fluorimeter and allow both to 
equilibrate to 25 °C. When the instrument and cuvette have reached a steady 
temperature, blank the instrument. 
 
5) Add the first aliquot (5 µL) of TNP-ATP into the solution containing the CIA 
scaffold. For aerobic assays, cover with parafilm, and invert gently several times 
to mix. For anaerobic titrations, TNP-ATP is added through the stopper with a 
gastight syringe and mixed by inversion. Return the cuvette to the fluorimeter and 
wait 5 minutes to reach thermal equilibrium. 
  
6) Collect fluorescence spectrum of the solution. It is important to make sure binding 
equilibrium has been reached and the fluorescence intensity is not changing with 
time. In our experiments, the CIA scaffold reaches binding equilibrium within a 
few minutes of TNP-ATP addition. 
 
7) Repeat Steps 5 and 6 for all TNP-ATP aliquots. 
 
8) Repeat steps 3 through 6 with 1x Assay Buffer in place of the protein solution. 
 
9) For data analysis, the observed fluorescence must be corrected for the inner filter 
effect (Eq. AI.5). 
 
𝐹𝑐𝑜𝑟𝑟 = 𝐹𝑜𝑏𝑠 ∗ 10
(𝑂𝐷𝑒𝑥+𝑂𝐷𝑒𝑚)/2  
Eq. AI.5. Inner Filter Effect Correction 
 
Where Fcorr is the fluorescence corrected for the inner filter effect, Fobs is the 
observed fluorescence (Step 6), ODex is the absorbance of the solution at the 
excitation wavelength, and ODem is the absorbance of the solution at the emission 
wavelength. 
 
10) Once the data collected both in the presence and absence of protein has been 
processed to account for inner filter effect, difference in fluorescence intensity 
(ΔF) between the protein containing sample and the buffer control can be 
determined. This is done by subtracting the values of excitation wavelength-
maximum of the buffer-only control from its corresponding protein containing 
sample (Eq. AI.6). 
 
∆𝐹 = 𝐹𝑐𝑜𝑟𝑟,𝑃𝑟𝑜𝑡𝑒𝑖𝑛 − 𝐹𝑐𝑜𝑟𝑟,𝐵𝑢𝑓𝑓𝑒𝑟  





Where ΔF is the change in fluorescence, 𝐹𝑐𝑜𝑟𝑟,𝑃𝑟𝑜𝑡𝑒𝑖𝑛 is the inner filter effect 
corrected fluorescence of the TNP-ATP in the presence of protein, and 
𝐹𝑐𝑜𝑟𝑟,𝐵𝑢𝑓𝑓𝑒𝑟 is the inner filter effect corrected fluorescence of the TNP-ATP in the 
absence of protein (buffer only). 
 
11) Plot ΔF versus the concentration of TNP-ATP to obtain the binding isotherm. The 
equilibrium dissociation constant of the interaction, KD, can be determined by 
fitting the data to the quadratic equation (Eq. AI.7). 
 
∆𝐹 = (∆𝐹𝑚𝑎𝑥 − ∆𝐹𝑚𝑖𝑛)
(𝑅𝑇+𝑥+𝐾𝐷)−√(𝑅𝑇+𝑥+𝐾𝐷)2−4𝑥𝑅𝑇
2𝑅𝑇
+ ∆𝐹𝑚𝑖𝑛  
Eq. AI.7. Quadratic Binding Equation for TNP-ATP Binding 
 
Where ΔF is the change in fluorescence, ΔFmin is the minimum ΔF signal, ΔFmax 
is the maximum ΔF signal, x is the concentration of TNP-ATP, RT is the 







APPENDIX II – Miscellaneous Methods and Data Inventory 
AII.1 Leu1 Transfer Assays 
AII.1.1 Introduction 
A widely used method for assessing the transfer rate of [Fe4S4] clusters from a 
scaffold is the Leu1 transfer assay.  Leu1 requires a [Fe4S4] cluster to isomerize 3-
isopropylmalate (β-IPM) to dimethylcitraconate.166  The intermediate of this conversion 
can be monitored at a wavelength of 235 nm and has an extinction coefficient of 4.35 mM-
1 cm-1.  The basics of the Leu1 transfer assay involve mixing apo-Leu1 with holo-scaffold 
so that the scaffold transfers its cluster to Leu1.  Monitoring the rate of β-IPM conversion 
as a function of time can be used to determine the second order rate constant for cluster 
transfer. 
The rate of cluster transfer from the CIA scaffold to Leu1 was measured to 
determine how mutations to the scaffold’s ATPase site affected the transfer rate.  This 
assay has been used successfully to characterize the FeS cluster transfer rates from a 
bacterial homolog of the scaffold, ApbC.111, 112  The results of these experiments quantified 
cluster transfer rates on the order of 25,000-45,000 M-1 min-1.   
AII.1.2 Experimental 
 Aerobically purified Leu1 (typically 1 mL of 3.5 mg/mL) was brought into the box, 
pre-reduced with 5 mM DTT and allowed to degas for at least one hour with stirring on the 
cold block.  The transfer reaction was initiated by mixing the apo-Leu1 with holo-scaffold 
protein, typically in a 1:1 or 1:2 molar ratio (Leu1:scaffold dimer).  Over the course of 120 




box to assay for Leu1 activity.  Leu1 activity assays (490 μL) contained 10 mM β-IPM in 
Leu1 Activity Assay Buffer (LAAB: 20 mM Tris (pH 7.5) and 50 mM sodium chloride).  
The buffer and substrate were incubated at 25 °C for 5 min then the reaction was initiated 
by the addition of the Leu1/scaffold mixture (10 μL).  The change in absorbance at 235 nm 
was monitored for 10 min at 25 °C.  The slope of the initial linear portion of the resulting 
trace was used to calculate the specific activity of Leu1 at that time point.  The specific 
activity was plotted as a function of time (Figure AII.1).  Time (min) indicates the time 
after the transfer reaction start that the isolated Leu1 aliquot was diluted into the assay 
mixture. 
 
Figure AII.1. Specific Activity of Leu1 vs Time. 
(A) Holo-Nbp35 was mixed with apo-Leu1 in a ratio of either 1:1 (●) or 2:1 (○) and 
incubated at room temperature.  At the specified times, an aliquot of the reaction mixture 
was removed and assayed for Leu1 activity (μmol β-IPM min-1 mg-1 Leu1).  (B) The time 
points from 0 – 35 minutes for 1:1 (●) or 2:1 (○) holo-Nbp35:Leu1 are plotted as a function 
of how much holo-Nbp35 remains at a given time point (Eq. AII.1).  The second order rate 
constant for cluster transfer is derived from the slope of the linear regression.  
 
 
To obtain the second order rate constant of the transfer of FeS cluster from scaffold 
to Leu1, the amount of remaining holo-scaffold at time ‘x’ must be determined utilizing 




[𝐻𝑜𝑙𝑜 − 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑] = [𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑆𝑐𝑎𝑓𝑓𝑜𝑙𝑑] − (𝑆𝐴𝑥 𝑆𝐴𝑚𝑎𝑥⁄ ) ∗ [𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑆𝑐𝑎𝑓𝑓𝑜𝑙𝑑]  
Eq. AII.1. Concentration of Holo-protein Present at Time Point x 
 
In Eq. AII.1, 𝑆𝐴𝑥  is the specific activity at time point ‘x’ and 𝑆𝐴𝑚𝑎𝑥  is the maximum 
specific activity observed.  Once [Holo-scaffold] is determined for each time point, the 
reciprocal of the concentration is plotted vs time (Figure AII.1).  Typically, only the initial 
time points in Figure AII.1A where the trace is increasing result in a linear plot in Figure 
AII.1B.  In the case of these representative data those time points are between 0 – 35 
minutes.  The slope of the linear regression is equal to the second order rate constant of the 
transfer. 
AII.1.3 Results 
 Both homodimeric as well as the heterodimeric forms of Nbp35-Cfd1 complex 
were assessed for FeS cluster transfer by the Leu1 transfer assay (Table AII.1).  
Additionally, two mutant forms of Nbp35 were tested, the N-terminal truncation 
(Δ53Nbp352) and the K86A substitution. 





Total Avg. 2nd Order 
Rate Constant (M-1min-1) 
Nbp352 1 1:1 40,900 ± 4,870 39,700 ± 4,750 
Nbp352 2 2:1 38,200 ± 4,080 
Cfd12 1 1:1 9,300 ± 2,980 13,600 ± 7,430 
Cfd12 2 2:1 9,000 
Cfd12 3 3:1 27,900 
Cfd12 4 1:3 15,500 ± 7,100 
Nbp35-Cfd1 1:3 16,200 ± 4,850 16,200 ± 4,850 
Δ53Nbp352 1 1:2 59,900 30,800 ± 20,800 
Δ53Nbp352 2 1:3 16,300 ± 3,850 
K86ANbp352 1 1:1 27,100 ± 2,700 32,800 ± 6,790 






 The second order rate constants of cluster transfer observed with the scaffolding 
constructs are listed above in Table AII.1.  From this data, a few trends in the rate constants 
of the scaffold variants can be observed.  WT Nbp352, for instance, transfers cluster with 
a rate constant of 39,700 ± 4,750 M-1min-1.  This rate constant is similar to that observed 
for the homologous, bacterial FeS scaffold ApbC.  WT ApbC transferred FeS cluster with 
an average rate constant of 39,000 ± 2,000 M-1min-1.111  Cfd12 and Nbp35-Cfd1 were 
observed to transfer FeS cluster with rate constants of 13,600 ± 7,430 and 16,200 ± 4,850 
M-1min-1 respectively.  The rate constant for Nbp352 is in line with the previously 
mentioned ApbC homolog data, but the reason for the two–fold difference between Nbp352 
and Cfd12/Nbp35-Cfd1 was not known.   
Mutated or truncated scaffold proteins were also assessed for FeS cluster transfer 
rates. Interestingly, truncated Nbp352 (
Δ53Nbp352) exhibited two different rate constants, 
exhibiting one rate constant of 16,300 ± 3,850 M-1min-1 and a second rate constant of nearly 
60,000 M-1min-1.  The values are in line with the rates observed for Cfd12/Nbp35-Cfd1 and 
Nbp352 respectively.  
K86ANbp352 was the last construct to be tested.  In ApbC, mutation 
of the homologous lysine residue, K121, led to an approximate 2-fold decrease in the 2nd 
order rate constant.111  Here, a slight decrease in the overall transfer rate for K86ANbp352 
was observed. 
Other FeS cluster trafficking systems have been assessed for cluster transfer 
rates.211-213  Nfu is an FeS cluster carrier that has an isoform that localizes to the cytosol.  




it could actively transfer this cluster to apo Fdx1 or apo Fdx2 with rate constants of 4,695 
± 832 M-1min-1 and 3,849 ± 1,242 M-1min-1 respectively.211  Nfu could accept glutathione 
ligated clusters ([Fe2S2](GS)4) at a rate of 1,930 ± 212 M
-1min-1 (Table AII.2).  In 
subsequent work, the FeS cluster transfer rate from holo-Nfu to apo-Grx3 was determined 
to be 36,200 ± 7,700 M-1min-1.211-213 
Table AII.2. FeS Cluster Transfer Rates 
Donor Recipient Method Rate (M-1min-1) Reference 
Nbp35-Cfd1 Leu1 Leu1 Activity 16,200 ± 4,850 This Work 
ApbC Leu1 Leu1 Activity 39,000 ± 2,000 111 
Nfu Fdx1 CD 4,695 ± 832 211 
Nfu Fdx2 CD 3,849 ± 1,242 211 
Glutathione Nfu CD 1,930 ± 212 211 
Nfu Grx3 CD 36,200 ± 7,700 213 
IscU Fdx CD/EPR ~300* 79 
*Rate constant in the presence of HscA/HscB/MgATP.  Rate constant is ~30 M-1min-1 in 
the absence of these three components.79 
 
 
An exciting future for this project would involve the inclusion of nucleotides and, 
potentially, the identified partner proteins.  The chaperones HscA and HscB were shown 
to stimulate the transfer of a [Fe2S2] cluster from IscU to apo-Fdx in an ATP dependent 
manner.79, 185, 186  The rate constant for cluster transfer from holo-IscU to apo-Fdx increased 
by ~10-fold in the presence of HscA, HscB, and excess MgATP (Table AII.2).79  In a 
similar fashion, the CIA scaffold could be tested to observe its FeS cluster transfer rates in 
the presence of nucleotide and, for example, Dre2 and Nar1.  The results of these 
experiments would provide valuable insight into the mechanism of FeS assembly and 




AII.2 Leu1 Activity in Yeast Crude Extract 
AII.2.1 Introduction 
 The Leu1 activity assays described in Section 3.2.1 required optimization for the 
yeast cell lysis procedure.  Following the protocol outlined by Pierik et al. resulted in low 
protein concentration in the extract.165  Therefore, a modified protocol was developed and 
implemented to increase protein yield in the extract.  Key changes to the protocol of Pierik 
et al. included changing the TNETG buffer to contain 25 mM Tris (pH 7.4) to increase 
buffering capacity, a decrease of Triton X-100 in the TNETG buffer to 0.1%, and 
optimization of lysate volume to glass bead ratio for the best recovery of protein 
(accounting for both the total mg recovered and volume of the lysate).  Additionally, EDTA 
was removed from the lysis buffer (resulting in buffer TNETG(-)) and leucine was removed 
from the SD growth media which was also supplemented with iron. 
AII.2.2 Cell Lysing Optimization 
 A single colony of yeast harboring NBP35 in the Nbp35-tsm strain was inoculated 
into 10 mL of SD media (-)His(-)Trp in the presence of 2.5 mM methionine.  The cells 
were grown overnight for 20 h at 30 °C.  The cells were collected, washed three times with 
water, and seeded into 500 mL of SD (-)His(-)Trp(-)Met (+)G418 to an OD600 of 0.05.  The 
cells were grown overnight at 30 °C, until reading an OD600 of ~3.  The culture was split 
into nine 50 mL conical vials, spun down, and the cell pellet weighed.  Tubes containing 
the cell pellets were flash frozen in liquid nitrogen and stored at -80 °C. 
 A lysing matrix was created (Table AII.3) to assess the best ratio of lysate volume 




of the nine tubes described above.  Lysing and recovery followed the referenced 
procedure165 with the following changes: lysing took place in 2 mL Eppendorf tubes and 
vortexing occurred for one minute cap side down, followed by 2 min on ice for six total 
cycles of 1 min on/2 min off.  The recovered soluble extracts were assayed immediately 
for both Leu1 activity and protein concentration.  These results are summed up in Table 
AII.3 and Figure AII.2.  For future assays, it was decided to use the conditions found in 
Tube #1 as it gave good yield, good protein concentration, adequate activity, and a good 
volume of lysate from which to draw from. 
Table AII.3. Optimization of Yeast Cell Lysis 
Tube # 1 2 3 
Bead Vol. (μL) 250 250 250 
Suspension Vol. (μL) 250 500 1000 
Cell Pellet Mass (g) 0.30 0.30 0.31 
Lysate Vol. (μL) 240 430 920 
Prot. Conc. (mg/mL) 17.9 9.4 3.2 
Total Protein (mg) 4.3 4.0 3.0 
Yield (mg/g) 14.3 13.3 9.7 
Tube # 4 5 6 
Bead Vol. (μL) 500 500 500 
Suspension Vol. (μL) 250 500 1000 
Cell Pellet Mass (g) 0.31 0.31 0.31 
Lysate Vol. (μL) 180 410 830 
Prot. Conc. (mg/mL) 17.0 9.3 1.6 
Total Protein (mg) 3.1 3.8 1.3 
Yield (mg/g) 10.0 12.2 4.2 
Tube # 7 8 9 
Bead Vol. (μL) 1000 1000 1000 
Suspension Vol. (μL) 250 500 1000 
Cell Pellet Mass (g) 0.30 0.31 0.31 
Lysate Vol. (μL) 70 250 740 
Prot. Conc. (mg/mL) 3.5 3.2 0.4 
Total Protein (mg) 0.24 0.81 0.27 






Figure AII.2. Lysing Optimization for Leu1 Activity 
Specific activity (nmol β-IPM min-1 nmol-1 protein) of Leu1 in the cell extract samples 1-
9 (Table AII.2).  The activity of each tube’s extract was assayed once. 
 
 
AII.2.3 Leu1 Activity Optimization 
 Initial efforts to assay Leu1 activity in crude extracts was hampered by the small 
window of the assay.  The overall rates of isomerase activity were relatively low, centering 
around 15-20 nmol IPM min-1 mg-1.  Several changes were made to the protocol in an 
attempt to increase Leu1 activity.  First, EDTA was removed from the lysis buffer to 
prevent degradation of the FeS clusters due to iron chelation.  Second, cell culture 
conditions were changed to include supplemental iron to ensure FeS cluster production was 
not limited by a lack of iron.  Third, the concentration of leucine in the growth media was 
decreased to cause upregulation of Leu1.   
 Resuspended yeast cells were seeded into 50 mL of SD-His-Trp-Met-Leu media 
supplemented as described in Table AII.4 and grown overnight for 20 h at 30 °C.  Cells 
were collected by centrifugation, masses recorded, and flash frozen in liquid nitrogen for 




from the above sections, namely no EDTA in the lysis buffer and using the conditions for 
Tube #1 from section AII.2.2.  The isomerase activity of the lysates were assayed in 
duplicate and these data are presented in Figure AII.3. 
Table AII.4. Growth Conditions for Supplementation/Depletion and Pellet Masses 
Flask # 100 μM Fe2+ 60 mg/L Leu EV Mass (g) WT Mass (g) 
1 + + 0.15 0.13 
2 + - 0.12 0.10 
3 - + 0.13 0.14 
4 - - 0.11 0.11 
 
 
Figure AII.3. Leu1 Activity for Iron and Leucine Supplementation/Depletion 
Leu1 activity (nmol IPM min-1 mg-1 protein extract) of growth optimizations outlined 
above.  Supplementation number corresponds to the Flask number in Table AII.4 (see 
above).  The highest specific activities of Leu1 were observed in flasks that were not 
supplemented with 60 mg/L leucine (flasks 2 and 4). 
 
 
 Removal of leucine from the growth media had the largest effect on the Leu1 
activity of the cell extract.  Iron supplementation did not have any significant effect.  
Additionally, the window of observed activity for WT ranges from zero to approximately 




AII.3 Nonspecific Binding Correction – Method of Rossi and Taylor 
AII.3.1 Introduction 
 When the KD for a scaffold interaction with mantATP/mantADP was above 50 μM, 
the anisotropy data was corrected for nonspecific binding.  Non-specific binding can 
contribute to a binding curve, making it appear that there is binding when in fact there is 
not.  The method employed was developed by Rossi and Taylor.158 
AII.3.2 Experimental Set-up 
 In order to make this determination, a number of specific sample well sets were 
prepared to determine the anisotropy values for calculating the degree of non-specific 
binding.  These sets were Set 1; protein bound to labeled ligand (mantATP), Set 2; protein 
bound to labeled ligand in the presence of a saturating amount of competing ligand (ATP), 
Set 3; protein bound to labeled ligand in the absence of Mg2+ and presence of EDTA (to 
chelate any residual Mg2+ required for mantATP binding), and Set 4; protein only.  Assay 
wells were prepared according to Table AII.5.  
Table AII.5. Assay Setup for Non-Specific Binding Determination 
Component [Stock] Set 1 Set 2 Set 3 Set 4 [Final] in 
Assay 
Nbp35 Dil.* 170 μL 170 μL 170 μL 170 μL Varies 
mantATP (20 μM) 5 μL 5 μL 5 μL - 0.5 µM 
BSA (4 mg/mL) 5 μL 5 μL 5 μL 5 μL 0.1 mg/mL 
EDTA (500 mM) - - 10 μL - 25 mM 
MgCl2 (200 mM) 10 μL 10 μL - 10 μL 10 mM 
ATP (422 mM) - 10 μL - - 21.1 mM 
TBS-AB 10 μL - 10 μL 15 μL - 






Figure AII.4. Nbp35/mantATP Non-specific Binding 
Equilibrium binding of Nbp352 (0 – 200 μM dimer) to mantATP in a 200 μL reaction in 
the presence or absence various reagents (see legend).  MantATP was supplied at 0.5 μM 
final, ATP was supplied at 42.2 mM final, and EDTA was supplied at 25 mM final.  The 
data represents the average ± the standard deviation of three reads and is fit to a hyperbolic 
binding model (See Eq. 2.1). 
 
 
AII.3.3 Data Analysis 
 First, it must be assumed that the nonspecific binding of ligand increases linearly 
with the increasing concentration of ligand.  Secondly, it is assumed that the anisotropy 
signal given by specifically bound ligand is the same as nonspecifically bound.158  The first 
calculation is to determine the fraction of labeled ligand, D*, bound to receptor utilizing 
Eq. AII.2.  Terms for equations Eq. AII.2-5 are contained within Table AII.6.  
𝐹𝐵 =  (𝐴𝑀 − 𝐴𝐷∗) (𝐴𝐷∗𝑅 − 𝐴𝐷∗)⁄  
Eq. AII.2. Determination of Fraction D* Bound 
 
The value of fraction bound, 𝐹𝐵, calculated above is a value between 0 and 1, where 1 is 
equivalent to 100% of the available D* bound to the receptor.  This value is derived from 
the total anisotropy signal given by both specific and nonspecific binding of the ligand.  
Nonspecific anisotropy is calculated from the binding data obtained in the presence of a 




𝐴𝑁𝑆 = (𝐴𝐼 − 𝐴𝐷∗)(1 − 𝐹𝐵) 
Eq. AII.3. Determination of Nonspecific Anisotropy 
 
From this point, it is a simple difference calculation to solve the anisotropy value of 
specifically bound labeled ligand as shown in Eq. AII.4. 
𝐴𝑆 = 𝐴𝑀 − 𝐴𝑁𝑆  
Eq. AII.4. Determination of Specific Anisotropy 
 
Finally, the fraction of D* specifically bound to the receptor can be determined utilizing 
Eq. AII.5.   
[𝐷∗𝑅] 𝐷𝑇
∗⁄ = (𝐴𝑆 − 𝐴𝐷∗) (𝐴𝐷∗𝑅 − 𝐴𝐷∗)⁄  
Eq. AII.5. Fraction of D* Specifically Bound 
 
This fraction, much like 𝐹𝐵 , is a value between 0 and 1.  Comparing the difference in 
[𝐷∗𝑅] 𝐷𝑇
∗⁄  derived from Eq., AII.5 and 𝐹𝐵 obtained in Eq. AII.2 yields the fraction of 
anisotropy signal arising from nonspecific binding.  In the case of our example of Nbp352 
binding to mantATP, this value only reached ~4.5%. 
 A full description of the calculations, experimental conditions, and assumptions can 
be found in the published method of Rossi and Taylor.158 
Table AII.6. Terms for Calculating the Contribution of Non-specific Ligand Binding 
Term Definition 
AD*R Anisotropy of bound ligand (mantATP) – max anisotropy of bound ligand 
AD* Anisotropy of free ligand when receptor (Nbp35) concentration is 0 
ANS Anisotropy of non-specific binding 
AI Anisotropy in the presence of saturating amount of competing ligand (ATP) 
AS Anisotropy of specific ligand binding 
[D*R] Concentration of specifically bound ligand 
D*T Total concentration of ligand 
AM Measured anisotropy 
D* Labeled ligand (mantATP) 
I Unlabeled competitive ligand (ATP) 




AII.4 Other Data and Inventory 
 The following pages include an inventory of all primers and plasmids created by 























AII.4.1 Primer Tables 
 















AII.4.3 Deviant Walker A Structures and PDB Codes Compilation
 























LIST OF BUFFERS AND THEIR COMPOSITION 
5x LAAB: Leu1 Activity Assay Buffer, 5x Concentrated – (100 mM Tris (pH 7.5) and 
250 mM sodium chloride) 
CD-B: Circular Dichroism Buffer – (10 mM potassium phosphate (pH 8.0), 100 
mM sodium chloride, and 1 mM TCEP)  
TBS-AB: Tris-Buffered Saline, Anisotropy Buffer – (50 mM Tris (pH 8), 100 mM 
sodium chloride, 10% glycerol, and 5 mM DTT) 
TBS-Box: Tris-Buffered Saline, for Anaerobic Box – (50 mM Tris (pH 8), 100 mM 
sodium chloride, and 4% glycerol) 
TBS-HS: Tris-Buffered Saline, High Salt – (50 mM Tris (pH 8), 300 mM sodium 
chloride, and 10% glycerol) 
TBS-LS: Tris-Buffered Saline, Low Salt – (50 mM Tris (pH 8), 100 mM sodium 
chloride, and 10% glycerol) 
TBS-LS-XL: Tris-Buffered Saline, Low Salt, Crosslinking – (50 mM Tris (pH 7), 100 
mM NaCl, 10% glycerol, and 5 mM TCEP) 
TBS-TNP: Tris-Buffered Saline for TNP Assays – (50 mM Tris (pH 8), 100 mM 
sodium chloride, 1 mM magnesium chloride, and 10% glycerol) 
TNETG: Yeast lysis buffer, Modified – (25 mM Tris (pH 7.4), 2.5 mM EDTA, 150 
mM sodium chloride, 10% glycerol, and 0.1% Triton X-100) 
TNETG(-): Yeast lysis buffer, Modified – (25 mM Tris (pH 7.4), 150 mM sodium 
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